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Abbreviations 
 
Ac acetyl His histidine 
ACBC aminocyclobutylcarboxylic acid HMBC heteronuclear multiple-bond  
ACC aminocyclopropylcarboxylic acid  correlation 
ACHC aminocyclohexylcarboxylic acid HMDS hexamethyldisilazane 
ACPC aminocyclopentylcarboxylic acid HMPA hexamethylphosphoramide 
Ala alanine HOBt hydroxybenzotriazole 
Ant anthranilic acid HP high pressure 
APAT ambient pressure / ambient  HPLC high performance liquid  
 temperature  chromatography 
APCI atmospheric pressure chemical  HRMS high-resolution mass spectrometry 
 ionization HSQC heteronuclear single-quantum  
aq aqueous  correlation 
Asp asparagine HT high temperature 
Bn benzyl i- iso- 
Boc tert-butyloxycarbonyl IR infrared 
Cbz carboxybenzyl JH Jørgensen-Hayashi 
CMDMCS chloromethyldimethylsilyl chloride Leu leucine 
COMU (1-cyano-2-ethoxy-2-oxoethyliden-  m.p. melting point 
 aminooxy)dimethylamino- Me methyl 
 morpholino-carbenium min minute(s) 
 hexafluorophosphate MS mass spectrometry 
Cys cysteine n- normal- 
conc. concentrated n/a not applicable 
d day(s) n.d. not determined 
DABCO 1,4-diazabicyclo[2.2.2]octane NMA N-methylacetamide 
DCM dichloromethane NMM N-Methylmorpholine 
DCP dicumyl peroxide NMR nuclear magnetic resonance 
DIPEA N,N-diisopropylethylamine NOESY nuclear Overhauser effect  
DMAP 4-dimethylaminopyridine  spectroscopy 
DMSO dimethylsulfoxide Ph phenyl 
DPPA diphenyl phosphoryl azide Phe phenylalanine 
dr diastereomeric ratio PLE pig liver esterase 
EDC 1-ethyl-3-(3-dimethylaminopropyl)-  ppm parts per million 
 carbodiimide Pr propyl 
ee enantiomeric excess Pro proline 
EI electron ionization PTFE polytetrafluoroethylene  
EIC extracted-ion chromatogram R arbitrary residue 
Eq. equation Rf retardiation factor 
equiv. equivalent(s) ref. reference 
ESI electrospray ionization rt room temperature 
FEP fluorinated ethylene propylene RT Raumtemperatur 
FT Fourier transform sat. saturated 
Glu glutamic acid Ser serine 
h hour(s) T3P n-propylphosphonic anhydride 
HATU 1-[Bis(dimethylamino)methylene]-1H- TBAB tetrabutylammonium bromide 
 1,2,3-triazolo[4,5-b]pyridinium 3-oxid tert tertiary 
 hexafluorophosphate Tf triflyl 
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TFA trifluoroacetic acid   
THF tetrahydrofuran   
TLC thin layer chromatography   
TMAO trimethylammonium N-oxide   
tmm trimethylene methane   
TMS trimethylsilyl   
TPS triisopropylbenzenesulfonyl   
triphos 1,1,1-tris(diphenylphosphinomethyl)-   
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wt% weight percent   
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A. Introduction 
 
In 2011, Paul Snelgrove, oceanographer and one of the leading members of the international “Census 
of Marine Life” research program, stated that man’s knowledge about the deep sea floor is smaller 
than the knowledge of the surfaces of the Moon and Mars.[1]* 
This is rather astonishing, as the oceans cover more than 70% of the entire planet’s surface and 
encompass more than 90% of the biosphere’s volume that supports life. While the photic zone 
between 0 – 200 m depth (the “light” zone) has been investigated to a larger extent, the aphotic zone 
of the oceans at depths greater than 200 m (the “dark” zone) remains almost unexplored.[2]  
Organisms living in those depths are subjected to rather extreme conditions: not only are they in total 
darkness with water temperatures not far from the freezing point, they also have to be able to 
withstand the tremendous forces of the increasing hydrostatic pressure at lower sea levels. As the 
pressure increases by 1 bar for roughly every 10 m in depth, this means that creatures living 1000 m 
below the surface of the ocean are already experiencing pressures a hundred times stronger than on 
land.[3] In the deepest reaches of the sea, pressures exceeding 1000 bar can be reached.[4] 
The harsh living conditions and high pressures often lead to bizarre appearances of the animals living 
in great depths, e.g. the Fangtooth fish with its disproportionally large teeth, the bioluminescent 
Vampire squid or the enormous Giant Spider crab. However, not only do high pressures lead to altered 
body structures but they also greatly influence the structure and efficacy of biomolecules and their 
associated biological and chemical processes. For instance, the activity of an enzyme can be 
significantly de- or increased under elevated pressures.[3–5] 
While effects like these can prove dramatic for an organism, requiring it to adapt in order to survive, 
they are highly interesting from a chemist’s point of view. It means that high pressure can act as a tool 
which can affect chemical and structural equilibria. Therefore, studying how high-pressure conditions 
influence the outcome of chemical reactions, as well as understanding its effect on the three-
dimensional structure of molecules, might aid scientists in the development of more active catalytic 
systems or even the discovery of new transformations which are not feasible under other conditions. 
  
                                                          
* "We know more about the surface of the Moon and about Mars than we do about [the deep sea floor], despite 
the fact that we have yet to extract a gram of food, a breath of oxygen or a drop of water from those bodies."[1] 
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1. The high-pressure activation principle – the volume of activation 
 
Already in the 19th century, Henry Le Chatelier discovered that a chemical equilibrium can be 
influenced by changing the reaction conditions.[6] Applying pressure to a chemical system leads to a 
reduction in volume, bringing it into a compressed state. This results in an increased concentration of 
the molecules, affecting intermolecular diffusion as well as the rate of molecular collisions (Figure 1).[7] 
It, therefore, becomes apparent that pressure must also have an impact on the equilibrium of chemical 
transformations.  
 
Figure 1: Graphical representation of the effect of compression on a chemical system. 
The key thermodynamic parameter that determines how and to which extent a chemical reaction can 
be influenced by pressure is the volume of activation ∆𝑉‡. Knowing the value of ∆𝑉‡ for a 
transformation allows the prediction of the pathway and the outcome of the reaction. To evaluate 
how ∆𝑉‡ relates to pressure, a brief explanation of the underlying thermodynamic correlations is given 
in this chapter.[7–27] 
 
Scheme 1: A standard bimolecular addition reaction proceeding through a transition state. Reproduced from ref. [28] with 
permission. 
Considering a bimolecular addition reaction where A and B react with each other to AB through the 
formation of a transition state[29] [AB]‡ (Scheme 1), the volume of activation is defined as: 
 ∆𝑉‡ = 𝑉[𝐴𝐵]
‡ − (𝑉𝐴 + 𝑉𝐵) (Eq. 1) 
with 𝑉[𝐴𝐵]
‡ , 𝑉𝐴 and 𝑉𝐵 being the partial molar volumes of the transition state [AB]
‡ and the starting 
materials A and B. This chemical reaction is inherently accompanied by a change of the Gibbs free 
energy ∆𝐺, which is expressed in the Gibbs fundamental thermodynamic relation as: 
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 ∆𝐺 = ∆𝑈 − 𝑇∆𝑆 + 𝑝∆𝑉 (Eq. 2) 
with ∆𝑈 being the change of the inner energy and ∆𝑆 the change of the entropy. From eq. 2 it can be 
seen that ∆𝐺 has a pressure dependent term 𝑝∆𝑉 which gains in influence with higher pressures and, 
therefore, larger degrees of compression. At the same time, changes to the chemical equilibrium of 
the reaction can be described by the van’t Hoff equation: 
 ∆𝐺 = −𝑅𝑇 ⋅ ln 𝐾 (Eq. 3) 
with 𝐾 representing the equilibrium constant. 
From Eq. 2 and 3, the following connection can be derived for the change of volume ∆𝑉: 
 
∆𝑉 = (
𝜕∆𝐺
𝜕𝑝
)
𝑇
= −𝑅𝑇 ⋅ (
𝜕 ln 𝐾𝑝
𝜕𝑝
)
𝑇
 (Eq. 4) 
with 𝐾𝑝 beeing the pressure-dependent equilibrium constant of the reaction. Based on transition state 
theory, Evans and Polyani deduced a similar correlation for the pressure-dependent rate constant 𝑘𝑝 
and the volume of activation ∆𝑉‡: 
 
∆𝑉‡ = (
𝜕∆𝐺‡
𝜕𝑝
)
𝑇
= −𝑅𝑇 ⋅ (
𝜕 ln 𝑘𝑝
𝜕𝑝
)
𝑇
 (Eq. 5) 
where ∆𝐺‡ represents the Gibbs energy of activation.[30] 
From Eq. 5 it becomes apparent that a negative volume of activation will lead to an increase in the rate 
constant. This infers that a chemical reaction is accelerated by pressure when ∆𝑉‡ < 0 (i.e. the 
transition state is smaller in size than the reactants combined), which is the case for all addition 
reactions. At the same time, pressure inhibits reactions when ∆𝑉‡ > 0, e.g. dissociations. However, 
this is only fully valid for homolytic dissociation reactions, as heterolytic reactions are often 
accompanied with a negative ∆𝑉‡. 
The explanation for this conundrum is that the volume of activation is composed of different 
contributing factors:  
 ∆𝑉‡ = ∆𝑉𝑠𝑡𝑟𝑢𝑐𝑡
‡ +  ∆𝑉𝑠𝑜𝑙𝑣
‡ + ∆𝑉𝑠𝑡𝑒𝑟𝑖𝑐
‡  (Eq. 6) 
While ∆𝑉𝑠𝑡𝑟𝑢𝑐𝑡
‡  represents the intrinsic volume changes of the reactants during the formation of the 
transition state, ∆𝑉𝑠𝑜𝑙𝑣
‡  describes the changes in volume as a result of electrostatic solvent-solute 
interactions.[7–9,11–16,18–28] This relates to the observed contraction of volume of charged species in a 
dielectric medium (the solvent) which is called electrostriction and can be described by the Drude-
Nernst equation: 
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∆𝑉𝑒 = −
𝑞2
2𝑟𝜀𝑟
2 ⋅ (
𝜕𝜀𝑟
𝜕𝑝
) (Eq. 7) 
with 𝑞 being the charge, 𝑟 the ionic radius and 𝜀𝑟 the relative static permittivity of the solvent.
[31] 
Electrostriction results from the reordering of charged species (ions, zwitterions or polarized species) 
and the surrounding solvent molecules which leads to a sharp decrease in volume. This contribution 
to the volume of activation can be very high (up to -100 cm3) especially in apolar (uncharged) media,[28] 
and explains why heterolytic dissociation reactions can be accelerated by pressure (Scheme 2). 
 
Scheme 2: Graphical representation of electrostriction: Reordering of the dipolar compound AB and the solvent molecules S 
results in a sharp volume contraction which can lead to complete dissociation of AB under pressure. Adapted from ref. [28] 
with permission. 
Besides ∆𝑉𝑠𝑡𝑟𝑢𝑐𝑡
‡  and ∆𝑉𝑠𝑜𝑙𝑣
‡ , Jenner et al. defined a third contributing factor ∆𝑉𝑠𝑡𝑒𝑟𝑖𝑐
‡ , which relates to 
the steric congestion of the transition state. As pressure forces molecules into close spatial proximity 
it has a beneficial effect on reactions with sterically hindered substrates, overcoming steric 
repulsion.[16,18,19,32] 
In general, the following conclusions can be drawn for the volume of activation and how it affects the 
pressure response of a chemical reaction:  
(1) If ∆𝑉‡ < 0: the reaction is accelerated by pressure. 
(2) If ∆𝑉‡ > 0: the reaction is hindered by pressure. 
(3) The formation of charged species is positively affected by pressure due to electrostriction.[7] 
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2. Methods to generate high pressures and applications in science and industry 
 
Several methods have been developed to generate and sustain high hydrostatic pressures for scientific 
and industrial applications (Figure 2). In the following, a small overview of the different devices will be 
given as well as examples for the use of pressure in scientific and industrial applications. 
 
Figure 2: Pressure ranges achievable by man and selected examples from nature and industrial applications for 
comparison.[25,27,33] DAC = diamond anvil cell. 
Lower pressures up to 1 kbar are omnipresent in everyday life: from the air pressure in tires of cars 
and bicycles to the water pressure generated by water jet cleaners, these pressures can be generated 
fairly easy by using high-pressure pumps. Industrial applications in this pressure range are quite 
common and often involves gases.[34] One of the most important chemical processes of all times, the 
Haber-Bosch process, is carried out under pressures up to 300 bar.[35,36] It is used to fix nitrogen from 
the atmosphere into ammonia, which is then utilized for the synthesis of fertilizers on a scale of several 
million tons per year.[36] Furthermore, pressure techniques are employed e.g. in the vulcanization of 
rubbers or in the dyestuff synthesis.[24] For scientific applications, experiments involving pressurized 
gases are usually carried out in gas-tight autoclave vessels, which are very scalable in terms of size. In 
medicine, autoclaves are used for the sterilization of medical equipment while in chemistry, these 
types of vessels are commonly used for e.g. hydrogenation reactions or polymerizations.[37] 
However, a multitude of chemical reactions, especially in organic chemistry, take place in solution. As 
these reactions often require pressures exceeding 1 kbar to be significantly influenced, the use of 
simple autoclave vessels becomes rather limited. This resulted in the invention of the hydraulic piston-
cylinder apparatus (Figure 3).  
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Figure 3: Depiction of the high-pressure apparatus used for high-pressure reactions in the course of making this thesis, 
capable of generating pressures up to 5 kbar. Left: schematic representation of the operation mode of the apparatus. The 
piston is held into position from the top by a manual screw and the medium-filled vessel is then pressed against the piston 
from below. Right: A) Picture of the high-pressure apparatus. B) Picture of the reaction vessels used: molten PTFE tubes and 
reusable PTFE/FEP vials of different sizes (2 € coin for size comparison). 
Devices of this type typically consist of a hydraulic pump, a pressure vessel (often cylindrical) and a 
moving piston. The sample is encapsulated air-free into a container (usually made from inert PTFE) and 
put into the pressure vessel, which is then filled with a pressure medium (e.g. oils, hydrocarbons or 
water/glycol mixtures). The piston is then inserted into the vessel and the medium (which ensures that 
the built-up pressure is uniformly transferred to the sample) is compressed with force through a 
manual or automatic pump. While pressures between 5 – 10 kbar can be reached with this setup, using 
it in combination with a hydraulic pressure intensifier can extend the operational limit up to 
40 kbar.[25,34,38] In applications on a laboratory scale, sample volumes are usually in the range of several 
milliliters, however, devices capable of compressing more than 1000 L have been developed.[34,39] 
Scientific application of high hydrostatic pressures between 1 – 20 kbar has been growing over the last 
decades. Besides its usefulness to enable and accelerate a multitude of chemical transformations, 
utilization of high pressure in combination with spectroscopic methodologies (e.g. IR, UV-VIS, NMR) 
has seen an increasing interest due to the improved availability of suitable equipment.[9,10,23,40,41] These 
techniques, for instance, allow the study of the conformational behavior of biomolecules found in deep 
sea fish or the kinetics of aggregation and unfolding of proteins.[42] Industrial applications also exist in 
this pressure range: in the food industry high-pressure processing (“Pascalization”) is utilized to 
preserve and sterilize foodstuffs. The process uses pressures up to 6 kbar and has established itself as 
a viable alternative to thermal pasteurization.[33,43] 
Pressures exceeding 50 kbar require the use of multi-anvil devices. Their typical mode of action is that 
a small sample (< 1 mL) is placed in between two opposing anvils and sealed by a gasket. Through 
pressing the anvils against each other, extremely high pressures can be generated. Early pioneering 
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work was carried out by Percy W. Bridgman in the early 20th century, reaching pressures up to 100 kbar 
by using tungsten carbide anvils.[26,38,44] For his contribution to the field of high-pressure science, he 
was awarded the Nobel Prize in Physics in 1946. The Bridgman anvil apparatus was improved with the 
invention of the diamond anvil cell (DAC) in 1958.[44,45] Using two diamonds as anvils allows the 
generation of pressures up to 7.5 Mbar, which is more than twice the pressure found at the earth’s 
core[46] and enough to compress even the densest metal, osmium.[47] The use of diamond also enables 
the combined use with optical spectroscopy and X-ray analysis, enabling measurements at extreme 
pressures.[44] Important findings in this pressure range have been, for instance, new modifications of 
ice,[48] polymeric nitrogen,[49] high-temperature superconductivity of sulfur hydride at 203 K[50] and the 
(still debated) metallic hydrogen.[51] Industrial applications using pressures greater than 50 kbar are 
scarce, as the sample sizes in the devices used to generate such pressures are limited. One notable 
example, however, is the artificial synthesis of diamond, which has seen increased interest over the 
last decades.[52] 
 
3. High pressure in organic chemistry 
 
Due to the unique activation principle, high-pressure techniques (> 1 kbar) have also found 
applications in organic chemistry. Studies on the effect of high hydrostatic pressures on organic 
reactions can be dated back as far as the early 20th century.[53,54] These early investigations often 
involved polymerization and cycloaddition reactions, for instance, Bridgman et al. who showed that 
the polymerization of isoprene is greatly accelerated under pressure.[53] As interest in high-pressure 
research increased, so did the understanding of its effects on thermodynamic parameters improve. 
Especially the significance of the volume of activation ∆𝑉‡ as an indicator for how compression will 
affect a reaction was recognized. This sparked the investigation of a multitude of different organic 
transformations under high pressure conditions between the 1970s and 1990s, which allowed the 
determination of average ∆𝑉‡ values (Table 1).* 
  
                                                          
* Several compendia have been published listing volumes of activation for a plethora of organic and inorganic 
transformations.[8,12,24,27] 
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Table 1: Average values ∆𝑉‡ for selected transformations. 
Reaction type 
Average volume of activation ∆𝑉‡ 
[cm3·mol-1] 
Reference(s) 
Radical decompositions -00 to +15 [7] 
Radical polymerizations -10 to -25 [7] 
Rearrangement reactions (Cope, Claisen) 0-8 to -15 [7] 
Diels-Alder reactions -25 to -50 [7,28] 
Michael-type reactions -20 to -50 [12,55,56] 
(Nitro-)Aldol reactions -20 to -25 [55,56] 
Baylis-Hillman reactions -60 to -80 [57] 
Wittig reactions -20 to -30 [58] 
Heck reactions -10 to -30 [28,59] 
In the following, a few examples are given for how pressure can affect the activity as well as selectivity 
of different organic reactions.  
The Diels-Alder reaction is one of the prime examples for the use of high pressures as activation mode 
to accelerate chemical reactions. The Diels-Alder reaction between dienamines and electron-deficient 
alkenes is rather sluggish under conventional heating conditions and results in a mixture of several 
different products.[60] In 1974, Dauben et al. demonstrated that high-pressure conditions did not only 
gave severely improved yields but also led to the exclusive formation of Diels-Alder adducts of the type 
3A (Scheme 3).[61] 
 
Scheme 3: Example from Dauben et al. for the pressure-mediated Diels-Alder reaction of dienamine 1 with acrylonitrile (2). 
Pressure greatly increases reactivity and improves regioselectivity. Reaction conditions: Heat = dioxane, reflux, 1 bar, 7 h; 
pressure = diethyl ether, 8.4 kbar, rt, 13 h.[60,61] 
An example of a practical application of a high-pressure Diels-Alder reaction was published six years 
later by the same group. The biologically active compound cantharidin (7) was conveniently 
synthesized through a cycloaddition of furan (4) with the bicyclic maleic anhydride derivative 5, 
followed by a desulfurization-hydrogenation step of cycloadduct 6b with Raney-Ni (Scheme 4). While 
the cycloaddition was not feasible under high-temperature conditions, the use of high pressures 
Introduction 
 
13 
 
resulted in quantitative formation of the cycloadducts, predominantly generating the desired isomer 
6b.[62] A scale-up of this process even enabled the synthesis of cantharidin (7) on a multi-gram scale.[63]* 
 
Scheme 4: Total synthesis of cantharidin published by Dauben et al. in 1980 using the pressure-induced Diels-Alder reaction 
between furan (4) and maleic anhydride derivative 5 as the key step.[62,63] 
However, the scope of transformations that can be influenced by pressure is not limited to 
cycloadditions. In 1997, Bellassoued et al. studied the effects of pressure on the Mukaiyama aldol 
reaction of benzaldehyde (8) with an unsaturated silyl ketene acetal 9 (Scheme 5). Not only did they 
observe an improved yield, but also a reversal of the regioselectivity of the reaction. While lower 
pressures (2 kbar) resulted in the predominant formation of the linear γ-adduct 10a, the preference is 
shifted towards the branched α-adduct 10b at 17 kbar, probably due to the fact that the transition 
state leading to 10b is more compact than that of 10a and is thus favored at higher pressures.[66] 
 
Scheme 5: The Mukaiyama aldol reaction of 8 and 9 under high-pressure conditions published by Bellassoued et al. in 1997. 
The more compact, branched product 10b is formed preferentially at very high pressures.[66] 
The related Henry (nitroaldol) reaction was subject of the investigations of Matsumoto et al. in 2002 
(Scheme 6). They could demonstrate that chiral α-amino aldehydes react smoothly with nitroalkenes 
at elevated pressures (8 kbar) without the need of an additional catalyst. No significant racemization 
of the stereocenters was observed, substantiating that high pressure can act as a “mild” activation 
mode.[67] 
                                                          
* There are more examples for the use of high pressure-promoted Diels-Alder reactions in the total synthesis of 
biologically active compounds, e.g. kainic acid[64] and (tetrahydro)cannabinol derivatives.[65]  
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Scheme 6: Example for the high pressure-mediated Henry reaction of an α-amino aldehyde (11) with nitromethane (12) 
without catalyst as reported by Matsumoto et al. in 2002.[67] 
In 2010, Kotsuki et al. showed that high-pressure techniques offers the capability to overcome steric 
strain in uncatalyzed aza-Michael reactions of secondary amines to α,β-unsaturated esters. While the 
reaction did not perform under reflux conditions at ambient pressures, the use of 14 kbar pressure 
rendered it possible, allowing the synthesis of highly congested adducts containing an aminated 
quaternary carbon center (Scheme 7).[68] 
 
Scheme 7: An example from Kotsuki et al. for the high-pressure aza-Michael addition of an amine (16) to an α,β-unsaturated 
ester (15). The formed adduct 17 contains a sterically congested quaternary carbon center.[68] 
Contributions to the field of high-pressure organic chemistry have also been made by the Reiser group. 
In 2001, they published a protocol for a high-pressure Domino-Horner-Wadsworth-Emmons-Michael 
reaction, illustrating that pressure can also be a useful tool for multicomponent reactions  
(Scheme 8).[69] 
 
Scheme 8: High-pressure Domino-Horner-Wadsworth-Emmons-Michael reaction of benzaldehyde (8), phosphonate 17 and 
piperidine (18) published by Reiser et al. in 2001.[69] 
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Furthermore, they demonstrated that also catalyzed organometallic reactions can be positively 
influenced by pressure (Scheme 9). The Pd-catalyzed arylation of 2,3-dihydrofuran (20) gave vastly 
improved results under pressure, enabling the use of significantly lowered catalyst loadings 
(≤ 0.01 mol%).[70] This is a good example that the use of high-pressure conditions can also be beneficial 
in economical as well as ecological terms, as it allows reducing the amount of costly and potentially 
harmful chemicals. 
 
Scheme 9: Reiser et al. demonstrated that the Pd-catalyzed Heck reaction of 2,3-dihydrofuran (20) with iodobenzene (21) is 
significantly accelerated upon pressurization. The yield of the reaction at 1 bar did not improve with longer reaction times.[70] 
While these examples are only a small excerpt of the research done over the last century, they 
definitely show the advantages high pressure can offer for organic transformations. The studies 
presented in this thesis were carried out as a part of the FOR 1979 research group “Exploring the 
Dynamical Landscape of Biomolecular Systems by Pressure Perturbation”. Focus was laid on the 
investigation of small, biologically-relevant compounds as well as biomimetic catalysts and how they 
are affected by high hydrostatic pressure in terms of reactivity and structure. The results are presented 
in the following chapters. 
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B. Main part 
1. Covalent Lewis base organocatalysts under pressure 
1.1 Introduction 
 
Ever since its “rediscovery” at the turn of the century by the groups of List[71] and MacMillan,[72] 
organocatalysis has been developing into a non-negligible tool for organic chemistry besides metal- 
and biocatalysis.[73,74] It provides access to a multitude of chemo-, regio- and stereoselective 
transformations as well as to completely new activation modes.[73,75,76] In addition, the catalyst systems 
can often be derived from abundant, non-toxic compounds like amino acids, sugars or alcohols, 
rendering them inexpensive and safe to use (Scheme 10).[71,74,77] Organocatalytic reactions have 
therefore gained popularity in the chemical community and have been employed in a variety of 
applications, e.g. in the synthesis of natural products or biologically relevant molecules for medicine.[78] 
 
Scheme 10: Overview of different covalent Lewis base organocatalysts and the corresponding research groups, who identified 
their efficacy in organocatalysis. All compounds contain a chiral pyrrolidine-motif and the majority can be derived directly 
from the naturally occurring amino acid L-proline (23). References: 23,[71,79] 24,[80,81] 25,[82] 26,[83] 27,[84] 28 and 29,[85–87] 
30.[88,89] 
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Despite these benefits, an often stated common disadvantage of organocatalysts is their rather low 
reaction rates (especially for covalent Lewis base catalysis),[76] which leads to the requirement of using 
higher catalyst loadings or prolonged reaction times.[77] A way to counteract these issues is the use of 
organocatalysts in combination with secondary activation modes. Several methods have been 
investigated over the years, including microwave irradiation, ultrasonication, ball milling or the use of 
high hydrostatic pressure.[90]  
Curiously, little research has been done on high-pressure activation in combination with 
organocatalyzed asymmetric reactions, although applications in the field are known since the 1980s. 
These initial studies were carried out by Matsumoto et al., who investigated the cinchona alkaloid-
catalyzed asymmetric addition of nitromethane (12) to chalcone (31). Using quinidine (32), the 
reaction did not proceed at all in apolar solvents under ambient conditions, however, it proceeded 
smoothly under high-pressure conditions. Interestingly, the enantioselectivity of the reaction 
displayed a pressure optimum at 9 kbar (60% ee), with lower or higher pressures resulting in 
diminished selectivities (Scheme 11).[91,92] 
 
Scheme 11: Matsumoto et al. reported the first use of high-pressure conditions in an organocatalyzed reaction. At 9 kbar, 
the quinine-catalyzed Michael addition of nitromethane (12) to chalcone (33) performed smoothly giving quantitative yields 
and fair enantioselectivities.[91,92] 
In 1995, Oishi et al. demonstrated that chiral DABCO derivatives are efficient catalysts for the 
condensation of methyl vinyl ketone and 4-nitrobenzaldehyde when submitted to high pressures (5 
kbar). Not only did they observe increased reactivity, the enantioselectivity could be increased as well 
(from 12 to 47% ee).[93] Unfortunately, despite these remarkable discoveries, further investigations 
into the subject were rather scarce. 
This changed slightly with the resurgence of organocatalysis in 2000, which sparked an increase in the 
investigation of organocatalyzed reactions under pressure. Focusing on L-proline (23) catalysis, Hayashi 
et al. and Kotsuki et al. investigated the effect of high-pressure conditions on the aldol addition 
between ketones and aldehydes independently. Kotsuki et al. performed the reaction without solvent 
in a piston-cylinder apparatus[94] and Hayashi et al. used DMSO and applied pressure by water induced 
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freezing in a closed autoclave, generating up to 2 kbar of pressure.[95] Both groups observed a 
significant increase in reactivity, less formation of the aldol condensation side product and slightly 
improved selectivities when using high-pressure activation (Scheme 12). Further studies of Hayashi et 
al. underlined that high pressure is a viable mode of activation in covalent organocatalysis, expanding 
the application scope to Baylis-Hillman[96] and direct Mannich reactions.[97] Kotsuki et al. also continued 
to prove the efficacy of high pressure in organocatalyzed Hetero-Diels-Alder[98] and aza-Michael 
reactions[99] as well as in the desymmetrization of cyclohexadienones.[100] 
 
Scheme 12: High-pressure organocatalytic aldol addition of acetone (34) to benzaldehyde (8), catalyzed by L-proline (23). 
Both, Hayashi et al.[95] and Kotsuki et al.[94] obtained improved results in comparison to the same reaction under ambient 
conditions as reported by List et al. in 2000.[71] Note, that this reaction also appears to show a pressure optimum in terms of 
enantioselectivity. 
The initial attempt of Matsumoto et al. was eventually picked up in 2011 when Kwiatkowski et al. 
investigated the asymmetric addition of nitroalkenes to sterically congested cycloalkenones catalyzed 
by cinchona alkaloid derivatives (Scheme 13). 
 
Scheme 13: Example from Kwiatkowski et al. in 2011, showing the high-pressure organocatalytic Michael addition of 
nitromethane (12) to 3-methylcyclohex-2-en-1-one (36).[101] 
While the reaction did not occur at ambient conditions, it proceeded smoothly under elevated 
pressures up to 10 kbar, successfully generating γ-nitroketones with quaternary stereocenters in good 
yields (73 - 90%) and excellent selectivities (96 – 99% ee).[101] They also improved the original protocol 
of Matsumoto et al. and expand its scope by using a cinchona alkaloid-based thiourea catalyst.[102] 
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Additionally, they were also able to perform sterically demanding Friedel-Crafts alkylations[103] and 
hydroxyalkylations of indoles[104] using high-pressure conditions. 
 
1.2 Development of the concept and catalyst preparation 
 
Despite the fact that these examples provided evidence for the high versatility of high-pressure 
activation, its application in organocatalysis in general (and covalent Lewis base catalysis in particular) 
has been rather scarce.* Usually, the most commonly used method of activating a not proceeding 
chemical reaction is through heating the reaction mixture, introducing thermal energy into the 
system.[105] Although this often leads to improved reactivity, heating might also have detrimental 
effects, especially with respect to diastereo- and enantioselectivites of the products.† Higher 
temperatures lead to increased molecular motion, thus complicating the formation of defined 
transition states which are essential for high selectivities. Here, the use of high pressure can have a 
decisive advantage: it adds energy into the system while limiting molecular movement through volume 
constriction at the same time.[19,20,24,26,28] Furthermore, once the pressure is build up and stable it does 
not require the constant addition of energy unlike heating rendering it more economical.[28] 
Interestingly, there are almost no comparative studies on how different activation methods influence 
the outcome of an organocatalyzed reaction.‡ Therefore, a study was conceived to compare the 
influence of high temperature (HT) and high pressure (HP) on an organocatalyzed reaction. As 
aforementioned, especially covalent Lewis base organocatalysis is reported to suffer from rather low 
reactivity, thus making catalysts of this type prime subjects for investigation in combination with a 
secondary activation mode.[76,77] In search of a suitable test reaction, the conjugate Michael addition 
between aldehydes (39a-g) and trans-β-nitrostyrene (40) was chosen (Scheme 14). 
                                                          
* This might be attributed to the perceived complexity of performing high pressure reactions and/or lack of 
equipment, however, with the previously mentioned method developed by Hayashi et al., at least the generation 
of pressures up to 2 kbar requires nothing more than an autoclave vessel.[95–97] 
† Elevated temperatures can also result in thermal decomposition of the reactants. 
‡ In 2006, Bolm et al. analyzed the thermal effects on the outcome of the organocatalyzed Mannich reaction by 
comparing results obtained from conventional heating against those using microwave irradiation.[106] In the same 
year, they published a study on the organocatalyzed aldol reaction, comparing the use of ball milling and 
conventional mechanical stirring.[107] However, the activation modes employed in these studies have the same 
underlying principle (temperature and mechanical force); studies with a direct comparison of two or more 
different activation modes appear to have not been published until now. 
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Scheme 14: The conjugate Michael addition of various aldehydes (39a-g) to trans-β-nitrostyrene (40), used as the test 
reaction in the comparative study of secondary activation modes. Catalysts were pyrrolidine (42) and the Jørgensen-Hayashi 
catalyst (28), 4-Nitrophenol was used as acidic cocatalyst. 
This transformation has developed into a standard test reaction in organocatalysis over the years and 
enables the exploration of reactivity as well as diastereo- and enantioselectivity with a broad substrate 
scope.[85,108,109,110] Furthermore, it has not been investigated with the combination of covalent Lewis 
base organocatalysis and high-pressure activation until now. Seven different aldehydes were chosen 
as substrates: while 39a-c are differing in the alkyl chain length, 39d and 39e provide considerable 
more steric bulk, thus potentially hampering the reaction. 39f and 39g were chosen as the most 
challenging substrates, as they possess only one proton in α-position, thus leading to the formation of 
products containing quaternary carbon centers. 
 
Scheme 15: Synthesis of the Jørgensen-Hayashi catalyst (28) from L-proline (23). 
In terms of catalysts, two substances were picked for the reaction: pyrrolidine (42) and the Jørgensen-
Hayashi catalyst (JH catalyst, 28). Pyrrolidine (42) represents the simple basic core of all L-proline 
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derived organocatalysts. As it contains no functional groups which could interfere during the reaction, 
it is ideal to study pressure and temperature effects, meaning that all changes in yield and 
diastereoselectivity can be attributed solely to the applied secondary activation mode. The Jørgensen-
Hayashi catalyst (28) was chosen as an asymmetric variant of a pyrrolidine-based catalyst, in particular, 
to investigate the effect secondary activation modes can have on the enantioselectivity of the 
reaction.[85–87,111] It can be conveniently synthesized starting from commercially available L-proline (23). 
Using the established procedure from Kanth et al., the precursor diphenylprolinol (44) could be 
synthesized in 92% yield over 3 steps.[112] TMS protection of the alcohol group then gave rise to the 
finished catalyst 28 in good yield (Scheme 15).[113]  
This sterically bulky, highly versatile catalyst has already been investigated in the chosen Michael 
addition under ambient conditions (AP/AT) by Hayashi et al. in 2005.[85] Since then, the underlying 
enamine-type reaction mechanism has been explored in detail by various research groups  
(Scheme 16).[114–121] The aldehyde is activated through formation of the (E)-enamine 45-1[119,122,123] with 
the catalyst 28, which then attacks the electron deficient Michael acceptor. This attack can proceed 
through different pathways: either through a [4+2] cycloaddition forming dihydrooxazine oxide 45-2A, 
through a [2+2] cycloaddition forming cyclobutane 45-2B or the elusive nitronate 45-TS1.* 
Interestingly, the direction the reaction takes is dependent on the substrate structure and the reaction 
conditions. For aldehydes bearing only one α-proton (39f-g), only cycle A can lead to product 
formation. Here, deprotonation of 45-2B to 45-TS2 is not possible, rendering the cyclobutane an off-
cycle side product in parasitic equilibrium with 45-2A and 45-TS1. The rate-determining-step is, 
therefore, considered to be the protonation of 45-2A (or 45-TS1), leading to the iminium species  
45-4A, which releases the catalyst 28 and the product 41f-g upon hydrolysis.[114,116] Using aldehydes 
with two α-protons, however, opens the reaction to two possible routes as ring opening of 45-2B is 
now feasible (cycle B). This leads to the formation of nitronate 45-TS2 which is further protonated to 
enamine 45-3B (again, this is considered to be the rate-determining step).[114,116] A second protonation 
step then leads to 45-4A, thus reentering cycle A. For aldehydes 39a-e, both catalytic cycles are viable 
and are probably occurring simultaneously, which is in so far interesting as the stereoselectivity-
inducing steps are different for each pathway. In cycle A, stereochemistry is determined in the initial 
addition step, in cycle B selectivity must arise from the selective protonation of enamine 45-3B by  
                                                          
* All three structures appear to be in an equilibrium with each other. While 45-2A and 45-2B have both been 
identified to be intermediates in the reaction mechanism, the occurrence of 45-TS1 is highly debated up until 
today.[114–121] Seebach et al. showed that linear aldehydes (like 39a-c) form the cyclobutane (45-2B) preferentially 
over the dihydrooxazine oxide (45-2A) with trans-β-nitrostyrene (40) in anhydrous benzene-d6. They also proved 
that stability of the cyclic intermediates is highly dependent on the solvent, showing almost immediate ring-
opening in DCM-d2 but high stability in benzene-d6 under anhydrous conditions.[117]  
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4-nitrophenol (HA). Due to the complexity of the underlying mechanism, it is not surprising that the 
reaction is still subject to investigation today.[110,114–121] 
 
Scheme 16: Proposed reaction mechanism based on the publications of Seebach, Blackmond and Pihko et al. for the Michael 
addition of aldehydes (39a-g) to trans-β-nitrostyrene (40) catalyzed by the Jørgensen-Hayashi catalyst (28). While all 
aldehydes (39a-g) can proceed through cycle A, only aldehydes with R1 = H (39a-e) can react through cycle B.[110,114–118,120,121] 
In order to facilitate analysis of the reactions, it was chosen to use an NMR standard.* This allowed the 
fast and accurate determination of yields and diastereomeric ratios in the crude reaction mixture and 
ensured that errors due to partial loss of product during purification were prevented. Purification was, 
therefore, only necessary to determine the enantiomeric excess of the products. To achieve 
comparability throughout the experiment, all reaction parameters were kept constant, varying solely 
in the use of the different secondary activation modes (Table 2).  
                                                          
* Diphenoxymethane (46) was chosen as standard as it generates a reliable signal in a non-crowded part of the 
spectrum. It has already proven itself to be a good NMR standard in the past, as it fulfills the criteria for a good 
NMR standard: it is high boiling, easy to handle and, as an ether, unreactive.[124] 
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Table 2: Conditions of the secondary activation modes used in the comparative study. 
Conditions Abbreviation Temperature [°C] Pressure [kbar] 
Ambient  AP/AT 22 10-3 
High temperature HT 55 10-3 
High pressure HP 22 4.6 
The AP/AT conditions basically represent an unaltered reaction sequence without any additional 
influences, thus setting benchmark results. Catalyst loadings were customized for each aldehyde under 
ambient conditions (AP/AT) in order to obtain yields between 30 – 50%. This ensured that changes in 
both directions could be tracked. This enabled the estimation of the influence of the secondary 
activation modes on the reaction, allowing the evaluation of basic trends for yields and selectivities.  
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1.3 Influence of secondary activation modes on reactivity 
 
The first parameter that was investigated was the reactivity (i.e. yield) of the reaction and the resulting 
changes that result from heating or pressurization (Figure 4).  
 
 
Figure 4: Obtained yields from the Michael reaction catalyzed by pyrrolidine (42, left) and the Jørgensen-Hayashi catalyst (28, 
right). Ambient conditions (AP/AT): black, high temperature (HT): red, high pressure (HP): blue. Reaction conditions: 39a-c: 
1 h, 1 mol% 42 or 28; 39d: 1 h, 1mol% 42 or 2.5 mol% 28; 39e: 1 h, 2.5 mol% 42 or 28; 39f-g: 4 h, 10 mol% 42 or 28. All results 
and parameters can also be found in tabular form in the appendix (see chapter G.1., Table 7 & Table 8).  
Before starting experiments, any occurrence of a background reaction under the applied conditions 
had to be ruled, as this would falsify the results. Therefore, blank reactions with 39a using no catalyst 
were conducted. Only slight conversion of the starting material trans-β-nitrostyrene (40) and no 
formation of product 41a was observed after 45 h, hence proving that the Michael addition only takes 
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place in the presence of a catalyst. Therefore, the catalyzed reaction could then be performed with the 
different aldehydes 39a-g and conditions.  
 
1.3.1 Pyrrolidine-catalyzed reactions 
 
The racemic variant of the reaction, using pyrrolidine (42) as catalyst, was performed first (Figure 4, 
left). Here, the results showed that both linear (39a-c) as well sterically more demanding aldehydes 
(39d-e) gave mediocre yields (35-60%) under AP/AT conditions. A clear trend was visible for linear 
aldehydes (39a-c), displaying decreasing reactivity with extended chain lengths (Ethyl > n-Propyl >  
n-Hexyl). This was expected, as the probability of effective collisions required for enamine formation 
should decrease with larger substrates. Interestingly, the most reactive aldehyde of these was the 
sterically hindered hydrocinnamic aldehyde (39d) which gave yields similar to n-butanal (39a). This 
might be attributed to the possibility of beneficial π-π-interactions with trans-β-nitrostyrene (40), 
guiding it to the enamine.* The bulky i-pentanal (39e) reacted the slowest, residing in the same range 
as n-octanal (39c), though requiring higher catalyst loadings (2.5 mol% for 39e instead of 1 mol% for 
39a-d). This is unsurprising, as the higher steric bulk should hinder the reaction. Finally, the more 
challenging substrates, containing only one proton in α-position, reacted significantly slower at AP/AT 
even with 10 mol% of catalyst. While at least small amounts of product could be obtained with  
i-butanal (39f), the use of the bulkier cyclohexyl carbaldehyde (39g) resulted in no product formation 
at all. This might be explained by the hampered addition of the bulkier enamine to trans-β-nitrostyrene 
(40) or a result of catalyst blockage due to the formation of the parasitic cyclobutane described earlier 
(Scheme 16, 45-2B). 
Applying secondary activation modes had drastic effects on the outcome of the reactions. Both HT and 
HP conditions appear to accelerate the reactions, however, to a different extent. This can be related 
to the different influences of HT and HP on the reaction. Generally, both activation modes increase 
reactivity by adding extra energy to the system, which is required to overcome activation barriers. HT 
works through adding kinetic energy to the system which leads to increased molecular motion, and 
therefore collisions, in a specific amount of time. HP also adds energy, however, by forcing molecules 
into close proximity to each other, which is advantageous for bond-forming reactions (∆𝑉‡ < 0). The 
important difference to HT is that HP also constrains the reaction volume and molecular flexibility, thus 
overcoming activation barriers and steric repulsion at the same time.[19,20,24,26,28] An example for these 
                                                          
* However, the reaction with hydrocinnamic aldehyde 39d was prone to side reactions. The resulting side 
products unfortunately proved inseparable and could thus not be identified. 
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beneficial effects are the observations made with the linear aldehydes 39a-c. The reactions of the 
short-chained n-butanal (39a) and the long-chained n-octanal (39c) could be driven to completion 
under HT as well as HP conditions, increasing the reaction rate by a factor of at least two (compared 
to AP/AT). However, the medium-sized n-pentanal (39c) was less susceptible to activation: while HT 
only led to slightly better yields, only HP conditions were able to significantly improve the outcome in 
this case. With the alkyl chain length being the only difference between the aldehydes 39a-c, it is likely 
a steric effect that causes the reactivity change. Scheme 17 depicts the transition state for the attack 
of the (E)-enamines[119,122,123] on trans-β-nitrostyrene (40) leading to the syn products, which were 
predominantly formed (see also chapter 1.4).  
 
Scheme 17: Possible explanation for the discrepancy in reactivity observed in the HT- and HP-activated reaction with  
n-pentanal 39c. 
Looking at 39b, it becomes apparent that rotation of the terminal methyl group in enamine 39b-A can 
lead to an unfavorable interaction with the nitroalkene (39b-B), resulting in steric repulsion. With the 
shorter 39a, this interaction should be severely hindered as rotation around the C2-C3 bond of the 
enamine would lead to 1,3-allylic strain.[125] For the longer 39c, the terminal methyl group should be 
too far away to have any influence. Of course, rotation around the inner alkyl bonds can also occur, 
Main part 
 
27 
 
although, moving the entire alkyl chain should require more energy than a simple methyl group. 
Additionally, 39c has a higher degree of freedom, making it less probable that the rotation occurs 
selectively at the C3-C4 bond of the enamine (in contrast to 39b where this displays the only bond 
rotation that can occur unhindered). Under standard conditions, the alkyl chains are probably arranged 
in a linear fashion as a result of least amount of steric strain. With the addition of energy, however, 
rotation of the chains should become more prominent as the rotational barriers can be overcome. 
Both activation modes add energy to the system, but only HP acts through constraining volume. 
Therefore, HP should, on the one hand, reduce flexibility of the molecules and, on the other hand, 
force molecules into spatial proximity despite steric repulsion. While unfavorable rotation and 
repulsion might still occur, its effect should hence be diminished by the use of HP. In contrast to this, 
HT only adds energy, which might increase overall reactivity but cannot counteract the rising influence 
of steric repulsion, thus explaining the observed discrepancy.* 
The tendency for HP conditions to outperform HT became more prominent with the sterically more 
demanding aldehydes (39d-e). Although the reaction with i-pentanal (39e) ran almost twice as fast 
under HT conditions (as there is no steric strain with the catalyst which could be detrimental), it could 
only be driven to completion with HP (> 3x faster). With hydrocinnamic aldehyde (39d), the use of HT 
even had detrimental effects on the reaction outcome. Increased formation of side products was 
observed under HT conditions resulting in diminished yields of 41d. In contrast, HP conditions boosted 
the activity of the reaction once more reaching complete conversion, while suppressing side product 
formation at the same time.  
The most drastic effects, however, could be observed with the challenging substrates 39f and 39g 
bearing only one α-proton. While the use of HT led to more than doubled yields in the reaction with  
i-butanal (39f), HP resulted in an almost six-fold increase in reactivity. As mentioned earlier, an issue 
for the low conversion under ambient conditions could be the formation of the cyclobutane (45-2B) in 
the conjugate addition step (Scheme 16, cycle B). With aldehydes 39f-g, this intermediate depicts an 
off-cycle resting state of the catalyst, as the lack of an abstractable α-proton prevents further 
transformation. Although these cyclobutanes can be fairly stable, Seebach et al. demonstrated that 
the reverse reaction back to the enamine and trans-β-nitrostyrene (40) is facilitated by increased 
temperatures. This means that higher temperatures should release the active catalytic species again if 
trapped in the cyclobutane species, thus increasing the chances for the reaction to proceed through 
cycle A and producing product 41f. While this is a plausible explanation for the improved activity under 
                                                          
* This could be also one reason why the anti product is formed to larger extent under HT conditions, as the steric 
hinderance is less prominent in the respective transition state (see chapter 1.4.1). 
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HT, this rationalization should not apply to HP conditions. Here, another mode of action is more 
reasonable, namely electrostriction, a result of the interaction between the medium and the reactant. 
In organic reactions, the occurrence of ionic transition states will lead to an ordering of the charged 
species, resulting in a tighter packing of the medium (i.e. CHCl3) around them. This effect is called 
electrostriction and is accompanied by a sharp volume decrease, which can have a significant impact 
on the volume of activation ∆𝑉‡. Therefore, reactions proceeding through highly dipolar or ionic 
transition states can be significantly accelerated by pressure.[19,20,24,26,28] This explains the increased 
reactivity under HP conditions for 39f, as the product-forming cycle A goes through the zwitterionic 
transition state 45-TS1 and eventually leads to the equally zwitterionic 45-4A, which should both be 
formed preferentially under pressure due to electrostriction effects.* Curiously, the bulky cyclohexyl-
bearing 39g, which did not form under AP/AT conditions, gave more or less comparable results for 
both activation modes. The even higher steric complexity of the enamine and the corresponding 
intermediates might be the reason that this reaction proceeds rather slowly. 
 
1.3.2 Reactions catalyzed by the Jørgensen-Hayashi catalyst 
 
After analyzing the reactivity with the simple, non-chiral pyrrolidine (42), focus was then turned 
towards the asymmetric Jørgensen-Hayashi catalyst (Figure 4, right). On first glance, it becomes 
obvious that the overall yields are generally lower than in the racemic reactions. This is not surprising 
as the catalyst bears a large stereoinducing group which lowers the general accessibility of the active 
center, thus hampering the reactivity. Although similarities exist to the pyrrolidine-catalyzed reactions 
regarding reactivity trends, some aldehydes react quite differently. For instance, the linear aldehydes 
39a-c now show the same discrepancy in reactivity already under AP/AT conditions, which was only 
observed under HT or HP in the racemic reactions. As mentioned earlier, the reason for this is likely to 
be a steric effect (see Scheme 17). Here, the issue is now further amplified because of the bulky 
substituent of the catalyst, thus being significant enough to be observed even at AP/AT. Unsurprisingly, 
HT conditions worsened this problem through increased rotation, leading to diminished yields with the 
short 39a and 39b. In contrast, HP conditions could achieve slightly increased yields, however, not to 
the same extent as in the pyrrolidine-catalyzed reactions. Interestingly, the longest chain aldehyde 39c 
was observed to be the most reactive and the only linear aldehyde, where HT seemed to have no 
detrimental effect. This might be attributed to its larger size. It makes rotations around bonds which 
                                                          
* This of course should then also be true for all the other HP-activated reactions with aldehydes 39a-g, making 
electrostriction an additional accelerating effect that has to be taken into account. 
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lead to unfavorable interactions stochastically less probable. Additionally, the volume decrease upon 
bond formation (i.e. in the transition state) should be higher than with the smaller sized aldehydes, 
resulting in a more negative volume of activation (∆𝑉‡), which in return leads to enhanced reaction 
rates upon pressurization.* 
With the sterically more demanding aldehydes (39d-e), the results were as expected. Yields were low 
under AP/AT and HT conditions; a result from the steric strain between the aldehydes and the catalyst 
(28) complicating productive collisions (in contrast to pyrrolidine (42), where no spatially demanding 
groups were present). Here, the benefits of HP activation came to play, as the constriction of volume 
could effectively bring the reactants into proximity for the reaction to occur. As a result, the use of HP 
resulted in a 3-fold increase in reactivity for 39d and a more than 6-fold for 39e.  
The reactions with the challenging substrates 39f and 39fg, bearing only one α-proton, again resulted 
in interesting outcomes. Curiously, i-butanal (39f) gave even better results with the Jørgensen-Hayashi 
catalyst (28) than with pyrrolidine (42). Moreover, both HT and HP conditions had a beneficial impact 
on the transformation, with HP even reaching complete conversion.† A possible explanation for this 
behavior might be that the earlier mentioned cycle-breaking cyclobutane is less stable with the 
Jørgensen-Hayashi catalyst (28). Its bulky substituent could lead to steric strain with the methyl groups, 
thus decreasing the amount of cyclobutane being formed and favoring the product-yielding catalytic 
cycle. However, this might not be the singular reason for this observation, as the other structurally 
complex aldehyde 39g showed almost no reactivity under AP/AT and HT conditions. Only HP could 
generate small amounts of product, indicating that either steric strain of the cyclobutane is not the 
only factor or that cyclohexyl carbaldehyde 39g is simply less active (e.g. prone to enamine formation) 
as 39f.‡ 
At this point, the results nicely demonstrated the overall beneficial effects HP has on the reactivity of 
the organocatalyzed Michael addition, which are much more constant and reliable than using plain HT 
activation methods. 
  
                                                          
* The slightly higher yield for 39c compared to 39a in the pyrrolidine-catalyzed reaction might also be indicative 
of this, however, both reactions had reached complete conversion making analysis difficult. 
† This is interesting as Blackmond et al. reported less than 5% yield for 41f in their investigations, although with 
benzene-d6 as solvent and acetic acid as additive.[120] However, Seebach et al. demonstrated that solvent and 
additives can have an significant effect on the reaction and its intermediates.[117,118] 
‡ A possibly activating coordinative effect of the protected or unprotected[126] alcohol moiety of the catalyst 28 
can be ruled out under the here employed conditions according to literature.[114–118,120,121] 
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1.4 Influence of secondary activation modes on selectivity 
With the analysis of the reactivity accomplished, the focus then turned to the selectivity of the 
reaction, as the use of aldehydes 39a-e led to products containing two stereocenters, resulting in the 
formation of syn and anti diastereomers. 
 
 
Figure 5: Obtained diastereomeric ratios from the Michael reaction catalyzed by pyrrolidine (42, left) and the Jørgensen-
Hayashi catalyst (28, right). syn/anti ratios are normalized to anti = 1. Ambient conditions (AP/AT): black, high temperature 
(HT): red, high pressure (HP): blue. 
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1.4.1 Pyrrolidine-catalyzed reactions 
 
Again, the pyrrolidine-catalyzed reactions are evaluated first. As pyrrolidine (42) itself is achiral, all 
changes in terms of selectivity can be attributed to the interactions between the reactants and the 
employed activation mode. Taking a first look at the results (Figure 5, left), a clear trend for selectivities 
in relation to the reaction conditions can be seen, as the formation of the syn product was preferential 
for all aldehydes and conditions. Initially, this might appear to be counterintuitive as no stereodirecting 
group is present in the catalyst (42), however, it becomes clear upon examining the transition states 
occurring in the reaction (Scheme 18). If the reaction proceeds through the catalytic cycle A (see 
Scheme 16), the stereochemistry will be defined in the initial addition step (Scheme 18 a)).  
Already in 1981, Seebach et al. investigated the Michael addition of aldehydes to nitroalkenes using 
achiral morpholine as catalyst.[127] They stated that the nitro group coordinates to the nitrogen atom 
of the enamine due to electrostatic interactions. This leads to (Re,Re)- and (Si,Si)-approaches, being 
favored over (Re,Si)- and (Si,Re)-approaches, thus explaining the observed selectivity for the syn 
product.[127–129] This hypothesis was later picked up and transferred by Alexakis and Hayashi et al. to 
explain the asymmetric variants of the Michael addition with other Lewis-base catalysts.[81,85] 
As mentioned in chapter 1.2, the reaction with aldehydes 39a-e can also proceed through a second 
catalytic cycle B. This involves a [2+2]-cycloaddition forming a cyclobutane intermediate whose 
stereochemistry is similarily influenced by the orientation of the nitroalkene. In Scheme 18 b), it can 
be seen that the (Si,Si)-approach of the reactants leads to the formation of the sterically favored  
all-trans cyclobutane (all-trans-45-2B), while a (Re,Si)-approach would generate the more strained 
(thus disfavored) cis,trans,cis,trans isomer (cis,trans,cis,trans-45-2B).* Although the stereochemistry 
of the cyclobutane has no direct influence on the final product (due to deprotonation 45-TS2 in the 
next step of cycle B), it is also in an equilibrium with species from catalytic cycle A, where the 
stereochemistry is defined in the initial addition step.[117,118] 
 
                                                          
* A similar conclusion can be drawn for the dihydrooxazine oxide intermediate 45-2A. The (Si,Si)-approach leads 
to formation of a six-membered ring with all substituents in equatorial position, while the (Re,Si)-approach 
requires at least one substituent to be in axial position. 
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Scheme 18: Evaluation of the different stereoinducing steps which can occur during the Michael addition. a) Transition states 
of the initial addition step for all stereoisomers, molecules in the front are depicted bold. Preferred outcome is the syn adduct 
through (Re,Re)- or (Si,Si)-approach of the enamine and trans-β-nitrostyrene (40), as this leads to favorable stereoelectronic 
interaction between the nitro group and the nitrogen on the enamine.[127–129] If the JH catalyst (28) is used, the (Si,Si)-
approach is favored due to shielding of the Re-side, generating syn-(2R,3S)-41.[85] b) Exemplary structures of the cyclobutanes 
formed by (Si,Si) or (Re,Si)-addition.[117,118] With pyrrolidine (42) as catalyst, also the not depicted (Re,Re) or (Si,Re)-additions 
are viable. c) Rational analysis of the diastereoselective protonation of enamine 45-3B, explaining the observed syn selectivity 
for catalytic cycle B. Re/Si-nomenclature relative to C2. [114,115,117,120] HA = 4-nitrophenol. 
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In catalytic cycle B, the stereochemistry is defined by the selective protonation of the enamine 45-3B 
(assuming all-trans-45-2B was formed earlier). Scheme 18 c) depicts the two possible pathways this 
can take place. When using pyrrolidine (42) as catalyst, there is no asymmetric substituent which could 
guide the proton source (4-nitrophenol). However, 45-3B should be orientated as portrayed in order 
to reduce 1,3-allylic strain, facing the bulky phenyl group to the Re-side (i.e. front in Scheme 18 c)).[125] 
This means that protonation from the Si-side (i.e. back) should be favored, as it is sterically more 
accessible, thus again leading to the syn product preferentially.[114,115,117,120] 
With these explanations, the experimentally determined selectivities and changes can be explained. 
Under AP/AT conditions, a dependence between the syn/anti ratio and the steric bulk of the used 
aldehyde could be observed. While small linear aldehydes (39a-b) showed lower selectivities, the 
larger 39c gave improved results. On the first look, this seems plausible, as the added steric bulk should 
lead to the increased differentiation between the different transition states. Rationally, this should be 
accompanied by a decreased reactivity, however, this was not observed (compare chapter 1.3.1, 
Scheme 17). An explanation might be that with the linear aldehydes, the [2+2]-cycloadduct 45-2A is 
formed initially. While the smaller aldehydes 39a-b could form both cyclobutanes due to their low size, 
39c should preferentially form the all-trans-adduct (all-trans-45-2B) as it possesses considerable more 
steric bulk (Scheme 18 b)). The adduct then undergoes ring-opening and the reaction proceeds through 
catalytic cycle A, explaining the simultaneous high selectivity and reactivity of 39c. Using the bulky  
i-pentanal (39e) led to an expected increase in selectivity, reaching the highest values for all aldehydes 
under AP/AT conditions (syn/anti = 92:8 or 11.5:1). Hydrocinnamic aldehyde (39d), however, gave 
selectivities comparable to 39c, probably due to its higher flexibility than 39e. 
Repeating the same reactions with the use of secondary activation modes resulted in a clear trend. On 
the one hand, the use of HT conditions led to diminished diastereoselectivities for all aldehydes. This 
is not surprising, as it is known that the anti-products are the thermodynamically more stable 
products.[114,115,120] The added thermal energy increases molecular motion, leading to a higher 
probability that also (Re,Si)- and (Si,Re)-approaches of the reactants occur (Scheme 18, a)). 
Additionally, the increased energy amount should weaken the guiding stereoelectronic coordination 
of the nitro group to the enamine nitrogen, thus diminishing the preference for the formation of the 
syn product. Another aspect is that diastereoselectivity can erode if the product stays in contact with 
the catalyst over an extended amount of time, especially near or after complete conversion. 
Blackmond et al. demonstrated that this occurs through equilibration of the iminium species 45-4A to 
the enamine 45-3B, which results in the loss of stereo information at C2 until a syn/anti ratio of around 
60:40 (= 1.5:1) is reached (under AP/AT).[114,115,120] This is very likely to occur under HT conditions, as 
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equilibration should be facilitated by the higher temperatures and is supported by the fact that 
syn/anti ratios of around 60:40 were found for all products except the bulky 41e. 
On the other hand, HP conditions had the complete opposite effect, as all diastereoselectivities were 
enhanced, reaching syn/anti ratios up to 96:4 (= 24:1). As with the reactivity study, this can be 
explained by the unique activation mechanism high pressure provides.[19,20,24,26,28] Through constraining 
the reaction volume and forcing the reactants into close spatial proximity, steric repulsion can be 
overcome. Transition states of smaller volume will be formed preferentially as their volume of 
activation (∆𝑉‡) is lower, hence increasing the yield of the sterically more constrained syn product. 
Additionally, HP stabilizes zwitterionic intermediates through electrostriction, thus effectively 
canceling out the erosion of stereoinformation through equilibration between the charged iminium 
species 45-4A and the uncharged enamine 45-3B. Interestingly, the discrepancy of the linear 
aldehydes, which was already observed in the reactivity studies (chapter 1.3.1), could also be observed 
here, as n-pentanal (39b) was less susceptible to pressurization as 39a and 39c. This might be 
attributed to a unfavorable rotation of the terminal methyl group, which hinders the (Re,Re)- or (Si,Si)-
approach (see Scheme 17). This issue is not as prominent with the (Re,Si) and (Si,Re)-approach of the 
reactants leading to the anti product. Indeed, the reaction with 39b resulted in an increased formation 
of the anti diastereomer, which is indicative that the explanation made earlier is correct.  
 
1.4.2 Reactions catalyzed by the Jørgensen-Hayashi catalyst 
 
Unsurprisingly, using the asymmetric Jørgensen-Hayashi catalyst (28) had a large impact on the 
diastereoselectivity of the reaction. The bulky stereoinducing group is shielding the Re-side of the 
enamines. This effectively blocks the (Re,Re)-approach of the reactants, leaving the (Si,Si)-transitions 
state as the favored one.* At the same time, the propensity of the reaction to proceed through the 
(Re,Si)-transition state (and to a smaller degree the (Si,Re)- approach as well) is decreased. In these 
cases, the phenyl group of trans-β-nitrostyrene (40) is adjacent to the asymmetric substituent of the 
catalyst 28, resulting in steric strain and, therefore, diminished formation of the anti products (see 
Scheme 18 a)). Additionally, the catalyst 28 shielding the Re-side of the intermediary enamine 45-3B 
also improves the stereocontrol in the selective protonation step leading to syn-45-4A, explaining the 
                                                          
* Reducing the available transition states from four to only one of course should have an effect on the reactivity, 
thus partially explaining the decrease in reactivity compared to the pyrrolidine-catalyzed reactions (see 
chapter 1.4.1). 
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overall tendency to form syn adducts (see Scheme 18 c)). 
Under AP/AT conditions, this led to an increase of selectivity over the pyrrolidine-catalyzed reactions 
with almost all aldehydes. All aldehydes gave syn selectivities greater than 90:10 (= 9:1), with the linear 
aldehydes profiting more from the use of an asymmetric catalyst. With the sterically demanding 
aldehydes 39d-e the influence was less prominent: while a reasonable increase in diastereoselectivity 
could be observed in the reaction with the moderately flexible hydrocinnamic aldehyde (39d), the use 
of i-pentanal (39e) resulted in unchanged values. Due to their steric bulk and inflexibility, these 
aldehydes (39d-e) cannot evade steric strain completely. Therefore, the propensity for the formation 
of the more stable, less strained anti-product is slightly higher compared to the reactions with the 
more flexible linear aldehydes 39a-c.  
The HT reactions catalyzed by the Jørgensen-Hayashi catalyst (28) behaved similarly to the thermally 
activated, pyrrolidine-catalyzed reactions. Compared to AP/AT, heating resulted in a severe drop of 
syn diastereoselectivity for all aldehydes (39a-e), as the formation of the thermodynamically favored 
anti products became more prominent. Again, the increased equilibration of the iminium species  
45-4A to the enamine 45-3B as well as the increased molecular motion leading to more (Re,Si)- and 
(Si,Re)-approaches of the reactants might be the main reason for this to occur. However, it is important 
to note that selectivities were considerably better than with achiral pyrrolidine (42). 
In contrast to these findings, using HP conditions also improved the stereoinduction for the asymmetric 
version of the reaction, reaching excellent syn selectivities for all aldehydes (≥ 94:6 or 15.7:1). This 
time, the diastereoselectivity of the linear aldehydes 39a-c were less respondent to pressurization than 
in the racemic reactions. The bulky aldehydes 39d-e, however, benefit clearly from the increased 
pressure. This fits well with the observations made in the AP/AT reactions: the steric repulsion, which 
led to lower selectivities of 39d-e under ambient conditions, now is overcome as HP forces the 
molecules closer together, constraining the reaction volume. It is therefore not surprising that the best 
overall selectivity ratio was observed with the bulkiest aldehyde 39e (syn/anti = 97:3 or 32.3:1). 
With the use of the asymmetric Jørgensen-Hayashi catalyst, the enantiopurity of the products also 
became a point of investigation. It is important that a secondary activation mode does not interfere 
with the enantioinduction of the catalyst. Lower enantioinduction is usually detrimental as it leads to 
the requirement of tedious workup procedures (e.g. crystallization, chiral HPLC, etc.) to obtain the 
product in enantiopure form.  
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Figure 6: Obtained enantiomeric excesses from the asymmetric Michael reactions catalyzed by the Jørgensen-Hayashi catalyst 
(28). 
With the use of an asymmetric catalyst, the enantiopurity of the products also became a point of 
investigation. It is important that a secondary activation mode does not interfere with the 
enantioinduction of the catalyst. Lower enantiomeric excess is usually detrimental as it leads to the 
requirement of tedious workup procedures (e.g. crystallization, chiral HPLC etc.) to obtain the product 
in enantiopure form. Therefore, the enantiopurities of all syn compounds obtained from the 
asymmetric reaction with 28 were determined (Figure 6). 
For aldehydes 39a-e, the use of a secondary activation mode appeared to have almost no influence on 
the enantioselectivity of the Jørgensen-Hayashi catalyst (28). While AP/AT and HP gave constantly 
excellent enantioselectivities, slightly decreased ee values were detected for the linear aldehydes  
39a-c under HT conditions, however, changes were marginal. This underlines, that the earlier 
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described (Si,Si)-approach of the reactants should lead to the most stable transition state with the 
Jørgensen-Hayashi catalyst (28), generating the syn-(2R,3S)-products 41a-e (see Scheme 18 a)).*  
As these results proved to be uneventful, the focus was then turned on 39f and 39g. These symmetrical 
aldehydes bear only one α-proton, thus generating no diastereomers but a quaternary carbon center 
at C2 (41f and 41g). The use of 39f led to an interesting discovery, as the products enantioselectivity 
was highly dependent on the reaction conditions. Under ambient conditions, (R)-41f was obtained in 
only moderate excess (39% ee). However, a sharp increase in enantioselectivity was observed under 
HP conditions, yielding (R)-41f with 78% ee. In contrast, heating led to a diminished enantioinduction, 
generating (R)-41f with poor 12% ee.  
 
Scheme 19: Depiction of the transition state leading to the two enantiomers of 41f. R = Ph2(C)OTMS. 
As the aldehyde 39f is symmetric, two possible transition states exist for the formation of each 
enantiomer (Scheme 19). For 39f-R1 and 39f-S1, trans-β-nitrostyrene (40) approaches from the side 
the bulky substituent of the Jørgensen-Hayashi catalyst (28) is facing, therefore, these should be 
disfavored at AP/AT and can be ruled negligible. This means that the preferentially formed (R)-
enantiomer (R)-41f is probably generated through 39f-R2, as it allows the stereoelectronic interaction 
of the nitro group and the nitrogen on the enamine.† However, as the (S)-enantiomer (S)-41f is also 
formed in considerable amount, this means that the reaction should also proceed through 39f-S2. This 
can be explained by the structure of the enamine: as it bears two methyl groups, the 39f-R2 approach 
should generate considerable steric strain with the phenyl group of 28. Transition state 39f-S2 avoids 
this partially, however, sacrificing the extra stabilization through the electronic interaction. This should 
also explain the observed changes upon heating and pressurization. The more thermal energy is added, 
                                                          
* The anti products were only formed to a minor extent and could, therefore, not be investigated in detail for 
each adduct, however, analysis of residual traces revealed them to be almost racemic. 
† This is in analogy to (Si,Si)-approach which is favored in the reaction with aldehydes 39a-e.[85] 
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the higher the molecular motion becomes. This leads to less ordered transition states and makes steric 
repulsion more decisive, thus decreasing the overall enantioselectivity as the reaction is forced to 
proceed through 39f-S2 as well. In contrast, high pressures lead to volume constriction, overcoming 
steric strain and stabilizing ionic interactions due to electrostriction. Therefore, the reaction proceeds 
preferentially through 39f-R2, resulting in the increased formation of (R)-41f as observed. The last 
aldehyde investigated was the challenging 39g. As only HP conditions led to the formation of significant 
amounts of product, no comparison to the other activation modes could be drawn. The product  
(R)-41g was obtained with fair 64% ee, slightly lower than in the analogous (R)-41f, probably due to 
increased steric strain.  
Overall, it can be clearly seen that HP conditions vastly improve the syn selectivity for racemic and 
asymmetric reactions, surpassing both AP/AT and HT conditions significantly. In contrast, the use of 
HT led to an increase in the formation of anti products. This might open up interesting synthetic 
strategies, as the syn/anti ratio can be directly influenced by using the appropriate activation mode. In 
the asymmetric reactions, the use of a secondary activation mode had only little effect on the 
enantioselectivity for aldehydes 39a-e. However, symmetric aldehydes bearing only one α-proton  
(39f-g) were decisively influenced by the reaction conditions. Again, HP conditions improved 
enantioinduction while HT led to erosion of the stereochemistry. 
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2. Peptidic organocatalysts containing cyclic β-amino acids under pressure 
2.1 Introduction 
 
The last chapter demonstrated the efficacy of using amino acid derivatives as catalysts in 
organocatalytic asymmetric reactions. While these compounds account for a significant amount of 
catalysts in the field of organocatalysis, it is not limited to only using those. An important subset of 
organocatalysts is formed by short synthetic peptides, which can be seen as a link between small 
organic molecule organocatalysis and biocatalysis (using enzymes).  
The use of peptides offers several potential advantages. Catalysts can be conveniently designed in a 
modular fashion using peptide coupling methodologies, allowing for the selective introduction of 
functional groups through the choice of appropriate amino acids. This allows for the design of 
structurally diverse, highly active catalysts which are able to adapt to certain transformations and 
substrates. At the same time, the reduced molecular size of the peptide can improve solubility in 
organic solvents compared to an equivalent enzyme.[130] 
The use of short peptides to catalyze organic reactions is known for several decades, e.g. Thr-Ala-Cys-
His-Asp in the hydrolysis of 4-nitrophenyl acetate (1968),[131] poly-Leu in the Juliá-Colonna epoxidation 
of olefins (1980),[132] and cyclo-Phe-Ser in the asymmetric hydrocyanation of aldehydes (1990).[133]* 
However, research on the subject was not picked up to a greater extent until 2000, with the 
“rediscovery” of organocatalysis[74,134] as an independent field in asymmetric catalysis.  
Over the last years, several research groups have made significant contributions to the field of modern 
peptide organocatalysis. Especially the work of Miller et al. can be seen as pioneering, demonstrating 
the efficacy and versatility of short peptide-based catalysts in a wide range of applications, e.g. in 
asymmetric azidation-cycloadditions,[135] Stetter[136] and Baylis-Hillman[137] reactions, Baeyer-Villiger 
oxidations,[138] kinetic resolutions of alcohols[139] or as tools for site-selective modifications of natural 
products.[140] Besides studying their catalytic properties, Miller et al. also conducted structural 
investigations on the relationship between flexibility and secondary structure elements of peptides 
and the resulting implications on catalysis.[141] 
                                                          
* Note that in this thesis all amino acids which are abbreviated with the conventional three letter code and do 
not contain stereodescriptors are in the naturally occurring L-configuration. Exceptions are highlighted. 
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Scheme 20: Michael addition of aldehydes to nitroalkenes catalyzed by the synthetic tripeptide H-D-Pro-Pro-Glu-NH2 (47) as 
published by Wennemers et al.[142] NMM = N-methylmorpholine. 
Other important discoveries were made by Wennemers et al., who discovered the catalytic efficiency 
of two privileged tripeptides, H-D-Pro-Pro-Glu-NH2 (47) and H-Pro-Pro-Asp-NH2 (48) While 47 proved 
to be remarkably active in asymmetric Michael reactions,[143,144,145] 48 showed excellent activity in 
asymmetric aldol additions (Scheme 20).[146,147]With complementary studies, they were able to 
determine functional group requirements for effective catalysis, e.g. demonstrating that amine (NH) 
and acid (CO2H) groups in close spatial proximity are required to obtain optimal results.[142,147,148] Based 
on these discoveries, immobilized variants of the catalysts were developed which could even be 
employed in a microreactor setup under flow conditions.[149] Finally, supplementary investigations 
revealed in-depth information about the conformational behavior of the tripeptides[150] and the 
underlying mechanisms and intermediates of the reactions.[151,152] 
In order to investigate the use of other than the natural α-amino acids, Reiser et al. introduced 
structurally confined cis-β-aminocyclopropane carboxylic acid (β-ACC, ) into their peptide 
catalysts.[153] This was done to ensure proper spatial arrangement of the functional groups, as cyclic  
β-amino acids are known to stabilize secondary structures.[154] From a library of several di-, tri- and 
tetrapeptides, H-Pro--Pro-OH (49) turned out to be the best catalyst, efficiently catalyzing intra- and 
intermolecular aldol reactions with very good yields and good selectivities.[153] In 2014, Pilsl could show 
that the activity of the catalyst 49 could be significantly improved by using high-pressure conditions, 
without erosion of enantioselectivity.[155] These promising results initiated further research on the 
effect cyclic β-amino acids have when incorporated into tripeptides and how this influences the 
catalytic performance. Herein, special focus was laid upon the relationship between pressure 
activation and ring size of the β-amino acid, as larger rings increase the conformational freedom (and 
therefore flexibility) of the catalyst (Scheme 21). Peptides containing larger rings should be more 
susceptible to pressurization and conformational change, which could influence catalysis.  
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In cooperation with Botines[156] and Ortuño et al.,[157] cis-β-aminocyclobutane carboxylic acid  
(β-ACBC, ) was introduced into the tripeptides and analyzed, while Ertl from the Reiser group 
investigated the corresponding cis-β-aminocyclopentane carboxylic acid (β-ACPC, )-containing 
peptides. [158] In this thesis, ultimately, the incorporation of cis-β-aminocyclohexane carboxylic acid  
(β-ACHC, ) into tripeptides is discussed, thus generating the most flexible catalysts of the sequence 
(52 and ent-52). Furthermore, a more rigid analog containing anthranilic acid (Ant), 53, was 
synthesized. The efficacy of these catalysts was then evaluated in different organocatalytic reactions 
and compared to the other peptides, 49, 50 and 51.  
 
Scheme 21: Different tripeptides with the structural motif H-Pro-Xxx-Pro-OH containing cyclic β-amino acids of various ring 
size synthesized by Reiser et al. and Ortuno et al. In most cases, both cis-diastereomers of the catalysts were synthesized 
(Prolyl configuration was always L). 
 
2.2 Synthetic approach to cis-β-ACHC 
 
The synthesis of the cis-β-ACHC-containing tripeptides can be roughly divided into two parts: the 
synthesis of the unnatural cyclic amino acid and the peptide couplings with protected L-proline, 
followed by the deprotection of the tripeptide. As orthogonally protected L-proline derivatives are 
commercially available and due to the fact that a large variety of peptide coupling methodologies exist, 
the main focus of this work laid upon the reliable synthesis of the unnatural cyclic amino acid. 
There are several literature known approaches to obtain protected cis-β-ACHC derivatives, in a racemic 
as well as a stereoselective manner.[159–161] In the following, three methodologies and their advantages 
and disadvantages will be elaborated to give an overview about potential synthetic approaches (see 
Scheme 22).  
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Scheme 22: Three potential starting materials for the synthesis of cis-β-ACHC derivatives. 
Probably the shortest and most convenient route is the hydrogenation of anthranilic acid (54). Due to 
the mechanism involved, it usually also leads to the (in this case desirable) exclusive formation of the 
racemic cis adduct in 60% yield.[162] However, as is common with the hydrogenation of aromatic 
compounds, the use of rather harsh conditions and expensive catalysts like rhodium is required, to 
overcome the significant aromatic stabilization.[163] Furthermore, at this point there are no known 
asymmetric variants for this particular transformation, limiting its usefulness even more.  
A second approach, which is more flexible in terms of stereoselectivity, is a methodology developed 
by Davies et al. from 1994.[164] Herein, cyclohexanecarboxylic acid (55) was used as starting material, 
transformed into the α,β-unsaturated tert-butyl ester and then subjected to a conjugate addition with 
a sterically demanding homochiral lithium amide. Changing the stereochemistry of the lithium amide 
and using low-temperature conditions enabled the selective synthesis of both cis adducts with 
excellent diastereomeric excess (> 95%). However, a major drawback was the efficiency of the process. 
The generation of the conjugate acceptor alone resulted in only 30% yield, after the conjugate 
addition, it dropped even further to just 21% overall yield. This, combined with the fact that the 
experimental procedure is rather elaborate, rendered this not the method of choice for the β-ACHC 
synthesis.  
The third approach is based on the fact that six-membered rings can be conveniently generated 
through [4+2]-cycloaddition reactions (the Diels-Alder reaction). The diastereoselectivity of these 
reactions is based on the structure of the reactants, allowing facile access to exclusively cis-
disubstituted products. In the synthesis of β-ACHC, the key compound is cis-4-Cyclohexene-1,2-
dicarboxylic anhydride (cis-56) which is obtained through a Diels-Alder reaction of 1,3-butadiene and 
maleic anhydride. The anhydride cis-56 can then be desymmetrizied and the resulting hemiester 
transformed into the orthogonally protected β-ACHC by the use of the Curtius reaction.[159–161]  
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This pathway was chosen for the tripeptide synthesis and will be elucidated later in the upcoming 
chapter. With a suitable way identified to synthesize the β-ACHC, the focus then turned to the actual 
diastereo- and enantioselective synthesis of the tripeptides.  
 
2.3 Synthesis of the flexible tripeptides from racemic β-ACHC 
 
As mentioned earlier, the concept of cyclic cis-β-amino acid-containing tripeptides as organocatalysts 
is not a new one. In their original approach from 2008, Reiser et al. coupled racemic β-ACC (rac-57) 
with commercially available N-Boc-L-Proline (58), resulting in a diastereomeric mixture of the 
protected dipeptide. Fortunately, the two diastereomers, Boc-Pro--OMe (59) and Boc-Pro--OMe 
(60), could be cleanly separated by column chromatography. This simplified the synthetic process, as 
no extra step had to be employed to obtain the β-ACC in an enantiopure form, hence generating both 
desired dipeptides in a one-pot fashion, rather than having to synthesize them in separate 
processes.[153] For these reasons, this approach was also chosen for the preparation of the peptides 
containing β-ACHC, first synthesizing the cyclic amino acid, then coupling it with N-Boc-L-Proline (57) 
and separating the resulting diastereomeric dipeptides.  
The Diels-Alder reaction was chosen as the go-to method to obtain the required cis-disubstituted 
cyclohexane derivatives, in this case, cis-4-Cyclohexene-1,2-dicarboxylic anhydride (cis-56).[159–161]  
cis-56 can be formally obtained by reacting maleic anhydride (61) with 1,3-butadiene.[165] However, 
rather than using gaseous 1,3-butadiene, solid 3-sulfolene (62) was chosen as the 1,3-butadiene 
source. 3-Sulfolene (62) is a shelf-stable, easy to handle solid and, upon heating, readily undergoes a 
[4+1]-Retro-Diels-Alder reaction, releasing 1,3-butadiene and sulfur dioxide.[166–168] Using the thermally 
induced reaction of 62 with maleic anhydride (61), cis-4-Cyclohexene-1,2-dicarboxylic anhydride  
(cis-56) was successfully synthesized on a 500 mmol scale, achieving a very good yield and purity.[168,169] 
As predicted from the Diels-Alder reaction mechanism involved, no formation of the trans product 
could be observed. The next step was the ring opening of the anhydride in such a fashion, that one of 
the resulting carboxylic acid moieties remained unchanged, while the other had to be protected. The 
introduction of a methyl ester group was chosen, as it provides orthogonality to the Boc-group which 
was about to be introduced later in the peptide coupling. This was accomplished by simply refluxing 
the anhydride in methanol, and gave rise to the racemic methyl hemiester rac-63 in quantitative yield. 
The next step towards the cyclic β-amino acid now required the conversion of the free carboxylic acid 
moiety into an amine functionality. A useful way to achieve this is by using the Curtius rearrangement. 
It involves the preparation of an acyl azide, which thermally rearranges to the isocyanate. Subsequent 
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trapping with a nucleophile then generates a substituted amine (often an amide).[170] One of the first 
implementations of this strategy for the synthesis of β-ACHC was done by Kobayashi et al. in 1990.[171] 
However, older protocols for this process are somewhat tedious, as they require several individual 
steps (activation of the carboxylic acid, azidation, rearrangement) and the use of hazardous and even 
potentially explosive compounds, e.g. NaN3 and the intermediary acyl azides.[172] Fortunately, by using 
diphenyl phosphoryl azide (DPPA) these issues can be circumvented and the complete rearrangement 
can be performed in a one-pot protocol.[173] Following the procedure from Timpano et al.,[174] and using 
benzyl alcohol as trapping reagent, enabled the direct synthesis of racemic, Cbz-protected β-ACHC  
cis-64 in good yield.* The final step before peptide coupling consisted of hydrogenolysis of the Cbz 
group and the hydrogenation of the double bond. Both could be achieved simultaneously, giving rise 
to the racemic β-ACHC methyl ester, H-(±)--OMe (rac-65), in 52% yield over four steps.  
 
Scheme 23: Synthesis of racemic H-(±)--OMe (rac-65).  
After successful synthesis of the racemic building block, the next step involved the coupling with  
N-Boc-L-proline (58), which was accomplished with a standard protocol using EDC hydrochloride 
(EDC·HCl).[153,155] The diastereomeric mixture Boc-Pro-(±)--OMe (rac-66) was obtained in good yield 
(72%). However, in contrast to the β-ACC-containing dipeptides of Reiser et al., separation of the two 
diastereomers of the β-ACHC-dipeptide rac-66 was unsatisfactory. To improve separability, the 
synthesis was continued further to the tripeptide stage. This required the selective deprotection of the 
methyl ester using LiOH,[176] followed by the second peptide coupling with L-Proline benzyl ester (67), 
                                                          
* The Cbz-group was chosen again with consideration to orthogonality, as it could be easily cleaved through 
hydrogenation. The purification of the crude product proved to be tedious, as BnOH was difficult to separate 
from the product due to similar Rf values. This issue was addressed by Gellman et al. in 2000. By skipping the 
purification of the Curtius product and performing the hydrogenolysis immediately afterwards this could be 
solved, as the BnOH could then be easily removed by extraction.[175] For similar reasons, this process was later 
also used in the synthesis of the β-ACHC containing tripeptides. 
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again using the EDC hydrochloride protocol.[153,155] Diastereomer separation was reattempted but 
unfortunately led to similar negative results as before. As further reaction steps only included the 
deprotection of the tripeptide (rac-68), a third and final attempt was made there. The first step, the 
Boc deprotection, was performed with HCl in ethyl acetate, a process already used by Reiser et 
al.[153,177] The resulting free amine moiety led to an increased polarity of the compound which was 
thought to aid the separation, however, even this was not sufficient. Despite this, the synthesis was 
still completed with the hydrogenolysis of the Cbz group, giving rise to the finished tripeptide in 23% 
overall yield from maleic anhydride (61), albeit as a diastereomeric mixture.  
 
Scheme 24: Synthesis of the diastereomeric mixture H-Pro-(±)--Pro-OH (rac-52). Reaction conditions: a) N-Boc-Pro-OH (58), 
EDC·HCl, NEt3, DCM, rt, 22 h, 72%; b) 1.) LiOH, THF/H2O, 0 °C to rt, 2 h, 2.) H-Pro-OBn·HCl (67·HCl), EDC·HCl, NEt3, DCM, rt, 
46 h, 79% (2 steps); c) 1.) HCl/EtOAc, 0 °C, 3 h, 2.) Pd/C, H2 (1 bar), MeOH, rt, 1 h, 77% (2 steps). 
The poor separability of the diastereomers might be attributed to the presence of the cyclohexane 
ring, as it allows the peptides a higher degree of conformational freedom compared to the rigid 
cyclopropane ring present in the β-ACC-peptides. The increased conformational ambiguity of the  
β-ACHC diastereomers could be the reason for their higher chemical similarity and, therefore, hampers 
their separation in chromatography. To still arrive at diastereomerically (and enantiomerically) pure  
β-ACHC-containing tripeptides, another pathway had to be found.  
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2.4 Synthesis of the flexible tripeptides from enantiomerically enriched β-ACHC 
While synthesizing the tripeptides from racemic β-ACHC turned out to be unfeasible, a viable option 
appeared to be the use of enantiomerically enriched β-ACHC. This would eliminate the need to 
separate the diastereomers after peptide coupling.  
Several methods to achieve this goal have already been mentioned in chapter 2.2.[159–161] However, 
rather than changing the complete procedure, it was decided to stick to the initial approach of using 
the Diels-Alder reaction to build up the core cyclohexane scaffold. Hence, a process had to be found 
which allowed the enantioselective synthesis of one of the intermediates in this procedure. When 
looking at the aforementioned synthetic route (Scheme 23), it quickly becomes clear that there are 
only two steps which have an impact on the stereochemical outcome of the products: the initial Diels-
Alder reaction or the subsequent generation of the hemiester 63-Pg.* While there are literature 
protocols for racemic synthesis through Diels-Alder reactions,[178] enantioselective routes are rather 
scarce, especially for unsubstituted, monocyclic β-ACHC. The intramolecular 1,3-dipolar cycloaddition 
of unsaturated nitrones fused with chiral auxiliaries, which then generate isoxazolidines, has been 
successfully used in the synthesis of the homologous β-ACPC.[179] A transfer of the procedure to  
β-ACHC through chain elongation of the starting material could be feasible, however, the required 
chemicals are expensive and the synthetic effort demanding. This, overall, renders the use of an 
enantioselective Diels-Alder reaction a rather unsuitable approach. 
Fortunately, the subsequent reaction intermediate, hemiester 63-Pg, is significantly easier to obtain in 
enantiopure form. Over the last decades, a variety of different methods and procedures have been 
developed to address this particular problem, with the majority revolving around one common theme: 
the desymmetrization of meso compounds.[180,181] A small overview of the available methods is 
depicted in Scheme 25. 
                                                          
* The other transformations (i.e. the Curtius reaction and the Cbz deprotection) do not alter the stereocenters 
and are, therefore, uncapable of changing the stereochemistry of the product. 
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Scheme 25: Literature examples of different approaches to the enantioselective synthesis of hemiesters (-)-63-Pg. 
Anhydride cis-56 belongs to this group and is often used as a common starting point in a number of 
approaches. In order to achieve desymmetrization, the anhydride cis-56 is opened using either a 
diastereoselective or an enantioselective ring opening reaction.  
The diastereoselective route usually involves the use of nucleophiles bearing chiral auxiliaries to open 
the anhydride. This leads to the formation of diastereomers, which then have to be separated. While 
these processes can be highly efficient, they also often rely on very elaborate chiral auxiliaries which 
can be very expensive and tedious to synthesize or require hazardous chemicals. Additionally, the 
auxiliaries must be removed to allow for subsequent transformations, which might be complicated 
(especially when using N-nucleophiles as auxiliaries).[182] 
In the enantioselective desymmetrization route, a chiral compound acts as stereoinducing mediator 
for other nucleophiles. Through creating a well-defined complex with the substrate they only allow the 
attack of nucleophiles from certain directions, thus directly generating the enantioenriched 
product.[180] Over the years, many compounds have been used to achieve stereoinduction: Lewis acids 
(e.g. Ti-TADDOLates[183]), Lewis bases (e.g. cinchona alkaloids,[184–187] thiourea organocatalysts[188,189]) 
or enzymes[190–193]. Especially with enzymes, the use of meso diester 69 instead of anhydride cis-56 
gave considerably better results.[190] 
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Besides the desymmetrization approach, the kinetic resolution of the methyl hemiester cis-63 is also 
feasible. Several different chiral amines have been known to form diastereomeric salts with cis-63 (e.g. 
(-)-ephedrine,[191] (+)-dehydroabietylamine[191] or cinchonidine[194]). Nearly enantiopure product can be 
obtained after recrystallization and acidic extraction. As with every kinetic resolution, the maximum 
achievable yield of the enantiomers is limited to 50% when starting from the racemic material.  
After careful consideration, three different approaches were chosen to obtain both enantiomers of 
the methyl hemiester cis-63 (Scheme 26). 
 
Scheme 26: Desymmetrization of meso anhydride (cis-56) to obtain both enantiomers of hemiester 63. PLE = pig liver 
esterase. 
The first attempt at generating enantiopure (-)-63 was conducted using the quinine mediated 
desymmetrization of meso anhydride cis-56 first published by Bolm et al. in 1999 (see Scheme 25, 
upper left).[186] The original protocol was, however, slightly modified. The reaction performed equally 
well in pure toluene, thus avoiding the use of hazardous CCl4.* Additionally, the temperature could be 
increased to -45 °C without having detrimental effects on the enantioselectivity. While the method 
required stoichiometric amounts of quinine and long reaction times at low temperatures, it gave 
hemiester (-)-63 in very good yield (90%) and satisfying enantiopurity (93% ee). As recrystallization of 
(-)-63 itself, in order to improve enantiopurity, is complicated due to its low melting point and tendency 
to form oils, the second approach was the kinetic resolution of the racemic hemiester cis-63. In 1986, 
                                                          
* This was already discovered by Bolm et al. in a follow-up publication in 2000, as they tested the 
desymmetrization of various meso anhydrides in pure toluene rather than in the CCl4/toluene mixture. They 
concluded that very similar results could be obtained with most substrates, although it required lower 
concentrations of the anhydrides.[184] 
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Gais et al. successfully separated the racemate cis-63 by forming the diastereomeric salt with  
(-)-ephedrine and subsequent recrystallization.[191] Utilizing this procedure gave access to enantiopure 
hemiester (-)-63 (> 99% ee) after recrystallizing the salt three times, although, in rather limited yields 
(31%). However, this issue could be mitigated as the process itself was easy to scale up, resulting in 
several grams of enantiopure material.* 
As both methods to obtain (-)-63 required the use of stoichiometric amounts of chiral compounds 
(although recovery was possible in both cases), a third method was chosen to synthesize the other 
enantiomer, (+)-63. In 1983, Mohr et al. first published the use of pig liver esterase (PLE) for the 
selective saponification of symmetrical diesters, including the synthesis of (+)-63 from meso diester 69 
in 95% yield with 85% ee.[193] This process was picked up quickly by other researchers and many 
iterations with slightly changed conditions were published over the last decades.[171,190–192] Using a 
slightly modified procedure from Kobayashi et al.,[171] the hemiester (+)-63 could be obtained with very 
good yields and good enantiopurity (96% ee). Both enantiomers in hand, the diastereomerically pure 
synthesis of the β-ACHC-containing tripeptides could now be reattempted (Scheme 27).  
The hemiesters were again subjected to the Curtius rearrangement. As previously mentioned, the 
required excess of BnOH complicated the purification of the product. The resulting Cbz-protected β-
ACHCs were, therefore, not purified, but immediately subjected to hydrogenolysis. The resulting, 
slightly volatile, free amines were conveniently separated by extraction and then directly coupled with 
N-Boc-L-Proline (58) to obtain the respective dipeptides. For the synthesis of Boc-Pro-(-)--OMe (66), 
the previously described EDC hydrochloride protocol was used again, as it gave good results earlier in 
the preparation of the diastereomeric mixture rac-66. This time, however, due to the use of 
enantioenriched β-ACHC, almost no other diastereomer was formed, meaning the successful synthesis 
of pure Boc-Pro-(-)--OMe (66) from (-)-63 in 34% yield over three steps. Following the route used 
earlier, the methyl ester of the dipeptide 66 was saponified and the free carboxylic acid coupled with 
H-Pro-OBn with EDC·HCl,[153,155] eventually giving rise to the diastereomerically pure tripeptide and 
Boc-Pro-(-)--Pro-OBn (68) in 90% yield over two steps. Two-step deprotection using first 
EtOAc/HCl[153,177] for Boc- and secondly hydrogenolysis for Bn-deprotection finally gave rise to enantio- 
and diastereomerically pure H-Pro-(-)--Pro-OH (52) in 28% overall yield from enantioenriched (-)-63. 
                                                          
* This method could also allow for the isolation of the other enantiomer, (+)-63, from the mother liquor after 
recrystallization. Gais et al. were able to obtain highly enantioenriched (+)-63 (98% ee) through inverse 
recrystallization. After liberating the free acid from the residue of the mother liquor, they added seed crystals of 
(±)-63 to the enantioenriched solution, which led to an increase of the ee in the solution.[191] Similar attempts 
were made, however, 76% ee for (+)-63 was the highest level of enantioinduction which could be achieved. 
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Scheme 27: Synthesis of diastereomeric H-Pro-(-)--Pro-OH (52) and H-Pro-(+)--Pro-OH (ent-52). Reaction conditions: a) 
1.) DPPA, BnOH, NEt3, toluene, reflux, 4 h, 2.) Pd/C, H2 (30 bar), rt, 4 h, 3.) N-Boc-Pro-OH (58), EDC·HCl, NEt3, DCM, rt, 22 h, 
34% (3 steps); b) 1.) LiOH, THF/H2O, 0 °C to rt, 3 h; 2.) H-Pro-OBn·HCl (67·HCl), EDC·HCl, NEt3, DCM, rt, 24 h, 90% (2 steps); c) 
1.) HCl/EtOAc, 0 °C, 3.5 h; 2.) Pd/C, H2 (1 bar), MeOH, rt, 3 h, 92% (2 steps); d) 1.) DPPA, BnOH, NEt3, toluene, reflux, 4 h, 2.) 
Pd/C, H2 (45 bar), rt, 19 h, 3.) N-Boc-Pro-OH (58), T3P, pyridine, EtOAc, -10 °C to rt, 20 h, 64% (3 steps); e) 1.) LiOH, THF/H2O, 
0 °C to rt, 21.5 h; 2.) H-Pro-OBn·HCl (67·HCl), T3P, pyridine, NEt3, -10 °C to rt, 48 h, 82% (2 steps); f) 1.) HCl/EtOAc, 0 °C to rt, 
22 h; 2.) Pd/C, H2 (1 bar), MeOH, rt, 20 h, 91% (2 steps). 
 
The synthesis of the diastereomer, H-Pro-(+)--Pro-OH (ent-52), was conducted in a similar fashion. 
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However, minor changes were made for the peptide couplings. As the EDC hydrochloride mediated 
coupling often gave varying and sometimes sluggish results, another reagent, n-propylphosphonic 
anhydride (T3P), was tested. T3P was introduced by Dunetz et al. and shown to be a reliable, easy-to-
handle coupling reagent, outperforming EDC·HCl in terms of epimerization.[195] With T3P, the pure 
dipeptide Boc-Pro-(+)--OMe (ent-66) was successfully synthesized from (+)-63 after using the 
Curtius/hydrogenolysis/peptide coupling sequence, this time in 64% yield. The subsequent methyl 
ester deprotection and second peptide coupling (again using T3P) gave rise to pure  
Boc-Pro-(+)--Pro-OBn (ent-68) in 82%.  
The synthesis was again completed by the deprotection of the Boc- and Bn-groups, this time giving rise 
to enantio- and diastereomerically pure H-Pro-(+)--Pro-OH (ent-52) in 48% overall yield from 
enantioenriched (+)-63. 
The diastereomeric purity of both peptides could be proven at the protected dipeptide and tripeptide 
stage using chiral HPLC analysis. In contrast to the β-ACC-containing tripeptides from Reiser et al.,[155] 
it was possible to crystallize H-Pro-(-)--Pro-OH (52) from methanol and obtain suitable crystal for  
X-ray analysis (Figure 7).  
 
Figure 7: Left: chiral HPLC chromatograms from the Boc/Bn-protected tripeptides. Upper left: pure 52, center left: 
diastereomeric mixture rac-52, bottom left: pure ent-52. Right: crystal structure from H-Pro-(-)--Pro-OH (52), proving the 
cis-configuration of the β-ACHC in the final product. As expected, the peptide exists in zwitterionic form. 
Main part 
 
52 
 
The crystal structure not only proved the successful synthesis of H-Pro-(-)--Pro-OH (52), but also 
confirmed the cis-configuration of the β-ACHC. As expected, the peptide appears to reside in a 
zwitterionic form. Interestingly, the two charged functional groups, the amine and the carboxylic acid, 
do not form an intramolecular ionic bond and pointed away from each other. They tend to form 
intermolecular interactions between another molecule of 52 and incorporated solvent molecules 
(MeOH). This was rather concerning, as Pilsl and Reiser et al. reported the importance of spatial 
proximity of the functional groups in order to catalyze organic reactions in an effective and selective 
manner.[153,155] However, the orientation of functional groups in a solid crystal structure does not 
directly translate into a similar behavior in the liquid phase, where molecules usually exhibit a much 
higher flexibility and often very different bonding properties.  
In a combined effort with Ertl[158] to further simplify the reaction sequence, the use of N-Cbz-L-Proline 
(70) instead of N-Boc-L-Proline (58) was considered. This would allow the complete deprotection of 
the tripeptides in only one step via hydrogenolysis. Test reactions gave Cbz-protected tripeptide  
ent-72 in diastereomerically pure form. Hydrogenolysis of ent-72 resulted in quantitative amounts of 
the deprotected tripeptide ent-52, proving the viability of this synthetic route. 
 
Scheme 28: Alternative synthetic route towards H-Pro-(+)--Pro-OH (52) using N-Cbz-L-Proline (70). Reaction conditions: a) 
1.) DPPA, BnOH, NEt3, toluene, reflux, 4 h, 2.) Pd/C, H2 (45 bar), rt, 16 h, 3.) N-Cbz-Pro-OH (70), T3P, pyridine, EtOAc, -10 °C 
to rt, 65 h, 44% (3 steps); b) 1.) LiOH, THF/H2O, 0 °C to rt, 21.5 h, 2.) H-Pro-OBn·HCl (67·HCl), T3P, pyridine, NEt3, EtOAc, -10 
°C to rt, 48 h, 74% (2 steps); c) Pd/C, H2 (40 bar), MeOH, rt, 25 h, 100%. 
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2.5 Synthesis of the rigid peptide H-Pro-Ant-Pro-OH 
 
After the flexible tripeptides 52 and ent-52 had been successfully obtained in diastereomerically pure 
form, the focus now turned to the synthesis of a counterpart containing a rigid β-amino acid. Such a 
system with low conformational freedom would then serve as a reference point in the upcoming 
catalytic evaluation of the β-ACHC-tripeptides.  
 
Scheme 29: Synthesis of Boc-Pro-Ant-OMe (74) and Cbz-Pro-Ant-OMe (75). 
The obvious β-amino acid to choose was anthranilic acid (Ant, 54). Its structure is closely related to  
β-ACHC and its core is, due to its aromatic character, completely inflexible. Literature procedures for 
the synthesis of the protected tripeptides Boc-Pro-Ant-Pro-OBn (77) and Cbz-Pro-Ant-Pro-OBn (78) are 
known, using commercially available anthranilic acid 53 as starting material.[196,197] These procedures 
have a high resemblance to the protocols used for the generation of the flexible peptides, requiring 
the formation of the methyl ester 73 as the first step as well. 73 was obtained in fair yield (68%) using 
standard thionyl chloride activation.[198] It was then subjected to the first peptide coupling and both, 
the Boc- and the Cbz-protected dipeptide (74[196,199] & 75[200]), could be prepared in excellent yields 
(Scheme 29). Continuing on, the methyl esters were saponified with LiOH and the now deprotected 
dipeptides coupled with H-Pro-OBn. However, the reaction turned out to be rather sluggish. Standard 
conditions with T3P as coupling reagent provided only very poor yields: 21% for Boc-Pro-Ant-Pro-OBn 
(77)[197] and 15% for Cbz-Pro-Ant-Pro-OBn (78). A small study with Boc-Pro-Ant-OH (76) was, therefore, 
conducted to examine whether different coupling reagents could result in improved yields (Table 3). 
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Table 3: Various reaction conditions tested for the synthesis of Boc-Pro-Ant-Pro-OBn (80). 
 
Entry Conditions 
Isolated yield 
(over 2 steps) 
Remarks 
1 
T3P, pyridine, NEt3,  
EtOAc, -10 °C to rt, 100 h 
21% 
SM partially recovered 
alongside side product  
2 
EDC·HCl, NEt3, 
DCM, 0 °C to rt, 50 h 
- Inseparable mixture 
3 
EDC·HCl, HOBt, NEt3, 
DCM, rt, 22 h 
36% SM partially recovered  
4 
COMU, DIPEA, 
DCM, 0 °C to rt, 4 h 
30% SM partially recovered 
The first attempt was made with previously mentioned EDC·HCl. Unfortunately, this only led to the 
formation of a complex, inseparable mixture and no product could be isolated. A second attempt was 
made by using the more effective combination of EDC·HCl and HOBt. This method was successfully 
employed by Vijayadas et al. in their synthesis of several di- and tripeptides with a Pro-Ant motif, and 
apparently resulted in very good yields (86%) of Boc-Pro-Ant-Pro-OBn (77).[197] With additional HOBt, 
it was actually possible to obtain 77, although only in poor yield (36%), yet still better than with T3P. 
As a final test, another coupling reagent was used: COMU, an uronium-type combined coupling- and 
activation reagent of the Oxyma family. Over the past years, COMU proved to be a valid, less dangerous 
alternative to benzotriazole-based coupling reagents like HATU, with a similar or even better 
performance.[201] While the COMU-mediated coupling of 76 with H-Pro-OBn (67) was significantly 
faster than with the other coupling reagents, still only 30% of 77 could be isolated in pure form. The 
overall poor performance of all applied reaction conditions triggered a small investigation for possible 
causes and could be traced to severe side product formation, which will be elucidated in a separate 
chapter (see chapter 2.6).  
Although all reaction conditions worked poorly, pure Boc-Pro-Ant-Pro-OBn (77) could eventually be 
synthesized in a sufficiently large quantity which made progression of the synthesis possible. Boc-/Bn-
deprotection was accomplished in analogy to the β-ACHC-tripeptides and H-Pro-Ant-Pro-OH (53) was 
finally obtained in 22% overall yield over six steps (Scheme 30). 
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Scheme 30: Final steps in the synthesis of H-Pro-Ant-Pro-OH (53) from 54. 
With all three tripeptides in hand, evaluation of the catalytic activity was examined to gain more insight 
into the relationship between conformational freedom, catalyst performance and high-pressure 
conditions (chapter 2.7). 
 
2.6 Identification of the side product obtained in the synthesis of H-Pro-Ant-Pro-OH 
 
As mentioned in the previous chapter, the synthesis of H-Pro-Ant-Pro-OH (53) was severely hampered 
by the extremely poor outcomes of the second peptide coupling, a problem that persisted even when 
using various different coupling strategies. In order to understand the probable causes, the reaction 
was analyzed in more detail. 
An initial point was an observation made with all conditions in the test reactions with the Boc-dipeptide 
76. The TLC analysis clearly showed the formation of a second product, with higher Rf values than the 
actual product. However, isolation of this side product was more difficult than expected, as it was 
always accompanied by another compound, the starting material 76. This was especially odd, as 76 
should have either been completely consumed during the reaction or (if not completely converted) 
retain on the silica column due to its high polarity caused by the free carboxylic acid group. Therefore, 
it was considered that 76 must have formed during or after purification (or even as late as during TLC 
analysis) and that the side product must be rather unstable. While the side product derived from  
Boc-Pro-Ant-OH (77) could not be obtained in pure form,[196] a crude mass spectrum gave new insight. 
Two mass peaks were found, one belonging to the starting material 76 (MH+ = 335.2), the other to a 
compound with a mass of MH+ = 317.1. As the new compound was 18 u lighter than 76, its formation 
could be explained as the elimination of water from 76. This gave the first hint into possible reaction 
paths and several theoretically possible structures were proposed (Scheme 31).  
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Scheme 31: Theoretically possible side product structures, based on the mass spectra obtained from the unknown 
compounds. Pg = protecting group. 
All of these compounds are in accordance with the observed mass, however, the anthranilium salt 86 
was excluded very quickly, as this should be highly unstable and there are no literature precedents in 
which a comparable substance was successfully isolated.* However, an unambiguous identification of 
the correct structure required the side product to be analyzed in more detail, for which pure material 
was needed. While this was not achievable with the Boc-derivative, the analogous side product could 
be isolated in 76% yield through careful workup in the synthesis of the related Cbz-tripeptide 78. With 
pure compound in hand, a full analysis of the compound was possible. NMR analysis underlined that 
the anthranilium salt 87 was not formed. The formal reduction of the carboxylic acid moiety of 79 
would have added an extra CH signal in the DEPT-135 and DEPT-90 spectra, which was not observed.  
The focus then turned to the Benzodiazepine 85. The formation from 79 was considered questionable, 
as it should be a stable compound and not be prone to hydrolysis. Furthermore, the formation would 
actually require the migration of the Cbz group from the proline moiety to the highly unreactive amide. 
The migration of Cbz-groups is not unprecedented, although, it usually requires special circumstances 
to take place[208] and no example for the here required transformation has been published. 
                                                          
* While N-alkylated anthranilium salts are known and have been isolated,[202–206] N-acylated derivatives have not 
been synthesized and were only once postulated in literature as a possible intermediate in a reaction 
sequence[207]. N-alkylated anthranilium salts have been successfully transformed into the corresponding N-
alkylated benzoazetinones.[202–206] 
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Fortunately, 85 had already been synthesized by Nagasaka et al. in the course of their Tilivalline total 
synthesis.[209] By comparing NMR and IR data, it could be shown that the side product was not the 
benzodiazepine 85.*  
The differentiation between benzoazetinone 81 and 4H-3,1-benzoxazin-4-one 83, however, was more 
complicated: NMR (1D & 2D COSY, HSQC, HMBC) and IR analysis were not sufficient to differentiate 
between both with absolute certainty. This stems from the fact that both compounds are closely 
related to each other, as they are basically isomeric intramolecular anhydrides of N-acylated 
anthranilic acid. Interestingly, the literature on this topic is complex. Although the compound class 
itself was known since 1883,[211] the determination of the structure of N-acylated anthranilic acid 
anhydrides had been a subject of a long-lasting debate in the scientific community.† Today, the 4H-3,1-
benzoxazin-4-one structure is widely accepted in the scientific community.[215,219–223,226] A literature 
search for 83 showed that it had already been published once by Spencer et al. in 1986,[227] however, 
neither an experimental procedure nor analytical data were provided, rendering a determination 
through comparison of data impossible (the synthesis of the analogous Boc-derivative was published 
three times[196,228]). Due to the fact that even today there are publications claiming to have synthesized 
N-acyl benzoazetinone type compounds (the most recent being from Ansary et al. in 2017[229] it 
appeared necessary to provide evidence for the 4H-3,1-benzoxazin-4-one structure, preferably using 
X-ray crystallography. Unfortunately, no crystalline material could be obtained as the compound is an 
oily substance at room temperature. Therefore, a simple derivative, N-acetyl anthranilic acid (88), was 
                                                          
* Although, benzodiazepine 85 should be possible to generate from a very similar compound as 79:  
H-Ant-Pro-OBn. Rather than coupling the N-terminus of anthranilic acid first, this would require the initial 
coupling to happen on the C-terminus. The resulting “inverse” dipeptide could then react to benzodiazepine 85, 
as the nucleophilic free amine would readily attack the activated ester. There are several literature reports which 
describe this kind of benzodiazepine formation.[199,210] 
† This topic was actually only a subplot of a bigger discussion around the turn of the 19th century, which involved 
the determination of the structure of anthranil.[212] Anthranil was found to be exactly 18 u lighter than anthranilic 
acid and was, therefore, considered to be its internal anhydride.[211,212] Several different structures were 
proposed, one of them being the β-lactam (or benzoazetinone).[211,213–218] As analytical methods like X-ray 
diffraction or NMR had just been invented or simply did not exist at that time, structural determination of 
compounds basically relied on elemental analysis and observations made during derivatization reactions of the 
analyte. One of these derivatizations was the N-acylation of anthranil.[211,213–215,217,219] Supporters of the 
benzoazetinone structure defined this to be simply the N-acylated β-lactam, to further substantiate their claim 
on the β-lactam structure of anthranil.[211–213,217] However, other scientists were more skeptical and concluded 
that the high steric strain made the presence of a β-lactam rather unlikely.[215,219,220] Through additional 
experiments they could prove that the acyl carbonyl group can actually partake in reactions rather than it being 
assumed “inert”.[219] This resulted in the postulation of the 4H-3,1-benzoxazin-4-one structure[220] (also 
sometimes termed “acylanthranil”[221–223]). In the end, this turned out to be correct and was later proven by  
X-ray diffraction.[224] The original debate concerning the structure of anthranil itself was laid to rest in 1924 by 
Auwers,[218,225] confirming it to be 2,1-benzisoxazole, again disproving the β-lactam theory.[218,225]  
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synthesized[230,231] and then subjected to similar reaction conditions as used in the peptide coupling of 
79. Although resulting only in 8% of pure material, a single crystal of the product 89 could be isolated 
and analyzed by X-ray diffraction (Scheme 32).  
 
Scheme 32: Synthesis (left) and X-ray structure (right) of 89. 
As can bee seen, the X-ray structure nicely proves the presence of a 4H-3,1-benzoxazin-4-one-type 
structure. Although this is not direct evidence for the structure of the side product, it, paired together 
with literature precedents, underlines the validity of the assumption that the side product obtained in 
the peptide coupling is actually 83 (or 82 for the analogous Boc-derivative).  
Curiously, 83 is rather unstable[196,232,233] (as observed with its tendency to hydrolyze) and should, in 
theory, be able to react with H-Pro-OBn (67) to the desired tripeptide over time. However, the rather 
demanding steric bulk of 67 might hamper this reaction, a point that could be underlined in a short 
study in relation to the hydrolytic stability of 83 (Appendix, Table 9). Besides proving the rapid 
hydrolysis of 83 under basic and acidic conditions,[232] it could be shown that 83 can, in fact, react 
smoothly with secondary amines, however, only if the amine does not possess sterically demanding 
substituents (Scheme 33). 
 
Scheme 33: Test reactions with 83 in a reactivity study. While 83 reacted fast and clean with unsubstituted pyrrolidine (42) 
to give 90, the use of sterically demanding Jørgensen-Hayashi (28) catalyst did not lead to any product (91) at all, even after 
prolonged reaction times. 
This explains that the side product was the preferred outcome of the peptide coupling reaction and 
implies that the formation of 83 must be significantly faster, a point which is supported by the fact that 
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intramolecular processes usually occur quicker than intermolecular ones.[6] Additionally, the aromatic 
core structure should provide a good alignment of the functional groups involved, facilitating the 
formation of 83 even further (Scheme 34).[199] 
 
Scheme 34: Proposed reaction mechanism of the different reaction pathways that can occur during peptide coupling of 79. 
R = T3P phosphonic ester. 
 
2.7 Catalysis with tripeptides 
 
Having all tripeptides successful synthesized, the focus could now be turned on the evaluation of their 
organocatalytic abilities. As the underlying activation mechanism of the tripeptides should be similar 
to L-proline catalysis (i.e. enamine catalysis), the test reactions were chosen accordingly.*  
The aldol reaction between 4-nitrobenzaldehyde (92) and acetone (34) was the benchmark reaction 
investigated, as it was the subject of ongoing research in the Reiser group in order to gain insight into 
the relationship between structural flexibility and catalytic performance of small organocatalysts. 
Therefore, the catalytic activity of several tripeptides containing β-amino acids of varying ring size, 
including cyclopropyl- (49),[153,155] cyclobutyl- (50),[156,157,234] and cyclopentyl (51)[158] derivatives, were 
                                                          
* Besides a multitude of examples under ambient (AP/AT) conditions, there are currently only two examples for 
the L-proline catalyzed aldol reaction under high pressure (HP) conditions.[94,95] 
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evaluated. Additionally, catalyzed reactions were carried out under high pressure (HP) conditions in 
order to investigate correlations between pressure and catalyst flexibility. As a higher degree of 
conformational freedom should make the catalyst more susceptible to pressure effects, pressurization 
could trigger a change in the spatial orientation of the active functional groups. This, in return, could 
then lead to improved activity and/or selectivity. In this connection, the synthesized β-ACHC-
tripeptides 52 and ent-52 would represent the most flexible systems, while the Ant-tripeptide 53 
would act as a rigid reference model to which the results could be compared to.  
In a first test run, a small solvent screening of the aldol reaction was conducted to identify the most 
suitable system for all future investigations (Figure 8 & Appendix Table 10). Reiser et al. had already 
reported that acetone/water mixtures turned out to be very suitable for the tripeptide-catalyzed aldol 
reaction.[153] Additionally, a second solvent system consisting of chloroform and isopropanol was 
evaluated, as this had been proven to be the most effective in the study of Wennemers et al. with their 
tripeptide organocatalysts.[143,145] The results indicated, that the acetone/water mixtures gave far 
superior results in comparison to the chloroform/isopropanol mixtures. Interestingly, highest activity 
required a specific amount of water to be present, with the optimum revolving around 10% (v/v). 
Decreasing or increasing the water amount led to significantly reduced yields.  
This might, on the one hand, be explained through the reaction mechanism: while small amounts of 
water could positively affect reprotonation, facilitate the release of the product and lead to a faster 
catalyst turnover, higher amounts might push the equilibrium of the initial enamine formation towards 
the starting materials, thus effectively canceling out the reaction.[157] On the other hand, the spatial 
arrangement of the functional groups of the catalyst could be influenced by the solvent. Here, it 
appears that polar aprotic solvents (like acetone) are the most suited in stabilizing an “active” 
conformation. As proximity of the amine and the carboxylic acid group is essential for catalytic 
activity,[147,155] the presence of a water molecule could aid this by acting as a mediator, bridging the 
functional groups through hydrogen-bonds, thus bringing them closer together and rigidifying the 
catalyst. If water levels are decreased or a non-polar solvent is used (e.g. chloroform), this mediating 
effect might be negated leading to more flexibility, while increased amounts of water or polar solvents 
(e.g. isopropanol) would lead to an increased interaction of the functional groups with the solvent 
molecules, rather than with each other. This can be somewhat underlined by the observations made 
in the X-ray analysis of 52. 
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Figure 8: Solvent screening of the benchmark aldol reaction catalyzed by tripeptide 52. Conditions: 1.00 mmol  
4-nitrobenzaldehyde (92), 10 equiv. acetone (34) (if not present as solvent), 2 mL solvent. Conversion and yield determined 
by NMR using diphenoxymethane (46) as internal standard. 
Having settled for acetone/water 10:1 (v/v) as solvent, focus was moved on evaluating the catalytic 
activity of the tripeptides under AP/AT and HP conditions (Table 4). Blank reactions were carried out 
first, in order to rule out the occurrence of a background reaction. Slight conversion of the aldehyde 
was observed (similar to the Michael reaction described in the previous chapter), however, no product 
formation could be detected under AP/AT as wells as HP conditions (entries 1&2). First reactions were 
carried out with 10 mol% of 52 at AP/AT (entry 5), reproducing the conditions used by Pilsl with the  
β-ACC-tripeptide 49 (entry 3).[155] The more flexible catalyst 52 led to improved yields after 24 h (from 
73% to 84%), however, the increased conformational freedom led to drastic losses of selectivity (69% 
to 19% ee). The reaction was repeated with a decreased catalyst load of only 1 mol% (entry 6) and, 
remarkably, 52 retained it's high reactivity, achieving similar yields as 49 but requiring only one-tenth 
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of the catalyst amount.* With less catalyst, however, a slight drop of (the already low) 
enantioselectivity could be observed (19% to 13% ee). Using the diastereomeric catalyst ent-52 gave 
similar reactivity (64% yield), but this time led to no enantioinduction at all (entry 9), indicating that 
the spatial arrangement of the functional groups is slightly better in 52. The best enantioselectivity 
could be achieved with the rigidified catalyst 53 (29% ee), although, this resulted in diminished 
reactivity (47% yield, entry 11). The R-enantiomer of 93 was formed exclusively with all catalysts, which 
is in accordance with the observations made with the other tripeptides bearing the same structural 
motif.[153,155,158] 
Table 4: Results of the catalyst evaluation of the aldol reaction. 
 
Entry 
Catalyst 
[Xxx] 
catalyst loading 
[mol%] 
Time 
[h] 
Pressure 
[kbar] 
Conversion 
[%]a) 
Yield 
[%]b) 
ee (R) 
[%]c) 
1 - - 24 10-3 9 0 - 
2 - - 7 4.8 12 0 - 
3d) (-)- (49) 10 24 10-3 84 68e) 69 
4d) (-)- (49) 10 4 4.8 97 73e) 67 
5 (-)- (52) 10 24 10-3 n.d. 84e) 19 
6 (-)- (52) 1 24 10-3 n.d. 71e) 13 
7 (-)- (52) 1 7 10-3 47 42 11 
8 (-)- (52) 1 7 4.8 87 74 22 
9 (+)- (ent-52) 1 24 10-3 75 64 0 
10 (+)- (ent-52) 1 7 4.8 93 69 9 
11 Ant (53) 1 24 10-3 61 47 29 
12 Ant (53) 1 7 4.8 79 77 28 
Reaction conditions: 1.00 mmol 4-nitrobenzaldehyde (92), 2 mL solvent. a) Determined by crude NMR using 
diphenoxymethane (46) as internal standard or through recovered starting material. b) Determined by crude NMR using 
diphenoxymethane (46) as internal standard. c) Determined using chiral HPLC (AS-H). d) From ref. [155], 0.2 mmol scale.  
e) Isolated yield. 
When comparing the reaction outcomes under AP/AT conditions, it became apparent that there 
seemed to be a correlation between the flexibility of the catalyst on the one hand, and the resulting 
reactivity and selectivity on the other hand. While the more flexible catalysts 52 and ent-52 gave 
improved yields, selectivity appeared to be positively influenced by the structural rigidity of 53. The 
increased flexibility allows the catalyst to better adapt to the reactants, bringing the active functional 
                                                          
* Neither Reiser et al.,[153] nor Pilsl[155] attempted to use less than 10 mol% of catalyst, therefore, it cannot be 
ruled out that the reaction would also occur with 1 mol% of 49. This is likely to be the case, as the reaction ran 
with all other tripeptide catalysts under these conditions (Table 5). 
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groups into proximity. However, the higher conformational ambiguity probably makes the transition 
state in the stereoinducing step of the reaction less stable, which leads to lower selectivities. 
To tackle this dilemma, the use of high-pressure conditions was considered, as HP forces molecules 
into more rigid, tightly-packed conformations while acting as activation mode at the same time. All 
tests were, therefore, rerun under HP conditions. Leading with 52, the reaction reached similar yields 
after only 7 hours under HP conditions (entry 8) compared to the same reaction under AP/AT 
conditions after 24 h (entry 6). Interestingly, enantioinduction was slightly increased as well (22% ee). 
The reaction was repeated under AP/AT conditions and 7 h (entry 7), which affirmed that the reaction 
indeed proceeded faster and more selective under HP conditions by a factor of two. The diastereomer 
ent-52 behaved similar, also achieving comparable yields and slightly increased enantioinduction 
(although only to a small degree) after just 7 h under HP conditions (entries 9&10). The reaction with 
the rigidified catalyst 53 profited most from the use of HP. It reached similar yields as the equally 
constrained β-ACC catalyst (entry 4) and the flexible catalysts under the same conditions, without 
erosion of enantioselectivity (entry 12). This indicated, that the accelerating effect of HP probably 
stems from it being a general activation method by the means of adding energy to the system and 
shifting the equilibrium, rather than through drastically influencing the conformation. Otherwise, the 
reaction catalyzed by the rigid 53 should not have shown such a drastic increase in yield when 
pressurized. However, HP appears to stabilize conformations and, therefore, transition states to a 
certain degree. This leads to a more defined, less flexible catalyst-substrate complex, which in return 
results in improved enantioinduction in the product, as was observed with the flexible catalysts. 
As mentioned before, the aldol reaction was also subject of a comparative study with tripeptide 
catalysts containing β-amino acids of varying ring size.[155,156,158,234] 52 represents the most flexible of 
all catalysts and the obtained results fit well in the series (Table 5).  
Selectivity-wise, a clear trend is observable. Enantioselectivity decreases steadily with increasing ring 
size of the β-amino acid. This underlines that a stereoselective reaction environment requires rigidity 
(i.e. low conformational freedom), in order to develop a well-defined catalyst-substrate complex with 
these types of compounds. The use of constraining HP conditions, therefore, has little effect on the 
selectivity of already inflexible systems (cyclopropyl and –butyl derivatives 49 & 50, entries 2&4). 
However, more flexible systems are positively influenced to a small extent (cyclopentyl and –hexyl 
derivatives 51 & 52, entries 6&8).  
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Table 5: Comparison of results obtained with tripeptide catalysts containing β-amino acids of varying ring size. 
 
Entry 
Catalyst 
[Xxx] 
Catalyst loading 
[mol%] 
Time 
[h] 
Pressure 
[kbar] 
Isolated 
yield [%] 
ee (R) 
[%]a) 
1b) (-)- (49) 10 24 10-3 68 69 
2b) (-)- (49) 10 4 4.8 73 67 
3c) (-)- (50) 1 24 10-3 45 47 
4c) (-)- (50) 1 7 5.0 66 41 
5d) (-)- (51) 1 24 10-3 82 31 
6d) (-)- (51) 1 6 4.6 57 41 
7 (-)- (52) 1 24 10-3 71 13 
8 (-)- (52) 1 7 4.8 65 22 
Reaction conditions: 1.00 mmol 4-nitrobenzaldehyde (92), 2 mL solvent. a) Determined using chiral HPLC (AS-H). b) From ref. 
[155], 0.2 mmol scale. c) From refs. [156,234]. d) From ref. [158]. 
In terms of reactivity, the results are a little more diverse. Under AP/AT conditions, the catalysts 
performed similar, with the exception of the slightly less active cyclobutyl analogue 50. Under HP 
conditions and shorter time periods, however, 50 (in comparison) achieved higher yields, while the 
cyclopentyl analogue 51 gave diminished yields. The HP reactions with the cyclopropyl and –hexyl 
derivatives gave comparable results to the standard AP/AT conditions. Due to this ambiguous 
behavior, it is difficult to draw a conclusion on the relation between ring-size-induced flexibility and 
reactivity. This might be attributed to the slightly different orientation of the catalytically active prolyl 
moieties in each catalyst. The dihedral angle between the two substituents of the β-amino acids is 
dependent on ring size,[235] thus changing the spatial arrangement of the functional groups for every 
catalyst, making a direct comparison impossible.* 
Although the overall accelerating effect of HP conditions on the tripeptide catalyzed aldol reactions 
might not be directly correlated to conformational changes, compression clearly has an observable 
impact on the reaction outcome. In this case, HP probably acts more as a general activation mode 
through addition of energy and the fact that Aldol reactions (as most reactions which are accompanied 
by entropy decrease) have a negative volume of activation ∆𝑉‡ and, therefore, benefit from the use 
                                                          
* To further extend this point, simple cis-dimethyl cycloalkanes were drawn in Chem3D® (Perkin Elmer), subjected 
to the implemented energy minimization protocol (using MM2 default parameters) and the dihedral bond angle 
of the methyl substituents were calculated. Cyclopropyl: 0°, Cyclobutyl: 23.1°, Cyclopentyl: 45.8°, Cyclohexyl: 
54.2°. 
Main part 
 
65 
 
of HP conditions.[236]  
To broaden the scope of applications, it was decided to test the synthesized catalysts in a second 
benchmark reaction, the conjugate Michael-type addition between acetone (34) and  
trans-β-nitrostyrene (40). The reaction had, again, been reported to proceed with L-proline (23) as 
catalyst under AP/AT conditions,* reassuring that it could be catalyzed by the tripeptides as well  
(Table 6).[237] Blank reactions again ruled out the occurrence of a background reaction forming product 
(entries 1&2). Some conversion of starting material could be observed, however, this was to be 
expected from earlier studies.[124]  
Table 6: Results of the catalyst evaluation of the Michael reaction. 
 
Entry 
Catalyst 
[Xxx] 
Time 
[h] 
Pressure 
[kbar] 
Conversion 
[%]a) 
Yield 
[%]a) 
ee (R) 
[%]b) 
1 - 48 10-3 10 0 - 
2 - 16 4.8 21 0 - 
3 (-)- (52) 48 10-3 92 91 13 
4 (-)- (52) 4 10-3 25 23 12 
5 (-)- (52) 16 4.8 98 79 9 
6 (-)- (52) 4 4.8 80 64 10 
7 (+)- (ent-52) 48 10-3 63 60 14 
8 (+)- (ent-52) 16 4.8 100 88 18 
9 Ant (53) 48 10-3 39 33 24 
10 Ant (53) 16 4.8 94 85 24 
Reaction conditions: 52 and ent-52: 0.50 mmol trans-β-nitrostyrene (40), 2 mL solvent, 53: 0.25 mmol trans-β-nitrostyrene 
(40), 1 mL solvent. a) Determined by crude NMR using diphenoxymethane (46) as internal standard. b) Determined using 
chiral HPLC (AS-H). 
In contrast to the aldol reaction, 1 mol% of catalyst did not lead to any significant conversion after 
24 h, thus requiring the use of 10 mol%. After 48 h under AP/AT conditions, 52 gave excellent yield 
(91%, entry 3), however, enantioinduction was equally poor as in the aldol reaction. Interestingly, the 
diastereomeric ent-52 reached only fair yield (60%, entry 7), contrasting the results of the aldol 
reaction where both flexible catalysts performed similar under AP/AT conditions. The use of the more 
rigid 53, however, led to similar results as in the aldol reaction: poor yield (33%) but highest selectivity 
of all (24% ee, entry 9). The significantly divergent results of the diastereomeric flexible catalysts 
indicated that, in the Michael addition, proper conformational alignment is probably more important 
                                                          
* There are currently no examples for the Michael reaction under HP conditions via covalent enamine-type 
catalysis. 
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to achieve good reactivity. This might be related to the different transition state the reaction proceeds 
through, which 52 can apparently stabilize to a higher extent. (Figure 9).  
 
Figure 9: Simplified transition states of the aldol and Michael reaction catalyzed by the tripeptide catalysts, demonstrating 
their different structure and size. The transition states were originally proposed by Wennemers et al.[148,152] 
To once again analyze the implications the use of high pressure has on the catalyst systems, all 
reactions were run under HP conditions. With 52, a slightly lower yield (79%, entry 5) than under AP/AT 
was obtained, however, the reaction time could be reduced to only 16 h. To see if this could be pushed 
even further, reaction times were once more reduced to 4 h. While under AP/AT conditions the 
reaction had only proceeded to a small amount (23% yield, entry 4), the analogous HP reaction had 
already reached a fair yield (64%, entry 6), which equates roughly to a tripled turnover number. 
Surprisingly, the diastereomeric catalyst ent-52 gave even an improved yield under HP conditions, 
leading to an almost six times faster reaction. The rigid 53 also gave a vastly improved yield under HP 
conditions (85%, entry 10), actually achieving a more than seven times faster reaction under HP than 
under ambient conditions. While high pressure had a clearly positive influence on reactivity, this time 
selectivity remained almost unchanged with both, flexible and rigid tripeptides. The increase in 
reactivity under high pressure, again, is most likely caused by the action of HP as a general activation 
mode through the addition of energy into the system. Whether the enantioselectivity is influenced by 
HP or not is probably dependent on the transition state of the catalyst-substrate complex and its 
stability, rather than on the flexibility of the catalyst in general.  
In conclusion, the results of this catalytic study neatly demonstrate that, in peptide organocatalysis, 
HP conditions positively affect reactivity, while retaining (or even improving) selectivity of reactions. 
This underlines the viability of HP as secondary activation mode in organocatalyzed reactions. 
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2.8 Conformational study of H-Pro-(-)--Pro-OH using HP-NMR 
 
Reiser et al. described the presence of two distinct conformations in the NMR of H-Pro--Pro-OH (49) 
at ambient pressure in a 3:1 ratio, which arose from the (literature known) cis/trans isomerism of the 
C-terminal proline moiety.[153] Pilsl further investigated 49 under HP-NMR conditions, demonstrating 
that conformations could be severely influenced by high pressure. Combining the results with 
theoretical calculations, he proposed that the functional groups were aligned best in the  
cis-conformer, thus it represents the catalytically most active and selective structure.[155] Interestingly, 
in the closely related H-Pro-(-)--Pro-OH (50), only the trans-conformer could be identified.[156] In both 
rigid peptides, no significant isomerism of the N-terminal proline could be detected. However, 
measurements of 49 and 50 were conducted in MeOH-d3 and not in the actual solvent system used for 
catalysis.  
Initial 1H- and 13C-NMR measurements in CDCl3 of H-Pro-(-)--Pro-OH (52) at ambient pressure 
indicated that 52 resides in at least two distinct conformational states, as the spectra showed clear 
signs of signal doubling, especially with the amide proton signal. It was unclear whether this stemmed 
from the cis/trans isomerism observed earlier with 49 or had a different origin. In order to gain insight 
into the conformational behavior of the flexible peptide, 52 was analyzed in a collaborative project 
within the FOR 1979 high-pressure research group using HP-NMR, as HP-NMR is a helpful tool for 
identifying rare conformational states.[238] The studies were carried out in the biophysical department 
of the University of Regensburg by Ertinger in the group of Kalbitzer and Kremer as a collaborative 
project.[239]  
To remain close to the catalytic conditions, the peptide was supposed to be measured in the solvent 
system used for catalysis, acetone-d6/D2O (10:1), utilizing one-dimensional 1H, 13C, DEPT and NOESY, 
as well as the two-dimensional COSY, HSQC and TOCSY experiments. However, 52 had to be measured 
in H2O/D2O (10:1) first to assign all signals, as directly measuring in acetone-d6/D2O proved to be 
complicated due to the large residual solvent signals. Overlaying the assigned spectra then allowed the 
successful identification of the respective signals in acetone-d6/D2O (10:1) and an NMR pressure series 
was recorded (Figure 11). Plotting the chemical shift values against the pressure allowed the extraction 
of thermodynamic parameters (∆𝐺𝑖, ∆𝑉𝑖), which in return gave information on the conformations.
[239] 
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Figure 10: 800 MHz NMR spectrum of 52 in H2O/D2O (10:1) at ambient pressure and 275 K, clearly showing several resonances 
of amine and amide protons correlating to different conformations being present.[239] The NH’/NH’’ ratio is approximately 
1:4. 
The measurements revealed that even at ambient temperature several conformers of 52 exist 
simultaneously (Figure 10). Two of them are associated to the cyclohexyl ring (seen by the two amide 
proton signals, NH’’ and NH’ in a 4:1 ratio) and three with the N-terminal proline (NH*, NH** and 
NH***) (Scheme 35). The two cyclohexyl conformations (52-A and 52-B) are probably caused by ring 
inversion of the cyclohexyl scaffold of the trans,trans-configured peptide, as trans amide bonds are 
known to be more stable.[240,241] The fact that both cyclohexyl conformations are detectable by NMR 
shows that they must (at least) be meta-stable and interconvert rather slowly. This hints on some sort 
of stabilization (probably through H-bonding of the amide proton and the amide carbonyl group), 
although one conformation should be favored due to the observed 4:1 peak integral ratio.  
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Scheme 35: Proposed conformations of H-Pro-(-)--Pro-OH (52) identified by HP-NMR.[239] The central 52-A represents the 
closest resemblance to the structure obtained from X-ray analysis and is probably the most stable. While depicted in 52-B, 
the hydrogen bond responsible for locking the rotation of the C-terminal proline is omitted in the other structures for reasons 
of clarity. 
The other conformations can be tracked to rotation of the N-terminal proline. While one amine signal 
stems from the stable trans,trans-isomer, isomerization of the amide bond leads to the cis,trans-
conformer 52-C (isomerisation of prolyl amides is more common as with other amino acids due to the 
increased steric bulk[240,241]). The other conformer 52-D is probably formed by rotation of the prolyl 
moiety around the bond adjacent to the carbonyl group (bond angle ψ). This, supported by the fact 
that the corresponding NMR signal is rather sharp, indicates the formation of a hydrogen bond that 
stabilizes the conformation. Interestingly, analysis of the obtained thermodynamic parameters 
showed that the C-terminal proline resides in only one conformation, stabilized through a hydrogen 
bond between the proton of the carboxyl group and the adjacent carbonyl group of the amide 
bond.[239] A similar observation was made for the cyclobutyl derivative 50.[156] 
With increasing pressure, it appeared that almost all conformations became less populated. Although 
high pressure can weaken intramolecular interactions,[242] this might be traced to the solvent system 
acetone-d6/D2O, which is not entirely inert in combination with the tripeptide. In analogy to the 
catalysis experiments, 52 can form an iminium ion with acetone (34),* which is facilitated under high 
                                                          
* Recently, Ortuño et al. reported the identification of iminium ion intermediates in acetone-d6 with tripeptides 
containing γ-cyclobutyl amino acids.[157] 
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pressure. This leads to the generation of new competing species that further complicates the 
interpretation of the spectra.[239] 
To facilitate the investigation of the cyclohexyl scaffold of β-ACHC in particular, simplified model 
compounds were synthesized which do not bear all the functional groups of the catalyst 52. The results 
are discussed in detail in the following chapter. 
 
Figure 11: Stacked plot of 600 MHz 1H-NMR spectra of 52 obtained at various pressures at 275 K in acetone-d6/D2O.[239] An 
indication for the formation of the iminium ion is the increasing signal of the residual water (around 4.1 ppm) and acetone 
(2.1 ppm), which is likely to be caused through isotope exchange with acetone-d6. 
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3. Synthesis and evaluation of β-ACHC model compounds 
 
The HP-NMR studies of the H-Pro-(-)--Pro-OH (52) revealed high conformational freedom making the 
tripeptide catalyst highly flexible,[239] which is believed to be a major contributing factor to the poor 
enantioselectivities in the catalytic test reactions. Amongst others, one observed behavior was the 
assumed ring inversion of the central cis-β-amino acid scaffold. The high flexibility and functional group 
density of 52, however, severely complicated the interpretability of the acquired data. In order to gain 
more insight into the matter, it became reasonable to analyze cis-β-ACHC independently, as its 
conformational behavior could prove useful for understanding that of the entire peptide 52.  
This idea was based on the studies of Gellman et al. in the 1990s, who used small, linear or cyclic model 
compounds that were structurally related to α-, β- and γ-amino acids. Analyzing these molecules with 
NMR and IR spectroscopy as well as theoretical calculations allowed them to obtain general 
information on the conformational behavior of different amino acids and their hydrogen-bonding  
(H-bonding) patterns.[243,244] Similar investigations have been carried out for cyclic β-amino acids, e.g. 
in the Reiser group for β-ACC[245,246] or by Ortuno et al. for β-ACBC.[247] 
Therefore, the synthesis of Ac--NMe2 (cis-95) was conceived, as it represented a structural analog to 
the cis-β-ACHC in the tripeptide 52, containing the entirety of the amino acid scaffold but omitted the 
large, substituted prolyl residues of 52 which would interfere and complicate the spectroscopic 
analysis (Figure 12). Besides cis-95 the corresponding trans-compound trans-95 was synthesized as 
well. It should not display ring inversion, as this would leave both substituents in the energetically 
disfavored all-axial orientation, rendering it a reference to compare results to. Both model compounds 
were then investigated using NMR spectroscopy and, in cooperation with the TU Dortmund, with  
HP-IR spectroscopy in order to learn more about their conformational properties and the influence of 
high-pressure conditions.  
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Figure 12: Chemical structures of the synthesized model compounds (left) for the investigation of the conformational 
behavior of the central β-amino acid in the tripeptide H-Pro-(-)--Pro-OH (52) (right). 
 
3.1 Synthesis of the model compounds 
 
As the final products are not literature known, a synthetic pathway had to be developed. Building on 
the approach used for the tripeptides (see Scheme 23), a slightly modified synthetic route was 
conceived to gain access to the model compounds. As the conformational analysis should not be 
influenced by the absolute stereochemistry of the molecules, this meant that only the relative 
stereochemistry (cis & trans) had to be introduced. This can be achieved conveniently in the initial 
Diels-Alder reaction and makes the kinetic resolution step (which was essential in the peptide 
synthesis) redundant. The opening of the resulting anhydrides (cis- & trans-56) with dimethylamine 
would then result in the formation of the hemi-amides (cis- & trans-96), which are subsequently 
subjected to Curtius rearrangement to convert the free carboxylic acid moieties into the protected 
amines (cis- & trans-97). As final steps, hydrogenation followed by simple N-acetylation would result 
in the final model compounds (cis- & trans-95). 
The synthesis was started with the same Diels-Alder reaction already employed in the tripeptide 
synthesis, using 3-sulfolene (62) as 1,3-butadiene precursor.[166–168] As the cis adduct cis-56 had already 
been obtained, only trans adduct trans-56 had to be synthesized. As direct generation was impossible 
(the corresponding “fumaric anhydride” does not exist), the equivalent diacid trans-99 had to be 
formed first with fumaric acid (98) as dienophile, following the procedure developed by Reddy et al. in 
2014.[248] Treatment with acetic anhydride then led to the successful formation of the trans anhydride 
(trans-56) in 82% yield over two steps (Scheme 36).[249] 
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Scheme 36: Synthesis of the cis- and trans-cycloadducts cis-56 and trans-56. 
With both anhydrides available, the next step was the ring-opening amidation using in situ generated 
dimethylamine (Scheme 37). In this reaction, the isomers displayed quite different properties as  
trans-56 showed a higher reactivity than its cis counterpart, probably a result of the decreased stability 
of the trans-anhydride. Unfortunately, the subsequent Curtius reaction did not proceed as planned. 
For reasons unknown, both diastereomers reacted extremely sluggish, providing almost no rearranged 
products (cis- & trans-97). This is probably related to the presence of the adjacent amide moiety, as 
previous reports exist describing this particular issue. Hibbs et al. experienced similar difficulties while 
synthesizing a structurally related amino acid containing a norbornene scaffold, proving that the use 
of DPPA as azide-transfer agent fails when an amide group is adjacent to the carboxylic acid.[250]  
 
Scheme 37: Initial synthetic strategy for the synthesis of the model compounds starting through ring-opening amidation. 
Therefore, this approach was rendered impractical and the route was changed to the strategy that had 
already been used to synthesize cis-β-ACHC for the tripeptides. Although this made the reaction longer 
and more elaborate, this sequence (including the Curtius reaction) had already proven to work reliably.  
Again starting from the cycloadducts (cis-56 and trans-56), both were reacted with methanol to obtain 
the corresponding hemiesters cis- and trans-63 in quantitative yield. With those in hands, the DPPA-
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mediated Curtius reaction with BnOH worked smoothly, introducing the Cbz-protected amine 
functionalities.[174] The crude product[175] was submitted to hydrogenolysis, cleaving the protecting 
group and hydrogenating the double bond. The now free amine was then reacted with acetyl chloride, 
yielding amides cis-100 in 46% and trans-100 in 50% yield over three steps. After saponification of the 
methyl ester,[176] only the final amidation of the carboxylic group with dimethylamine was left to be 
performed for both isomers. Two different approaches were attempted. The first included the 
generation of the acid chloride using thionyl chloride, which was subsequently treated with a freshly 
prepared 1.26 M solution of dimethylamine in THF. The second attempt was a one-pot procedure 
where activation and amidation proceeded simultaneously, using T3P as activating agent and the same 
dimethylamine solution.[195] In the end, the one-pot procedure turned out to be more effective, as it 
was easier to work up, resulted in higher yields and was less prone to side product formation.  
 
Scheme 38: Synthesis of the model compounds cis- and trans-95. Reaction conditions: a) MeOH, reflux, 2 h, 100%; b) 1.) 
DPPA, BnOH, NEt3, toluene, reflux, 18.5 h, 2.) Pd/C, H2 (40 bar), rt, 17 h, 3.) AcCl, DCM, 0 °C to rt, 17.5 h, 46% (3 steps); c) 
LiOH, THF/H2O, 0 °C to rt, 18 h, 95%; d) 1.26 M HNMe2 in THF, T3P, pyridine, THF/DMF, -10 °C to rt, 46 h, 66%; e) MeOH, 
reflux, 0.5 h, 95%; f) 1.) DPPA, BnOH, NEt3, toluene, reflux, 19 h, 2.) Pd/C, H2 (40 bar), rt, 16 h, 3.) AcCl, DCM, 0 °C to rt, 0.5 h, 
50% (3 steps); g) LiOH, THF/H2O, 0 °C to rt, 20 h, 81%; h) 1.26 M HNMe2 in THF, T3P, pyridine, THF/DMF, -10 °C to rt, 46 h, 
52%. 
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With this procedure, cis-95 was obtained with 25% yield over seven steps and trans-95 with 16% yield 
over eight steps, both starting from the cycloaddition of 3-sulfolene (62) respectively (Scheme 38). The 
two isomers could be recrystallized and the obtained crystals were subjected to X-ray analysis which 
confirmed their structures. A closer look at the crystal structures gives a first insight into their 
conformational behavior and already reveals several differences between both diastereomers  
(Figure 13). Model compound cis-95, which resembles the building block present in the tripeptides, 
features two molecules forming a well-defined dimer. Hydrogen bonding occurs between the amide 
and carbonyl functionality located at the cyclohexyl ring of the respective molecules. The external 
carbonyl of the acetyl group does not partake in any kind of coordinative action. In contrast, trans-95 
behaves very differently. Rather than forming dimers like cis-95, trans-95 appears to order itself into a 
stacked, chain-like multimer through H-bonding. While these results of course only resemble the solid 
state case, the difference in the spatial arrangement of the molecules and H-bonding has observable 
effects. For instance, the melting point of trans-95 is around 20 °C higher than that of cis-95. This might 
be explained through the H-bonding pattern: while cis-95 forms only dimers, trans-95 is able to 
generate larger coherent H-bond networks, thus stabilizing the crystal lattice and increasing the 
required amount of energy to melt the molecule. However, to get more insight into the actual behavior 
in the liquid phase, more experiments had to be conducted in solution using NMR and HP-IR 
spectroscopy.  
 
Figure 13: X-ray single crystal structures obtained from cis-95 (left) and trans-95 (right). Non-essential hydrogen atoms are 
omitted for the sake of clarity, H-bonds are depicted in cyan. The substituent-bearing carbon atoms of the cyclohexyl ring are 
numbered to facilitate comparison between chemical and X-ray structure. 
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3.2 Conformational studies of the model compounds in solution using NMR and HP-IR 
3.2.1 Conformational analysis with NMR spectroscopy 
 
After successful synthesis and preliminary investigation of the solid state properties, conformational 
analysis of cis- and trans-95 in solution was carried out with NMR spectroscopy. In order to minimize 
solvent-solute interactions that would influence the conformational behavior, both compounds were 
measured in CDCl3 at room temperature. A full set of 1D- and 2D-spectra were recorded, including 1H, 
13C + DEPT, COSY, HSQC, HMBC and 2D-NOESY-experiments, allowing the unambiguous assignment of 
all relevant signals. 
Against expectations, NMR spectra of cis-95 displayed a single set of signals, indicating that it resided 
in only one conformation under the investigated conditions.* Evaluation of the spectroscopic data 
revealed that the NHAc moiety is likely to be in axial position, leaving the C(O)NMe2 group in an 
equatorial position of the cyclohexane chair (Figure 14). The lack of ring inversion might be explained 
by a fixed spatial orientation of the substituents due to a stabilizing intramolecular H-bond between 
the carbonyl- and the amide groups. It is worth mentioning that this conformation is directly opposite 
to the one found in the crystal structure of cis-95 (see Figure 13), but exactly resembles the one in the 
tripeptide 52 (see Figure 7). This leads to the assumption that the observed flexibility of the tripeptide 
52 should be a result of the additional inter- and intramolecular interactions of the Prolyl-residues, 
rather than it being an intrinsic property of β-ACHC. 
 
Figure 14: Depiction of the proposed conformation for cis-95 based on NMR data (ax = axial, eq = equatorial, NOE = signal 
present in NOESY). 
The investigation of the corresponding trans-isomer trans-95 again led to unexpected findings. Here, 
the existence of two distinct conformations in a 5:1 ratio could be detected. The occurrence of ring 
inversion is highly unlikely, as this would lead an all-axial orientation of the substituents, which is highly 
                                                          
* It is also conceivable that it resides in two (or more) conformations which are rapidly interconverting. However, 
this should lead to significant line broadening in the NMR spectrum, which was not observed. 
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disfavored energetically. Furthermore, the formation of a stabilizing intramolecular H-bond is only 
possible in the all-equatorial configuration. Analysis of the 3J(H,H)-coupling constants of the proton 
located at the same carbon center as the C(O)NMe2-group (proton Hd, Scheme 39) proved that no ring 
flip occurs.* Unfortunately, the low abundance of the second conformer and the large signal overlap 
made structure determination rather difficult. However, the spectral data indicated that the 
conformational ambiguity probably stems from the N-acetyl moiety and two possible explanations 
were proposed (Scheme 39).  
 
Scheme 39: Possible structures of the minor conformer observed for trans-95. The protons are labeled in accordance with 
the assignment of the NMR spectra found in the appendix and are mentioned in the text.  
The first one is the occurrence of an isomerization of the amide bond, leading to the (disfavored) cis 
amide 95-B. This is supported by literature reports as it was also observed for structurally related 
compounds.[253] The second one is the breaking of the intramolecular H-bond in favor of an 
intermolecular one, as observed in the crystal structure (see Figure 13). The fact that the coupling 
constant of the amide proton is different for both conformers substantiates this assumption. While 
the main conformer (3J(Hg,Hh) = 6.2 Hz) indicates a dihedral angle θ(Hg,Hh) of 60°, the minor conformer 
has a higher coupling constant (3J(Hg,Hh) = 10.4 Hz), hinting on θ(Hg,Hh) = 180° which would resemble 
95-A.[251,252] 
The tendency of intermolecular H-bonds being formed is highly dependent on the concentration of the 
compound and increases with higher concentrations. Whether this occurs or not can be determined 
                                                          
* In cyclohexanes, the 3J(H,H) coupling constant is dependent on the dihedral angle θ(H,H) between the hydrogen 
atoms on adjacent carbon centers. This dependence can be described by the Karplus equation. Dihedral angles 
of around 60° (i.e. an axial-equatorial or equatorial-equatorial orientation of the adjacent protons, like Hd↔Hb 
in Scheme 39) leads to 3J = 2 - 5 Hz. Angles of 180° (i.e. axial-axial orientation, like Hd↔Hg  in Scheme 39) results 
in 3J = 8 - 15 Hz. In an all-axial conformation of the substituents, proton Hd would be in equatorial position. This 
would result in θ(H,H) = 60° for all adjacent protons, meaning that the 3J coupling constants should all be rather 
small. However, proton Hd gave similar coupling constants for both conformers: 3J = 3.5 & 11.3 Hz (major) and J 
= 3.3, 10.3 Hz (minor), which is only possible for the all-equatorial conformation (as θ(H,H) = 60° and 180°). 
Therefore, the presence of the all-axial conformation was ruled out.[251,252] 
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by analyzing NMR spectra at variable concentrations, as the chemical shift of the amide proton is 
sensitive to hydrogen bonding. If H-bonded, the N-H bond is weakened, therefore, the proton should 
resonate at lower fields.[245] Hence, NMR spectra of both cis- and trans-95 were measured at 
concentrations of 1 mM, 5mM, 10 mM and 50 mM (Figure 15). 
 
Figure 15: Excerpts of 300 MHz 1H-NMR spectra of cis-95 (left) and trans-95 (right) at variable concentrations in CDCl3 at 293 
K, in order to determine the presence of intermolecular H-bonds. The large signal on the left of both spectra is from the CDCl3 
signal, acting as reference. Both compounds were measured with 64 scans, however, in case of trans-95, the signal-to-noise 
ratio is rather poor, which is probably attributed to the presence of two conformers which lowers the effective concentration. 
At 1 mM, the signal of the main conformer of trans-95 disappears under the CDCl3 signal; the minor conformer could not be 
traced at concentrations lower than 10 mM. 
The cis-95 showed no shift over the complete concentration range, indicating that it forms an 
intramolecular hydrogen bond, as previously proposed. Curiously, trans-95 displayed a significant 
downfield shift of the amide proton at higher concentrations. This is odd as it would mean a weakening 
of the H-bonding in more concentrated solutions, potentially due to a rearrangement of the hydrogen 
bond network. At the same time, this decreases the likelihood of intermolecular hydrogen bonds  
(95-A) being the cause for the observation of the minor conformer in the NMR spectra and tips the 
scale in favor of 95-B. 
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3.2.2 Conformational analysis with high-pressure infrared spectroscopy (HP-IR) 
 
The NMR analysis revealed, that it was worthwhile to further elucidate the hydrogen bonding behavior 
of cis- and trans-95. Infrared spectroscopy measurements are an ideal tool for identifying hydrogen-
bonded states, as H-bonding leads to a weakening of the bond strengths of the donor and acceptor 
groups. This is observable as a shift to lower wavenumbers in the IR spectrum of the respective 
vibrational modes. Analysis of three important vibrational bands, amide A (N-H stretching), amide I 
(C=O stretching) and amide II (C-N stretching and N-H bending), will provide information on the 
hydrogen bonding state of the model compounds (Figure 16).[254] 
 
Figure 16: Investigated vibrational modes of the model compounds. 
As the influence of elevated pressure is known to affect hydrogen bonding,[40,41,242,255] this investigation 
became a cooperative project within the FOR 1979 high-pressure research group. This enabled the 
measurement of HP-IR spectra of cis- and trans-95 in collaboration with Winter et al. at the TU 
Dortmund. Spectra were recorded at relatively high concentrations, meaning that intra- as well as 
intermolecular hydrogen bonding (if present) would be observed, while the use of CHCl3 made sure 
that solvent-solute interactions remained minimal.*  
The HP-IR spectra of cis-95 appeared to be rather simple (Figure 17). At low pressures, the amide A 
band showed two peaks, a narrow one at 3427 cm-1, which is considered to arise from a non-hydrogen 
bonded state, and a broad one at 3338 cm-1 as a result of hydrogen bonding. As no concentration 
dependence of the amide proton was observed in the NMR experiments (see Figure 15), both states 
should be rapidly interconverting.  
                                                          
* Recording spectra at lower concentrations (which would eliminate the intermolecular contribution) was not 
possible due to technical limitations in the experiment setup. 
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Figure 17: Normalized HP-IR spectra of cis-95 in CHCl3 (236 mM) at 298 K. 
This indicates that the H-bond is rather weak, which is presumably caused by the non-linearity of the 
N-H···O bond angle and the non-planarity of the N-C=O···H torsional angle in an intramolecular H-
bond.[244]* Upon pressurization, the intensity of the non-bonded state decreased while the bonded 
state increased, and both peaks shifted to lower wavenumbers (3423 and 3317 cm-1). These 
observations correspond to a strengthening of the hydrogen bond of cis-95 as well as an increase in its 
tendency to form under pressure. This appears to be a logical consequence when the volume is 
confined and is in agreement with literature reports on the influence of pressure on  
H-bonding.[40,41,242,255] Analyzing the Amide I band, it has to be considered that the molecule contains 
two carbonyl groups from which only one (C(O)NMe2) is involved in effective hydrogen bonding, 
explaining the two relatively narrow peaks at 1657 and 1629 cm-1. The band at 1657 cm-1 displayed a 
higher susceptibility to pressurization (shifting to 1651 cm-1) than the band at 1629 cm-1 (which only 
                                                          
* Studies of Gellman et al., investigating hydrogen bonding patterns in relation to their ring sizes, revealed a 
similar behavior for linear model compounds of comparable structure. The compound with a six-membered 
hydrogen bond did also display a bonded and a non-bonded state, with a prevalence for the bonded state. They 
attributed the observed stability of the hydrogen bond to the lack of torsional strain and a minimal entropic 
barrier during formation.[244] 
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shifted to 1626 cm-1). As the C=O bond is weakened by H-bonding and the observations for the amide 
A band indicated that H-bonding increases with pressure, this indicates that the band at 1657 cm-1 
originates from the carbonyl group that is involved in hydrogen bonding (C(O)NMe2). The amide II band 
is rather broad with only one visible maximum at 1513 cm-1. Here, pressurization leads to a shift to 
higher wavenumbers (1518 cm-1), corresponding to a stronger C-N bond as a result of both, the N-H 
and C=O bonds, being weakened by increased H-bonding.[256] Overall, cis-95 was found to reside in one 
conformer, which is stabilized partially by a weak hydrogen bond which strengthens upon 
pressurization.* 
 
Figure 18: Normalized HP-IR spectra of trans-95 in CHCl3 (236 mM) at 298 K. 
The data obtained from trans-95 proved to be more complex than for cis-95 (Figure 18). The amide A 
band showed three major bands at ambient pressure. The narrow one at 3449 cm-1 should again 
represent the non-hydrogen bonded N-H, however, the presence of a shoulder to the right side of the 
                                                          
* In the last chapter, it was discovered that the enantioselectivity of the β-ACHC-tripeptide-catalyzed aldol 
reaction improved under HP conditions. It was argued that pressurization should result in rigidification, leading 
to a more defined catalyst structure (see chapter 2.7). The increased tendency of hydrogen bond formation of 
cis-95 under higher pressures might be an important contributing factor to this conformer stabilization. 
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peak indicates that there should be at least two different non-bonded states. Interestingly, there are 
two separate bands which probably associate with some sort of hydrogen-bonded state, the broad 
peak at 3323 cm-1 and the small peak at 3385 cm-1. Due to the high sample concentration, 
intermolecular H-bonding could not be ruled out, which means that the second peak could also arise 
from this (see 95-A in Scheme 39). However, the appearance of a third peak like the one at 3385 cm-1 
was also reported by Gellman et al., who analyzed their (comparable) model compounds at low 
concentrations (1 mM) where an intermolecular contribution could be ruled out. They indicated that 
the peak might arise from a weak H-bonding of the amide proton with the π-system of the 
dimethylamide moiety.[244] The pressure response of the system is comparable to cis-95: while the non-
bonded state decreases (3437 cm-1), the H-bonded state becomes more populated at higher pressures 
and the strength of the H-bond increases (3302 cm-1). The third, weakly-bonded state is barely 
influenced at all (3384 cm-1). Analysis of the amide I band gave little to interpret, as the spectrum at 
ambient pressure showed several overlapping peaks (1669, 1653, 1635 cm-1) and shoulders in a small 
area. Upon pressurization, the spectrum became simpler as several peaks converged and shifted to 
lower wavenumbers, leaving only two peaks (1653 and 1632 cm-1). The amide II band provided more 
information. While only two bands were observed at 1 bar (1552 cm-1 and 1514 cm-1), the high-
pressure spectra showed a split-up of the signal at 1514 cm-1 into two separate maxima at 1523 cm-1 
and 1506 cm-1. As the amide II band is partially associated with the C-N stretching vibration, this might 
provide evidence for the cis-trans isomerization of the amide bond (see 95-B), as intermolecular 
hydrogen bonding should not lead to the observed splitting but rather lead to a general shift to higher 
wavenumbers (as in cis-95).* This is underlined by investigations from Sahai et al. who demonstrated 
that the amide II band of a cis amide bond is shifted to lower wavenumbers than the corresponding 
trans amide.[257] Comparing this to the observed peak splitting of trans-95 provides strong evidence for 
the cis-trans isomerization of the amide bond (see 95-B) and nicely demonstrates the usefulness of 
high pressure as a tool for stabilizing and identifying rare conformational states. 
In conclusion, the investigation of the model compound revealed that even small cyclic model 
compounds can possess a high conformational ambiguity. Therefore, the model compounds should be 
further investigated in the FOR 1979 research group, by using other spectroscopic methods  
(e.g. HP-NMR), analyzing them in more polar solvents (e.g. acetone/H2O) and through complementary 
theoretical calculations to determine low energy conformers. 
                                                          
* However, this only disproves that the intermolecular hydrogen bonded system is the cause behind the second 
conformer observed in the NMR. It does not disprove the existence of intermolecular hydrogen bonds in general, 
which are still very likely to form. 
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4. Synthesis of 15N-labeled compounds 
 
The development of NMR spectroscopy methods has advanced rapidly since their establishment in the 
1950s.[258,259] From non-invasive body imaging in medicine[260] to the analysis of complex physical, 
chemical and biological processes and compounds it plays a vital role as a versatile analytical tool in 
modern science.[258,259] Especially in the field of structure determination of large biological 
macromolecules like, e.g. proteins it plays a pivotal role, as it is one of few experimental methods 
capable of determining the conformation in solutions.[261]  
NMR spectroscopy requires the presence of respondent nuclei with a nonzero spin.[259] Besides 
hydrogen and carbon, nitrogen nuclei are probably one of the most important for measuring biological 
compounds, due to the high presence of nitrogen in biomolecules like DNA, RNA, or peptides. 
Measuring nitrogen’s main isotope 14N (99.6%) is hampered by the fact that it is a quadrupole which 
leads to extremely broadened, hard to interpret signals.[259,262] Using the naturally occurring isotope 
15N counteracts these problems, however, its abundance is only around 0.4%.[263] Coupled with a rather 
low sensitivity, recording natural abundance 15N spectra would be immensely time-consuming, 
especially when only limited amounts of sample are available.[259,262] Therefore, the most viable way to 
approach this problem is by using isotopically enriched compounds.  
In the FOR 1979 high-pressure research group, two molecules are of high interest:  
trimethylammonium N-oxide (TMAO, 102) and N-methylacetamide (NMA, 103). Both are currently 
investigated in detail, especially in relationship with pressure effects. 
The challenge in synthesizing both 15N-labeled derivatives was, besides the requirement of analytically 
pure samples in sufficient amounts (> 500 mg), the limitation to a common, commercially available 
starting material: 15NH4Cl (15N-104). This was chosen primarily due to economic reasons. As mentioned 
above, the natural abundance of 15N is very low, therefore, 15N-labeled compounds are usually very 
costly. 15NH4Cl (15N-104) is used routinely in minimal bacterial growth media in biology for the 
expression of isotopically enriched proteins and DNA, it is widely available and rather inexpensive.* 
Moreover, as an inorganic salt, it can be easily handled and stored without deterioration. However, 
this also posed complications, as its inorganic nature renders it almost non-reactive in organic 
reactions. Special focus had to be laid upon ensuring that no inseparable byproducts (e.g. salts) were 
formed to preserve the analytical purity of the final product. Preliminary test experiments were carried 
                                                          
* Prices for 1 g of compound (>98% 15N) from Sigma Aldrich (19.02.2018): 15NH4Cl (15N-104): 75.50 €. 15NMe3·HCl 
(15N-105, intermediate in the 15N-TMAO synthesis): 551.00 €. 15N-acetamide (15N-106, intermediate in the  
15N-NMA synthesis): 385.00 €. 
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out using non-labeled NH4Cl to develop reliable synthetic routes which could then be transferred to 
the actual syntheses using the labeled 15NH4Cl (15N-104). 
 
Scheme 40: The two 15N-labeled target molecules which had to be synthesized from 15NH4Cl (15N-104): 15N-TMAO (15N-102) 
and 15N-NMA (15N-103). 
 
4.1 Synthesis of 15N-TMAO 
 
Trimethylammonium N-oxide (102) is a naturally occurring osmolyte found in saltwater organisms. As 
an osmolyte, TMAO (102) serves as a stabilizing agent for proteins against external influences like 
temperature fluctuations and salinities. It preserves the proteins folded structure, and therefore 
functional state, thus preventing undesired denaturation and subsequent loss of functionality. 
Interestingly, the TMAO concentration in the tissue of deepwater fish increases the lower their natural 
habitat is located. Therefore, TMAO (102) appears to also play a major role in protein stabilization 
against high hydrostatic pressures. It also appears in the human body as a metabolite and elevated 
TMAO levels are believed to be linked to a higher risk of cardiovascular attacks.[264] This makes TMAO 
(102) a primary research subject of the FOR 1979 research group. 
As 15N-labeled TMAO (15N-102) is not commercially available, it had to be synthesized. The idea for the 
straightforward synthesis of 15N-TMAO (15N-102) from 15NH4Cl (15N-104) was to perform a triple  
N-methylation, N-oxidation sequence. This required a reliable protocol for the selective triple 
methylation, rendering standard conditions using MeI and base useless, as they result in low 
selectivities and tend to lead to quaternization. In 2016, Beydoun et al. published an efficient protocol 
for the selective catalytic N-methylation of ammonium chloride with CO2 and H2 in dioxane/water.[265] 
Although the use of CO2 as a methylating agent is interesting, especially in terms of using waste 
products as reactants, the process required the use of a non-commercial ruthenium catalyst 
[Ru(triphos)(tmm)].  
A more convenient approach was the utilization of the Eschweiler-Clarke reaction. Herein, an aldehyde 
reacts with the amine generating an imine, which is subsequently reduced by the acts of a reductant, 
usually formic acid. Already in 1921, Adams et al. published the highly selective synthesis of 
trimethylamine hydrochloride (105) from NH4Cl (104) with the use of paraformaldehyde.[266] This 
simple process does not require the use of an additional reductant and can be performed completely 
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without solvent and worked smoothly (Scheme 41). Considering that the next step would involve the 
liberation of gaseous trimethylamine followed by N-oxidation, purification of the obtained crude 
trimethylamine hydrochloride (105) was deemed to be unnecessary. The N-oxidation would then be 
achieved by leading the trimethylamine directly into a cooled solution of hydrogen peroxide. This 
procedure ensured that no other impurities were introduced into the final product, especially 
inorganic salts which would have been very difficult to separate otherwise. Following this route, non-
labeled TMAO (102) could be synthesized as the dihydrate in 72% yield in analytically pure form. 
Therefore, the chosen reaction sequence was transferred to the synthesis of 15N-TMAO (15N-102), 
which could be obtained as the dihydrate in 67% yield in analytically pure form (Scheme 41).  
 
Scheme 41: Synthesis of labeled and non-labeled TMAO dihydrate (102·2H2O). 
This describes the first successful chemical synthesis of 15N-TMAO (15N-102). It was handed over to the 
biophysical department of the University of Regensburg and is currently being analyzed and used in 
further experiments in collaborative work within the FOR 1979 research group. 
 
4.2 Synthesis of 15N-methylacetamide 
 
N-methylacetamide (103) represents a prototypical amide bond and can thus act as a model compound 
for the protein amide backbone in spectroscopic and computational methods.[267] In particular, high-
pressure NMR spectroscopy (HP-NMR) proved to be a powerful tool in the analysis and determination 
of rare, low-populated protein conformation states.[238] Detailed knowledge of these conformations 
allows a better understanding of the behavior of proteins in solution, which itself might lead to the 
development of new, more selective drugs.[268] Identification of these rare states is accomplished by 
plotting chemical shift values against pressure and subsequent extrapolation of relevant 
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thermodynamic parameters using a polynomial fit function.[269] However, due to the high complexity 
of protein NMR spectra, the in-depth analysis of all data sets is often tedious and time-consuming. 
Furthermore, the correct interpretation of the obtained parameters requires the knowledge about 
whether the observed shifts are due to the pressure itself or simply because of the changing electronic 
properties of the solvent under pressure.[267] Here, computational models are often a helpful tool for 
additional input. Within the research group FOR 1979, Kast et al. from the TU Dortmund developed 
the “Embedded Cluster Reference Interaction Site Model” (EC-RISM) computational method.[270] It 
allows the prediction of NMR shifts with respect to high-pressure influences, using N-methylacetamide 
(103) as a model for the prototypical amide backbone.[267,271] However, to verify the validity of the 
method it needed to be compared to experimental data. Therefore, HP-NMR experiments were 
conducted which required the synthesis of 15N-labeled N-methylacetamide (15N-103). 
There are several methods known how to synthesize NMA (103) on a laboratory scale. Common 
synthetic methods include, e.g. the Beckmann rearrangement of acetone oxime,[272] the acetylation of 
methylamine[272] or the thermal decomposition of methylammonium acetate.[273] These methods, 
however, are impractical if the choice of starting materials is limited to ammonium chloride. They 
would require either hydroxylamine or methylamine, which both are tedious to synthesize on a small 
scale. Therefore, a different approach was pursued. It was considered to first synthesize acetamide 
(106) from ammonia and then do a subsequent N-methylation. Morgan et al. already published a 
synthesis of 15N-labeled acetamide (15N-106) in 1991, using an aqueous ammonia solution in 
combination with 2,2,2-trifluoroethyl acetate (107) as acetylating agent. While 2,2,2-trifluoroethyl 
acetate (107) could be readily synthesized from 2,2,2-trifluoroethanol and acetyl chloride,[274] an 
aqueous ammonia solution was generated from heating a solid mixture of NH4Cl (104) and Ca(OH)2 
and transferring the gas into cooled water. The reaction between the ammonia solution and  
2,2,2-trifluoroethyl acetate (107) was successful, giving rise to non-labeled acetamide (106) in 56% 
yield (Scheme 42).  
The next step, the N-monomethylation of acetamide (106), proved to be rather complicated. A first 
attempt was made to use a modified Eschweiler-Clarke reaction published by Rosenau et al., in analogy 
to the TMAO synthesis.[275] Unfortunately, the reaction failed as no conversion of the starting material 
was detectable. This is probably due to the fact that the amide is too unreactive to form the imine, 
which is crucial for the reaction to perform. A second attempt was made by using a procedure 
published by Bassindale et al. in 2000.[276] Herein, they reported the use of chloromethyldimethylsilyl 
chloride (CMDMCS), hexamethyldisilazane (HMDS) and cesium fluoride to efficiently synthesize  
N-methylpropanamide from propanamide. Application of these conditions, however, gave only 
unsatisfactory results as only traces of product were formed.  
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Scheme 42: Synthetic approach to non-labeled N-methylacetamide (103). DCP = dicumyl peroxide. 
In 2013, Xia et al. were able to methylate a variety of aromatic and non-aromatic amides with dicumyl 
peroxide (DCP) in combination with copper catalysis.[277] They provided evidence for a radical 
mechanism in which a methyl radical from the DCP was transferred to the amide. With this process, 
acetamide (106) could be successfully methylated to N-methylacetamide (103), although it required 
an elaborate purification process. The complete reaction sequence in hand now enabled the synthesis 
of 15N-methylacetamide (15N-103) starting from 15NH4Cl (15N-104). 15N-Acetamide (15N-106) and  
15N-methylacetamide (15N-103) were both synthesized successfully in analytically pure form, giving 
access to 15N-methylacetamide (15N-103) in 37% overall yield starting from 15N-104 (Scheme 43). 
 
Scheme 43: Synthesis of 15N-methylacetamide (15N-103). DCP = dicumyl peroxide. 
The 15N-labeled compound 15N-103 was investigated in detail under HP NMR conditions by Kalbitzer 
and Kremer et al. in the biophysical department of the University of Regensburg. Pressure dependent 
1H-, 13C- and 15N-spectra were recorded and all relevant thermodynamic parameters determined. 
Comparison of the empirical results with the ones obtained with computation revealed that the 
computational model delivered quite accurate results for 1H and 13C, although the 15N predictions still 
require further optimization.[267] This work is currently further pursued within the FOR 1979 network. 
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C. Summary 
 
Over the last century, the use of high hydrostatic pressure has established itself as a valuable tool in 
chemistry, either as activation mode for chemical reactions or in combination with spectroscopic 
methods in order to investigate the structural and conformational behavior of (bio-)molecules. 
The first chapter of this thesis compares the influence of high-temperature and high-pressure 
conditions on the Lewis base-organocatalyzed Michael addition of aldehydes (39a-g) to  
trans-β-nitrostyrene (40), using a racemic (42) as well as an asymmetric catalyst (28) (Scheme 44). 
 
Scheme 44: Organocatalytic asymmetric Michael addition using the Jørgensen-Hayashi catalyst (28) under high pressure and 
high-temperature conditions.  
The investigations demonstrated that pressurization clearly outperforms conventional heating as 
secondary activation mode. Compression provided higher reactivities and vastly improved 
diastereoselectivities compared to ambient conditions and led to no erosion of enantioselectivity in 
the asymmetric reactions. These results illustrate the viability of the high-pressure technique as a mild 
and powerful alternative to the established heating procedure. 
The second chapter describes the synthesis of three different tripeptide organocatalysts containing 
unnatural β-amino acids and the evaluation of their catalytic as well as structural behavior under 
pressure. Key step for the synthesis of the flexible tripeptides 52 and ent-52 was the desymmetrization 
of meso anhydride cis-56 in order to obtain the enantiopure β-amino acids. For the rigidified 53, 
anthranilic acid (54) could be used as starting material (Scheme 45).  
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Scheme 45: Synthesized tripeptide catalysts containing unnatural β-amino acids. 
Their catalytic abilities were subsequently put to the test in an intermolecular aldol and a Michael 
addition under ambient as well as high-pressure conditions. In both transformations, the catalysts 
exhibited significantly increased reaction rates at elevated pressures. While the rigidified tripeptide 53 
proved to be the most susceptible to pressure in terms of reactivity, the flexible catalysts 52 and  
ent-52 displayed a slight increase in enantioselectivity in the aldol reaction upon pressurization 
(Scheme 46). 
 
Scheme 46: Tripeptide-catalyzed aldol reaction under high-pressure conditions. 
As this observation might be linked to a pressure-induced conformational change, it was decided to 
further investigate the structural behavior of catalyst 52. High-pressure NMR studies in acetone-
d6/D2O (10:1) revealed that the tripeptide 52 resides in at least three different conformations. These 
are probably caused by ring inversion of the central β-amino acid and rotations around the peptide 
bond of the N-terminal prolyl moiety. 
Since the high structural ambiguity of 52 complicated the conformational analysis, two model 
compounds were synthesized in order to solely investigate the behavior of the central β-amino acid. 
The findings are described in the third chapter. Both molecules were synthesized from their respective 
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meso anhydrides: cis-95 representing the structural analog to 52 and trans-95 as a reference which 
does not undergo ring inversion (Scheme 47). NMR- as well as high pressure IR-spectroscopy in 
chloroform revealed that cis-95 resides in only one conformation which is stabilized by an 
intramolecular hydrogen bond. The isomeric trans-95, however, resides in two conformations, which 
are probably caused by a cis-trans-isomerism of the peptide bond of the N-acetyl moiety.  
 
Scheme 47: Synthesis of β-ACHC derivatives used as model compounds for conformational analyses. 
The final chapter describes the synthesis of two 15N-labeled compounds for investigations with NMR 
spectroscopy. Both molecules, 15N-TMAO (15N-102) and 15N-NMA (15N-103), were obtained from 
inorganic, affordable 15NH4Cl (15N-104) in analytically pure form and have been used in an ongoing 
collaborative research project within the FOR 1979 high-pressure research group (Scheme 48).  
TMAO (102) represents a naturally occurring osmolyte that stabilizes proteins of deep sea fish against 
high pressures, making it a relevant research subject. The synthesis 15N-NMA (15N-103) became 
necessary in order to enable validation of a computational model for the prediction of NMR shifts 
under pressure developed by Kast et al. with actual empiric data. First promising results have already 
been published, with further investigations still ongoing within the research group. 
 
Scheme 48: Synthesis of 15N-labeled TMAO dihydrate (15N-102·2H2O) and NMA (15N-103) from affordable 15NH4Cl (15N-104). 
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D. Zusammenfassung 
 
Über das letzte Jahrhundert hat sich die Verwendung von hohem hydrostatischen Druck als wertvolles 
Werkzeug in der Chemie etabliert, entweder als Aktivierungsmethode für chemische Reaktionen oder 
in Kombination mit spektroskopischen Methoden um das strukturelle und konformelle Verhalten von 
(Bio-)Molekülen zu untersuchen. 
Das erste Kapitel dieser Arbeit vergleicht den Einfluss von Hochtemperatur- und 
Hochdruckbedingungen auf die Lewis-Base-organokatalysierte Michael-Addition von Aldehyden  
(39a-g) an trans-β-Nitrostyrol (40), unter Verwendungen eines racemischen (42) und eines 
asymmetrischen Katalysators (28) (Schema 1). 
 
Schema 1: Organokatalytische Michael-Addition unter Hochtemperatur- und Hochdruckbedingungen. 
Die Untersuchungen zeigten, dass Druckbeaufschlagung als sekundäre Aktivierungsmethode das 
konventionelle Heizen klar übertrifft. Kompression führte zu höherer Reaktivität und erheblich 
verbesserter Diastereoselektivität im Vergleich zu Normalbedingungen und führte zu keiner Abnahme 
der Enantioselektivität in den asymmetrischen Reaktionen. Diese Ergebnisse verdeutlichen die 
Wirksamkeit der Hochdruckmethodik als eine milde und zugleich leistungsfähige Alternative zum 
konventionellen Aufheizen der Reaktionsmischung. 
Das zweite Kapitel beschreibt die Synthese von drei verschiedenen Tripeptidorganokatalysatoren, 
welche unnatürliche β-Aminosäuren enthalten, und die Evaluierung ihres katalytischen sowie 
strukturellen Verhaltens unter Druck. Den Schlüsselschritt für die Synthese der flexiblen Tripeptide 52 
und ent-52 stellte die Desymmetrisierung des meso-Anhydrids cis-56 dar, um die enantiomerenreinen 
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β-Aminosäuren zu erhalten. Für das rigidere 53 konnte Anthranilsäure (54) als Startmaterial verwendet 
werden (Schema 2). 
 
Schema 2: Synthetisierte, β-Aminosäure-enthaltende Tripeptidkatalysatoren. 
Ihre katalytischen Fähigkeiten wurden anschließend in einer intermolekularen Aldol- sowie einer 
Michael-Addition unter Normal- sowie Hochdruckbedingungen getestet. In beiden Reaktionen zeigten 
die Katalysatoren signifikant gesteigerte Reaktionsgeschwindigkeiten unter erhöhtem Druck. Während 
der Druck den deutlichsten Einfluss auf die Reaktivität des rigideren Tripeptids 53 hatte, zeigten die 
flexibleren Katalysatoren 52 und ent-52 eine leicht erhöhte Enantioselektivität in der Aldolreaktion bei 
Druckbeaufschlagung (Schema 3). 
 
Schema 3: Tripeptidkatalysierte Aldolreaktion unter Hochdruckbedingungen. 
Da diese Beobachtung mit einer druckinduzierten Konformationsänderung zusammenhängen könnte, 
wurde entschieden das strukturelle Verhalten des Katalysators 52 weiter zu untersuchen. Hochdruck-
NMR-Studien in Aceton-d6/D2O (10:1) zeigten, dass das Tripeptid 52 in mindestens drei verschiedenen 
Konformationen vorliegt. Diese werden vermutlich durch Ringinversion der zentralen β-Aminosäure 
sowie durch Rotationen um die Peptidbindung des N-terminalen Prolylrests verursacht. 
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Nachdem die strukturelle Vieldeutigkeit von 52 die konformelle Analyse erschwerte, wurden zwei 
Modellverbindungen synthetisiert, um allein das Verhalten der zentralen β-Aminosäure studieren zu 
können. Die Ergebnisse werden im dritten Kapitel beschrieben. Beide Moleküle wurden ausgehend 
von den entsprechenden meso-Anhydriden synthetisiert: cis-95 als strukturelles Analogon zu 52 und 
trans-95 als eine Referenzverbindung, welche keine Ringinversion zeigt (Schema 4). NMR- sowie 
Hochdruck-IR-Spektroskopie in Chloroform  zeigte, dass cis-95 in nur einer Konformation vorliegt, 
welche durch eine intramolekulare Wasserstoffbrückenbindung stabilisiert wird. Das isomere trans-95 
hingegen liegt in zwei Konformationen vor, welche vermutlich von einer cis-trans-Isomerie der 
Peptidbindung des N-Acetylrests hervorgerufen werden. 
 
Schema 4: Synthese der für die konformelle Analyse als Modellverbindungen genutzten β-ACHC-Derivate. 
Das letzte Kapitel beschreibt die Synthese von zwei 15N-markierten Verbindungen für NMR-
Untersuchungen. Beide Moleküle, 15N-TMAO (15N-102) und 15N-NMA (15N-103), wurden aus 
anorganischem, kostengünstigen 15NH4Cl (15N-104) in analysenreiner Form hergestellt und in 
gruppenübergreifenden Projekten innerhalb der FOR 1979 Hochdruckforschergruppe verwendet 
(Schema 5). TMAO (102) stellt einen natürlich vorkommenden Osmolyt dar, welcher Proteine von 
Tiefseefischen gegen hohe Drücke stabilisiert, was es zu einem relevanten Forschungsobjekt macht. 
Die Synthese von 15N-NMA (15N-103) war notwendig, um ein von Kast et al. entwickeltes 
Computermodell zur Vorhersage von NMR-Verschiebungen unter Druck mithilfe von empirischen 
Daten validieren zu können. Erste vielversprechende Ergebnisse wurden bereits publiziert und weitere 
Untersuchungen werden innerhalb der Forschergruppe fortgeführt. 
 
Schema 5: Synthese von 15N-markiertem TMAO-Dihydrat (15N-102·2H2O) und NMA (15N-103) ausgehend von kosten-
günstigem 15NH4Cl (15N-104).  
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E. Experimental Part 
1. General Information 
 
1H-NMR spectroscopy 
1H-NMR spectra were recorded on a Bruker Avance 300 (300 MHz), a Bruker Avance 400 (400 MHz) 
and a Bruker Avance III HD 600 spectrometer (600 MHz) at ambient temperatures unless otherwise 
noted. The spectra were recorded in CDCl3, CD2Cl2, CD3OD, (CD3)2SO and D2O. Chemical shifts are 
reported as δ, parts per million (ppm), relative to the center of the residual solvent signals:  
CDCl3 = 7.26 ppm, CD2Cl2 = 5.32 ppm, CD3OD = 3.31 ppm, (CD3)2SO = 2.50 ppm, D2O = 4.79 ppm. 
Spectra were evaluated in first order and coupling constants (J) are given Hertz (Hz). The multiplicity 
of the signals is given as follows: s = singlet, bs = broad singlet, d = doublet, t = triplet, q = quartet,  
quint = quintet, m = multiplet, dd = doublet of doublets, ddd = doublet of doublets of doublets,  
dt = doublet of triplets, dq = doublet of quartets, td = triplet of doublets, tt = triplet of triplets,  
pt = pseudo triplet. The integrals display the relative number of hydrogen atoms associated with the 
signals. 
 
19F-NMR spectroscopy 
19F-NMR spectra were recorded on a Bruker Avance 300 (300 MHz) spectrometer at ambient 
temperatures. All spectra were recorded in CDCl3. Chemical shifts are reported as δ, parts per million 
(ppm). Spectra were evaluated in first order and coupling constants (J) are given Hertz (Hz). The 
integrals display the relative number of fluorine atoms associated with the signals. 
 
13C-NMR spectroscopy 
13C-NMR spectra were recorded on a Bruker Avance 300 (75.5 MHz), a Bruker Avance 400 (101 MHz) 
and a Bruker Avance III HD 600 spectrometer (151 MHz) at ambient temperatures unless otherwise 
noted. The spectra were recorded in CDCl3, CD2Cl2, CD3OD, (CD3)2SO and D2O. Chemical shifts are 
reported as δ, parts per million (ppm), relative to the center of the residual solvent signals: CDCl3 = 
77.16 ppm, CD2Cl2 = 53.84 ppm, CD3OD = 49.00 ppm, (CD3)2SO = 39.52 ppm. If necessary, DEPT 135 
and DEPT 90 spectra were recorded to determine the number of hydrogen atoms attached to each 
carbon atom (DEPT: distortionless enhancement by polarization transfer). Signals are therefore stated 
as either + for a primary or tertiary carbon atom (positive DEPT signal), - for a secondary carbon atom 
(negative DEPT signal) or Cq for a quaternary carbon atom (no DEPT signal). 
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2D-NMR spectroscopy 
Two-dimensional NMR spectra (COSY, HSQC, HMBC, 2D-NOESY) were recorded on a Bruker Avance 
400 (400 MHz) and a Bruker Avance III HD 600 spectrometer (600 MHz) at ambient temperature in 
CDCl3. Chemical shifts are reported as δ, parts per million (ppm). 
 
Chiral high-performance liquid chromatography (chiral HPLC) 
Chiral HPLC was performed on a Varian LC-902 Liquid Chromatograph using a Chiralpak AS-H column 
(4.6 × 250 mm, 10 μm), as well as Phenomenex Lux Cellulose-1 and Cellulose-2 columns (4.6 × 250 mm, 
5 μm). The absolute configuration of the product was determined through comparison with literature 
values. 
 
Column chromatography 
(Flash-) Column chromatography was performed using Merck Gerduran 60 (0.063 – 0.200 mm) or 
Merck flash (0.040 – 0.063 mm) silica gel. 
 
High-pressure infrared spectroscopy (HP-IR) 
High-pressure infrared spectra were measured at the TU Dortmund on a Thermo Nicolet 6700 FT IR 
with a custom built pressure cell. The sample was measured as a 236 mM solution in CHCl3 at ambient 
temperatures, using BaSO4 as a pressure sensor.  
 
High-pressure NMR spectroscopy (HP-NMR) 
High-pressure NMR spectra were measured on a Bruker Avance 600 (600 MHz) and a Bruker Avance 
800 (800 MHz) at 275 K using a custom-built high-pressure system and a ceramic high-pressure cell in 
the biophysical department of the University Regensburg.[278] The sample concentrations were 
14.8 mM (H2O/D2O 10:1, v/v) and 3.2 mM (acetone-d6/D2O, 10:1, v/v), 4,4-dimethyl-4-silapentane-1-
sulfonic acid was used as reference material. Water suppression was accomplished by using 
appropriate pulse sequences.[239] 
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High-pressure reactions 
High-pressure reactions up to 5 kbar were performed using a custom-built hydraulic high-pressure 
apparatus from Unipress (Warsaw). Either melted PTFE tubes or reusable self-made PTFE/FEP vials 
were used as reaction vessels. The apparatus used a 1:1 (v/v) mixture of decahydronaphthalene 
(mixture of cis & trans) and 2,2,4-trimethylpentane as pressurizing medium. The pressurization and 
depressurizations step usually took no more than 5 min individually. 
 
Infrared spectroscopy (IR) 
Infrared spectra were recorded on a Bio-Rad Excalibur FTS 3000 MX equipped with a Specac Golden 
Gate Diamond Single Reflection ATR-System and an Agilent Cary 630 FT-IR spectrometer. Both solid 
and liquid compounds were measured neat. The wavenumbers are reported as cm-1. 
 
Mass spectrometry (MS) 
Mass spectrometry was performed in the Analytical Department of the University of Regensburg 
(“Zentrale Analytik”) on a Jeol AccuTOF GCX, a Finnigan MAT SSQ 710 A, a Finnigan ThermoQuest TSQ 
7000 and an Agilent Q-TOF 6540 UHD. 
 
Melting points 
Melting points were determined using an SRS MPA 100 OptiMelt apparatus with a silicon oil bath and 
are thus uncorrected. 
 
Optical rotation 
Optical rotation values were determined using a Perkin Elmer 241 polarimeter at a wavelength of 
589 nm (sodium-d-line) in a 1.0 dm cell with an inner volume of approximately 1 mL. 
 
pH measurements 
pH measurements have been performed using Hanna Instruments HI 991001 portable pH meter. 
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Solvents and chemicals 
All commercially available chemicals were purchased in high quality and used without further 
purification unless otherwise noted. EtOAc, hexanes (60/40) and DCM were freshly distilled before 
usage. Anhydrous solvents were prepared via established procedures.[279] If necessary, chloroform was 
filtrated through basic aluminum oxide in order to remove acidic impurities. 
Maleic anhydride (61) was purified by dissolving in CHCl3 or DCM and filtering off the remaining solid. 
Aldehydes (39a-g) were purified prior to use according to established procedures, if necessary.[280] 
Isotopically enriched 15NH4Cl (99% 15N, 15N-104) was purchased from Cambridge Isotope Laboratories 
Inc. and was used as received. 
 
Thin layer chromatography (TLC) 
Thin layer chromatography was performed on silica gel coated aluminium plates (Merck silica gel 60 
F254 and Macherey-Nagel ALUGRAM® Xtra SIL G/UV254). Visualization was accomplished with UV light 
(λ = 254 nm) and through the use of TLC stains, e.g. KMnO4, vanillin/sulfuric acid, phosphomolybdic 
acid, bromocresol green, Mostain and ninhydrin solutions, followed by heating. 
 
X-ray crystallography 
X-ray crystallography was performed in the analytical department of the University of Regensburg 
(“Zentrale Analytik”) on an Agilent Technologies SuperNova, an Agilent Technologies Gemini R Ultra, 
an Agilent GV 50 and a Rigaku GV 50.  
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2. Small organocatalysts under pressure 
2.1. Synthesis of catalyst and starting materials 
 
 
N-Ethoxycarbonyl-L-proline methyl ester (43)[112] 
L-proline (3.45, 30.0 mmol, 1 equiv., 23) was filled into a flame-dried 100 mL Schlenk flask and dissolved 
in dry MeOH (60 mL). K2CO3 (4.15 g, 30.0 mmol, 1 equiv.) was added to the solution and the flask sealed 
with a rubber septum. Subsequently, ethyl chloroformate (6.3 mL, 7.15 g, 65.9 mmol, 2.2 equiv.) was 
added dropwise over 5 min at 0 °C. The resulting slurry was then stirred at 0 °C for 8 h, followed by 
stirring at ambient temperature for further 16 h. After completion, all volatiles were removed by 
distillation and the residue transferred into a separating funnel with H2O (30 mL). The aqueous phase 
was extracted with DCM (4x 40 mL) and the combined organic phases washed with sat. NaCl solution 
(80 mL). The extract was dried over Na2SO4, filtered, the solvent evaporated and the residue dried 
under high vacuum. Colorless oil (6.03 g, 30.0 mmol, 100%). 
Rf = 0.30 (hexanes/EtOAc 4:1); 1H-NMR (300 MHz, CDCl3) δH (ppm) = 4.40 – 4.22(1 H, m), 4.21 – 3.98  
(2 H, m), 3.70 (3 H, d, J = 4.9 Hz), 3.63 – 3.35 (2 H, m), 2.30 – 2.06 (1 H, m), 2.05 – 1.80 (3 H, m), 1.21  
(3 H, dt, J = 21.3, 7.1Hz); 13C-NMR (75 MHz, CDCl3) δC (ppm) = 173.54 (Cq), 173.40 (Cq), 155.26 (Cq), 
154.70 (Cq), 61.44 (-, CH2), 61.31 (-, CH2), 59.11 (+, CH), 58.89 (+, CH), 52.30 (+, CH3), 52.22 (+, CH3), 
46.81 (-, CH2), 46.41 (-, CH2), 30.99 (-, CH2), 30.01 (-, CH2), 24.44 (-, CH2), 23.63 (-, CH2), 14.79 (+, CH3), 
14.74 (+, CH3) (signal doubling due to rotamers). 
 
 
(2R)-α,α-Diphenyl-2-pyrrolidinemethanol (44)[112] 
A flame-dried 50 mL two-necked Schlenk flask equipped with dropping funnel and reflux condenser 
was charged with Mg (1.94 g, 80.0 mmol, 4.0 equiv.), dry THF (15 mL) and a catalytic amount of I2. PhBr 
(4.2 mL, 40 mmol, 2.0 equiv.) was filled into the dropping funnel and diluted with dry THF (15 mL). 
Subsequently, a small amount of the PhBr solution was added to the Mg suspension without stirring 
and heated gently. After the Grignard reaction had started, the rest of the solution was added dropwise 
while stirring in such a fashion that the reaction proceeded not to violently (only slight reflux). After 
complete addition, the now brownish slurry was stirred for another 10 min at ambient temperature. 
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During this time, a second 100 mL Schlenk flask was charged with 43 (2.01 g, 10.0 mmol, 1.0 equiv.) 
and dry THF (20 mL). The flask was sealed with a rubber septum, cooled down to 0 °C with an ice bath 
and the freshly prepared PhMgBr solution was added dropwise using a syringe. Once the addition was 
completed, the mixture was stirred for 3.5 h at 0°C, followed by 24 h at ambient temperature. The 
greyish-green reaction was quenched with sat. NH4Cl solution (20 mL), resulting in the precipitation of 
a white solid. The overstanding yellowish solution was decanted off, the solid dissolved in H2O and 
extracted with CHCl3 (2x 20 mL). All organic phases were combined, dried over MgSO4, filtered, 
evaporated and dried under high vacuum. The yellowish oil was redissolved in dry MeOH (20 mL) and 
KOH (5.73 g, 102 mmol, 10 equiv.) added. The mixture was refluxed for 4 h, the solvent evaporated 
and the residue transferred into a separating funnel with H2O (10 mL). The aqueous phase was 
extracted with CHCl3 (4x 15 mL), the combined organic extracts dried over MgSO4, filtered and all 
volatiles distilled off. The crude product was purified by column chromatography (hexanes/EtOAc 3:1 
+ 1% NEt3). Slight yellow solid (2.34 g, 9.24 mmol, 92%). 
Rf = 0.13 (hexanes/EtOAc 3:1 + 1% NEt3); 1H-NMR (300 MHz, CDCl3) δH (ppm) = 7.60 – 7.58(2 H, m), 
7.53 – 7.48 (2 H, m), 7.33 – 7.24 (4 H, m), 7.20 – 7.13 (2 H, m), 4.26 (1 H, t, J = 7.5 Hz), 3.08 – 2.89  
(2 H, m), 1.80 – 1.50 (4 H, m); 13C-NMR (75 MHz, CDCl3) δC (ppm) = 148.28 (Cq), 145.52 (Cq) 128.36  
(+, CH), 128.10 (+, CH), 126.59 (+, CH), 126.48 (+, CH), 125.98 (+, CH), 125.65 (+, CH), 77.22 (Cq), 64.59 
(+, CH), 46.89 (-, CH2), 26.41 (-, CH2), 25.64 (-, CH2). 
 
 
(2S)-2-[Diphenyl[(trimethylsilyl)oxy]methyl]pyrrolidine (28)[113] 
A flame-dried 50 mL Schlenk was charged with 44 (1.06 g, 4.18 mmol, 1.0 equiv.) and of dry DCM (25 
mL). Dry triethylamine (0.83 mL, 4.6 mmol, 1.1 equiv.) was added and the solution cooled down to 0 
°C in an ice bath. Subsequently, TMSOTf (0.64 mL, 4.6 mmol, 1.1 equiv.) was added dropwise and the 
mixture stirred at ambient temperature. After 21 h, the reaction was quenched with H2O, transferred 
into a separating funnel and extracted with DCM (3x). The combined organic extracts were washed 
with sat. NaCl solution, dried over Na2SO4, filtered, the solvent evaporated and the residue dried under 
high vacuum. The crude product was purified by flash column chromatography (hexanes/EtOAc 9:1 + 
0.5% NEt3). Yellow oil (1.06 g, 3.26 mmol, 78%). 
Rf = 0.15 (hexanes/EtOAc 9:1 + 1% NEt3); 1H-NMR (300 MHz, CDCl3) δH (ppm) = 7.48 – 7.43(2 H, m), 
7.38 – 7.32 (2 H, m), 7.30 – 7.17 (6 H, m), 7.20 – 7.13 (6 H, m), 4.06 – 4.00 (1 H, m), 2.89 – 2.75  
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(2 H, m), 1.69 (1 H, bs), 1.63 – 1.50 (3 H, m), 1.45 – 1.30 (1 H, m), -0.09 (9 H, s); 13C-NMR  
(75 MHz, CDCl3) δC (ppm) = 146.98 (Cq), 145.93 (Cq) 128.57 (+, CH), 127.74 (+, CH), 127.71 (+, CH), 
127.66 (+, CH), 127.03 (+, CH), 126.86 (+, CH), 83.31 (Cq), 65.55 (+, CH), 47.30 (-, CH2), 27.64 (-, CH2), 
25.19 (-, CH2), 2.33 (+, CH3). 
 
 
Diphenoxymethane (46)[281] 
KOH (118.9 g, 2.119 mol, 14.5 equiv.) was added to a 500 mL round bottom flask equipped with a reflux 
condenser and dissolved in H2O (100 mL) while cooling to 0 °C. After complete dissolution, phenol 
(25.24 g, 268.2 mmol, 1.0 equiv.), TBAB (10.37 g, 32.18 mmol, 0.1 equiv.) and DCM (250 mL) were 
added successively and the mixture stirred vigorously at 40 °C for 24 h. The solution was transferred 
into a separating funnel, the aqueous phase was discarded and the organic phase washed with H2O 
(3x), sat. NaHCO3 (5x) and sat. NaCl solution (5x). The organic phase was then dried over Na2SO4, 
filtered, all volatiles distilled off and the residue dried under high vacuum. Colorless, slightly oily liquid 
(26.08 g, 130.3 mmol, 97%). 
Rf = 0.73 (hexanes/EtOAc 9:1); 1H-NMR (300 MHz, CDCl3) δH (ppm) = 7.38 – 7.28(4 H, m), 7.18 – 7.11  
(4 H, m), 7.10 – 7.01 (2 H, s), 5.76 (2 H, s); 13C-NMR (75 MHz, CDCl3) δC (ppm) = 157.11 (Cq), 129.69  
(+, CH), 122.55 (+, CH), 116.57 (+, CH), 91.24 (-, CH2). 
 
 
trans-β-Nitrostyrene (40)[282]  
A 250 mL three-necked round bottom flask equipped with an internal thermometer and a dropping 
funnel was charged with benzaldehyde (10.2 mL, 10.6 g, 100 mmol, 1.0 equiv.), nitromethane (5.40 mL, 
6.16 g, 101 mmol, 1.0 equiv.) and EtOH (20 mL) and then cooled to 0 °C in an ice bath. Subsequently, 
2 M NaOH (55 mL, 4.40 g, 110 mmol, 1.1 equiv.) was added dropwise in a fashion that the internal 
temperature did not rise above 10 °C. After complete addition, the mixture was stirred further for 1 h, 
diluted with H2O (50 mL) and then poured slowly into a 250 mL Erlenmeyer flask filled with 50 g ice 
and conc. HCl (16 mL, 37wt%, 1.9 equiv.). An orange solid precipitated which was filtered off and rinsed 
twice with ice-cold H2O (10 mL). The crude product (11 g) was recrystallized from EtOH (9 mL). Yellow 
needles (5.83 g, 39.1 mmol, 39%). 
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Rf = 0.50 (hexanes/EtOAc 9:1); 1H-NMR (300 MHz, CDCl3) δH (ppm) = 8.01 (1 H, d, J = 13.7 Hz), 7.59  
(1 H, d, J = 13.7 Hz), 7.58 – 7.41 (5 H, m); 13C-NMR (75 MHz, CDCl3) δC (ppm) = 139.23, 137.22, 132.29, 
130.17, 129.53, 129.28. 
 
2.2. Catalysis 
 
Both, racemic and asymmetric reactions have been performed under the exact same conditions, using 
stock solutions of the respective catalysts 28 and 42 in CHCl3. The general procedures are written using 
the reaction of n-butanal (39a) catalyzed by 28 as an example. 
 
General procedure for reactions under ambient conditions (GP-1) 
A 10 mL round bottom flask was charged with trans-β-nitrostyrene (149 mg, 1.00 mmol, 1.0 equiv., 40) 
and 4-nitrophenol (1.4 mg, 10 μmol, 1 mol%). The solids were dissolved in 2 mL of a 5.0 mM stock 
solution of catalyst 28 in CHCl3 (3.3 mg of 28, 10 μmol, 1 mol%) and spiked with the internal standard 
diphenoxymethane (180 μL, 200 mg, 1.00 mmol, 1.0 equiv., 46). The reaction was started through the 
addition of n-butanal (360 μL, 4.00 mmol, 4.0 equiv., 39a) and stirred for 1 h at ambient temperature 
(22 °C). Subsequently, the volatiles were evaporated, the residue dissolved in CDCl3 and a 1H-NMR 
measured immediately. For HPLC analysis, the crude mixture was purified via flash column 
chromatography, using hexanes/EtOAc as eluent.  
 
General procedure for high-temperature reactions (GP-2) 
A 10 mL pressure tube was charged with trans-β-nitrostyrene (149 mg, 1.00 mmol, 1.0 equiv., 40) and 
4-nitrophenol (1.4 mg, 10 μmol, 1 mol%). The solids were dissolved in 2 mL of a 5.0 mM stock solution 
of catalyst 28 in CHCl3 (3.3 mg of 28, 10 μmol, 1 mol%) and spiked with the internal standard 
diphenoxymethane (180 μL, 200 mg, 1.00 mmol, 1.0 equiv., 46). The reaction was started through the 
addition of n-butanal (360 μL, 4.00 mmol, 4.0 equiv., 39a), the tube sealed and stirred for 1 h at 60 °C. 
Subsequently, the volatiles were evaporated, the residue dissolved in CDCl3 and a 1H-NMR measured 
immediately. For HPLC analysis, the crude mixture was purified via flash column chromatography, 
using hexanes/EtOAc as eluent.  
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General procedure for high-pressure reactions (GP-3) 
A 5 mL snap cap vial was charged with trans-β-nitrostyrene b(149 mg, 1.00 mmol, 1.0 equiv., 40) and 
4-nitrophenol (1.4 mg, 10 μmol, 1 mol%). The solids were dissolved in 2 mL of a 5.0 mM stock solution 
of catalyst 28 in CHCl3 (3.3 mg of 28, 10 μmol, 1 mol%) and spiked with the internal standard 
diphenoxymethane (180 μL, 200 mg, 1.00 mmol, 1.0 equiv., 46). n-Butanal (360 μL, 4.00 mmol, 
4.0 equiv., 39a) was added, the mixture stirred for a few seconds until it became homogeneous and 
then transferred into a high-pressure vial. The vial was sealed, inserted into the apparatus and 
pressurized with 4.6 kbar for 1 h at ambient temperature (22 °C). Subsequently, the pressure was 
released, the mixture transferred into a round bottom flask and the volatiles were evaporated. The 
residue was dissolved in CDCl3 and a 1H-NMR measured immediately. For HPLC analysis, the crude 
mixture was purified via flash column chromatography, using hexanes/EtOAc as eluent.  
 
 
(2R,3S)-2-Ethyl-4-nitro-3-phenylbutanal (41a)[85,108]  
Prepared by using n-butanal (0.36 mL, 4.0 mmol, 39a). Colorless oil (88.1 mg, 398 μmol, 40%).  
Syn diastereomer:  
Rf = 0.33 (hexanes/EtOAc 6:1); 1H-NMR (400 MHz, CDCl3) δH (ppm) = 9.72 (1 H, d, J = 2.6 Hz),  
7.38 – 7.27 (3 H, m), 7.20 – 7.15 (2 H, m), 4.72 (1 H, dd, J = 12.7, 5.0 Hz), 4.63 (1 H, dd, J = 12.7, 9.6 Hz), 
3.79 (1 H, td, J = 9.8, 5.0 Hz), 2.72 – 2.64 (1 H, m), 1.56 – 1.47 (2 H, m), 0.84 (3 H, t, J = 7.5 Hz);  
13C-NMR (101 MHz, CDCl3) δC (ppm) = 203.32 (+, CH), 136.94 (Cq), 129.25 (+, CH), 128.28 (+, CH), 128.14 
(+, CH), 78.68 (-, CH2), 55.15 (+, CH), 42.86 (+, CH), 20.51 (-, CH2), 10.81 (+, CH3). 
Anti diastereomer:  
1H-NMR (400 MHz, CDCl3) δH (ppm) = 9.49 (1 H, d, J = 2.9 Hz), 7.38 – 7.27 (3 H, m), 7.20 – 7.15 (2 H, m), 
4.81 (1 H, dd, J = 12.9, 6.2 Hz), 4.78 – 4.72 (1 H, m), 3.85 – 3.75 (1 H, m), 2.61 – 2.54 (1 H, m),  
1.79 – 1.56 (2 H, m), 0.99 (3 H, t, J = 7.4 Hz); 13C-NMR (101 MHz, CDCl3) δC (ppm) = 203.44 (+, CH), 
136.43 (Cq), 129.23 (+, CH), 128.37 (+, CH), 128.35 (+, CH), 78.07 (-, CH2), 55.07 (+, CH), 44.28 (+, CH), 
20.75 (-, CH2), 11.62 (+, CH3). 
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Chiral HPLC performed on Chiralcel Phenomenex Lux Cellulose-1 (n-heptane/i-PrOH = 70:30,  
λ = 215 nm, 0.5 mL/min). Syn diastereomer: tr(major) = 24.8 min, tr(minor) = 20.1 min; enantiomeric 
excess: 98%. Anti diastereomer: tr(major) = 36.7 min, tr(minor) = 21.6 min. 
 
 
(R)-2-((S)-2-Nitro-1-phenylethyl)pentanal (41b)[85]  
Prepared by using n-pentanal (0.43 mL, 4.0 mmol, 39b). Colorless oil (54.4 mg, 398 μmol, 23%). 
Syn diastereomer:  
Rf = 0.40 (hexanes/EtOAc 6:1); 1H-NMR (400 MHz, CDCl3) δH (ppm) = 9.71 (1 H, d, J = 2.8 Hz),  
7.38 – 7.27 (3 H, m), 7.20 – 7.14 (2 H, m), 4.70 (1 H, dd, J = 12.7, 5.3 Hz), 4.64 (1 H, dd, J = 12.7, 9.4 Hz), 
3.77 (1 H, td, J = 9.5, 5.4 Hz), 2.74 – 2.67 (1 H, m), 1.75 – 1.10 (4 H, m), 0.80 (3 H, t, J = 7.1 Hz); 13C-NMR 
(101 MHz, CDCl3) δC (ppm) = 203.36 (+, CH), 136.95 (Cq), 129.27 (+, CH), 128.30 (+, Ph), 128.14 (+, CH), 
78.56 (-, CH2), 53.97 (+, CH), 43.33 (+, CH), 29.63 (-, CH2), 19.92 (-, CH2), 14.07 (+, CH3). 
Anti diastereomer:  
1H-NMR (400 MHz, CDCl3) δH (ppm) = 9.48 (1 H, d, J = 3.0 Hz), 7.38 – 7.27 (3 H, m), 7.20 – 7.14 (2 H, m), 
4.82 (1 H, dd, J = 13.0, 6.2 Hz), 4.75 (1 H, dd, J = 13.0, 9.0 Hz), 3.83 – 3.74 (1 H, m), 2.67 – 2.59 (1 H, m), 
1.75 – 1.10 (4 H, m), 0.93 (3 H, t, J = 7.3 Hz); 13C-NMR (101 MHz, CDCl3) δC (ppm) = 203.51 (+, CH), 
136.39 (Cq), 129.24 (+, CH), 128.38 (+, CH), 128.36 (+, CH), 78.03 (-, CH2), 53.42 (+, CH), 44.63 (+, CH), 
29.79 (-, CH2), 20.48 (-, CH2), 14.12 (+, CH3). 
Chiral HPLC performed on Chiralcel Phenomenex Lux Cellulose-1 (n-Heptane/i-PrOH = 70:30,  
λ = 215 nm, 0.5 mL/min). Syn diastereomer: tr(major) = 24.3 min, tr(minor) = 18.4 min; enantiomeric 
excess: 99%. Anti diastereomer: tr(major) = 33.5 min, tr(minor) = 21.2 min. 
 
 
(R)-2-((S)-2-Nitro-1-phenylethyl)octanal (41c)[283] 
Prepared by using n-octanal (0.63 mL, 4.0 mmol, 39c). Slightly yellow oil (132 mg, 474 μmol, 47%). 
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Syn diastereomer:  
Rf = 0.45 (hexanes/EtOAc 6:1); 1H-NMR (400 MHz, CDCl3) δH (ppm) = 9.70 (1 H, d, J = 2.8 Hz),  
7.37 – 7.27 (3 H, m), 7.19 – 7.15 (2 H, m), 4.71 (1 H, dd, J = 12.7, 5.2 Hz), 4.64 (1 H, dd, J = 12.7, 9.5 Hz), 
3.79 (1 H, td, J = 9.6, 5.3 Hz), 2.73 – 2.65 (1 H, m), 1.56 – 1.01 (10 H, m), 0.82 (3 H, t, J = 7.0 Hz);  
13C-NMR (101 MHz, CDCl3) δC (ppm) = 203.39 (+, CH), 136.95 (Cq), 129.25 (+, CH), 128.29 (+, CH), 128.14 
(+, CH), 78.58 (-, CH2), 54.06 (+, CH), 43.28 (+, CH), 31.47 (-, CH2), 29.18 (-, CH2), 27.48 (-, CH2), 26.49  
(-, CH2), 22.54 (-, CH2), 14.08 (+, CH3). 
Anti diastereomer:  
1H-NMR (400 MHz, CDCl3) δH (ppm) = 9.47 (1 H, d, J = 3.0 Hz), 7.37 – 7.27 (3 H, m), 7.19 – 7.15 (2 H, m), 
4.81 (1 H, dd, J = 12.9, 6.2 Hz), 4.75 (1 H, dd, J = 12.8, 9.1 Hz), 3.83 – 3.73 (1 H, m), 2.65 – 2.58 (1 H, m), 
1.76 – 1.01 (10 H, m), 0.87 (3 H, t, J = 6.8 Hz); 13C-NMR (101 MHz, CDCl3) δC (ppm) = 203.55 (+, CH), 
136.41 (Cq), 129.24 (+, CH), 128.38 (+, CH), 128.36 (+, CH), 78.05 (-, CH2), 53.63 (+, CH), 44.61 (+, CH), 
31.62 (-, CH2), 29.31 (-, CH2), 27.68 (-, CH2), 27.16 (-, CH2), 22.64 (-, CH2), 14.13 (+, CH3). 
Chiral HPLC performed on Chiralcel Phenomenex Lux Cellulose-1 (n-heptane/i-PrOH = 70:30,  
λ = 215 nm, 0.5 mL/min). Syn diastereomer: tr(major) = 20.4 min, tr(minor) = 16.1 min; enantiomeric 
excess: 99%. Anti diastereomer: tr(major) = 27.7 min, tr(minor) = 17.2 min. 
 
 
(2R,3S)-2-Benzyl-4-nitro-3-phenylbutanal (41d)[118] 
Prepared by using 3-phenylpropanal (0.53 mL, 4.0 mmol, 39d). Yellow oil. This product could not be 
completely purified by chromatography or other methods and contained several unidentifiable side 
products. 
Syn diastereomer:  
Rf = 0.38 (hexanes/EtOAc 5:1); 1H-NMR (400 MHz, CDCl3) δH (ppm) = 9.72 (1 H, d, J = 2.3 Hz),  
7.42 – 7.10 (8 H, m), 7.06 – 7.00 (2 H, m), 4.73 (1 H, d, J = 1.3 Hz), 4.71 (1 H, d, J = 3.7 Hz), 3.83  
(1 H, td, J = 8.7, 6.2 Hz), 3.16 – 3.08 (1 H, m), 2.78 (1 H, d, J = 4.4 Hz), 2.76 (1 H, d, J = 1.4 Hz);  
Chiral HPLC performed on Chiralcel AS-H (n-heptane/i-PrOH = 95:5, λ = 215 nm, 0.5 mL/min).  
Syn diastereomer: tr(major) = 28.6 min, tr(minor) = 26.9 min; enantiomeric excess: 95%. 
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(2R,3S)-2-Isopropyl-4-nitro-3-phenylbutanal (41e)[85,108]  
Prepared by using 3-methylbutanal (0.42 mL, 4.0 mmol, 39e). Slightly yellow oil (108 mg, 457 μmol, 
46%). 
Syn diastereomer:  
Rf = 0.35 (hexanes/EtOAc 6:1); 1H-NMR (400 MHz, CDCl3) δH (ppm) = 9.93 (1 H, d, J = 2.4 Hz),  
7.37 – 7.27 (3 H, m), 7.21 – 7.14 (2 H, m), 4.67 (1 H, dd, J = 12.6, 4.4 Hz), 4.58 (1 H, dd, J = 12.5, 9.9 Hz), 
3.90 (1 H, td, J = 4.4, 10.3 Hz), 2.77 (1 H, ddd, J = 10.7, 4.1, 2.5 Hz), 1.79 – 1.66 (1 H, m), 1.10  
(3 H, d, J = 7.2 Hz), 0.89 (3 H, d, J = 7.0 Hz); 13C-NMR (101 MHz, CDCl3) δC (ppm) = 204.48 (+, CH), 137.25 
(Cq), 129.31 (+, CH), 128.24 (+, CH), 128.10 (+, CH), 79.13 (-, CH2), 58.93 (+, CH), 42.09 (+, CH), 28.06  
(+, CH), 21.88 (+, CH3), 17.13 (+, CH3). 
Anti diastereomer:  
1H-NMR (400 MHz, CDCl3) δH (ppm) = 9.48 (1 H, d, J = 4.2 Hz), 7.37 – 7.27 (3 H, m), 7.21 – 7.14 (2 H, m), 
4.77 (1 H, dd, J = 12.9, 6.1 Hz), 4.66 (1 H, dd, J = 12.7, 9.2 Hz), 3.97 (1 H, dt, J = 9.0, 6.6 Hz), 2.36  
(1 H, td, J = 7.2, 4.2 Hz), 2.09 – 1.96 (1 H, m), 1.16 (3 H, d, J = 6.8 Hz), 1.00 (3 H, d, J = 6.8 Hz);  
13C-NMR (101 MHz, CDCl3) δC (ppm) = 204.52 (+, CHO), 135.99 (Cq), 129.27 (+, CH), 128.53 (+, CH), 
128.40 (+, CH), 78.63 (-, CH2), 59.17 (+, CH), 42.92 (+, CH), 27.09 (+, CH), 21.06 (+, CH3), 19.26 (+, CH3). 
Chiral HPLC performed on Chiralcel AS-H (n-heptane/i-PrOH = 95:5, λ = 215 nm, 0.5 mL/min).  
Syn diastereomer: tr(major) = 31.8 min, tr(minor) = 30.5 min; enantiomeric excess: 99%.  
Anti diastereomer: tr(major) = 39.4 min, tr(minor) = 35.9 min. 
 
 
(R)-2,2-Dimethyl-4-nitro-3-phenylbutanal (41f)[85]  
Prepared by using 2-methylpropanal (0.37 mL, 4.0 mmol, 39f). Slightly yellow oil (190 mg, 857 μmol, 
86%). 
Rf = 0.10 (hexanes/EtOAc 9:1); 1H-NMR (400 MHz, CDCl3) δH (ppm) = 9.53 (1 H, s), 7.37 – 7.27 (3 H, m), 
7.23 – 7.17 (2 H, m), 4.86 (1 H, dd, J = 13.0, 11.2 Hz), 4.69 (1 H, dd, J = 13.1, 4.2 Hz), 3.78 (1 H, dd,  
J = 11.2, 4.2 Hz), 1.14 (3 H, s), 1.01 (3 H, s); 13C-NMR (101 MHz, CDCl3) δC (ppm) = 204.22 (+, CH), 135.35 
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(Cq, CH), 129.08 (+, CH), 128.73 (+, CH), 128.17 (+, CH), 76.33 (-, CH2), 48.51 (+, CH), 48.23 (Cq), 21.70 
(+, CH3), 18.92 (+, CH3); Chiral HPLC performed on Chiralcel Phenomenex Lux Cellulose-1  
(n-heptane/i-PrOH = 90:10, λ = 215 nm, 1.0 mL/min). tr(major) = 16.5 min, tr(minor) = 23.8 min; 
enantiomeric excess: 78%; [α]D
22: +6.8 (c = 1.01, CHCl3). 
 
 
(R)-1-(2-Nitro-1-phenylethyl)cyclohexane-1-carbaldehyde (41g)[89] 
Prepared by using cyclohexane carbaldehyde (0.48 mL, 4.0 mmol, 39g). Yellow oil (56 mg, 214 μmol, 
21%). 
Rf = 0.21 (hexanes/EtOAc 19:1); 1H-NMR (300 MHz, CDCl3) δH (ppm) = 9.55 (1 H, s), 7.36 – 7.27 (3 H, m), 
7.17 – 7.08 (2 H, m), 4.80 (1 H, dd, J = 13.1, 10.8 Hz), 4.73 (1 H, dd, J = 13.2, 4.9 Hz), 3.54 (1 H, dd,  
J = 10.8, 4.8 Hz), 2.15 – 2.00 (1 H, m), 1.94 – 1.80 (1 H, m), 1.75 – 1.50 (3 H, m), 1.48 – 1.32 (1 H, m), 
1.31 – 1.03 (4 H, m); 13C-NMR (75 MHz, CDCl3) δC (ppm) = 207.49 (+, CH), 135.01 (Cq), 129.21 (+, CH), 
128.84 (+, CH), 128.32 (+, CH), 76.22 (-, CH2), 51.36 (Cq), 50.62 (+, CH), 31.20 (-, CH2), 29.88 (-, CH2), 
25.22 (-, CH2), 22.82 (-, CH2), 22.70 (-, CH2); Chiral HPLC performed on Chiralcel Phenomenex Lux 
Cellulose-1 (n-heptane/i-PrOH = 90:10, λ = 215 nm, 1.0 mL/min). tr(major) = 27.9 min, tr(minor) = 
12.2 min; enantiomeric excess: 64%; [α]D
22: -15.9 (c = 1.00, CHCl3).   
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3. Synthesis of tripeptides containing unnatural β-amino acids 
3.1. Synthesis of racemic β-ACHC 
 
 
cis-4-Cyclohexene-1,2-dicarboxylic acid anhydride (cis-56)[169] 
A 500 mL round bottom flask was charged with freshly powdered 3-sulfolene (80.4 g, 680 mmol, 
1.36 equiv., 62) and maleic anhydride (49.0 g, 500 mmol, 1.00 equiv., 61). Dry xylenes (35 mL) were 
added and the flask equipped with a reflux condenser and bubble counter. The mixture was stirred at 
ambient temperature for 5 min and then gently heated up to 130 °C in such a manner that the only 
weak gas evolution occurred. After 9 h, another batch of freshly powdered 3-sulfolene (10.0 g, 
86.6 mmol, 0.17 equiv., 62) was added, the bubble counter exchanged for a CaCl2 filled drying tube 
and the mixture stirred further for 18 h at 130 °C. The now deep brown reaction was then stopped, 
diluted with dry xylenes (250 mL) and mixed with 3 g of fine powdered activated charcoal. The resulting 
slurry was then stirred for 20 min at 70 °C, immediately filtered hot and washed with xylenes. Upon 
cooling, a colorless solid started to precipitate from the yellowish solution. The already crashed out 
solid was redissolved by heating the filtrate in a water bath and cyclohexane (100 mL) added. The 
solution was then stirred for 1 h in an ice bath. During this time, the product crystallized from the 
solution. The solid was filtered off and washed with small amounts of ice-cold toluene and cyclohexane 
and then dried in a desiccator over silica gel. A second crop of product was obtained through further 
cooling the mother liquor and filtration. White solid (64.8 g, 426 mmol, 85%). 
1H-NMR (300 MHz, CDCl3) δH (ppm) = 6.01 – 5.96 (2 H, m), 3.41 – 3.35 (2 H, m), 2.68 – 2.56 (2 H, m), 
2.36 – 2.24 (2 H, m); 13C-NMR (75 MHz, CDCl3) δC (ppm) = 174.38, 127.74, 38.63, 23.42. 
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cis-2-Methoxycarbonyl-4-cyclohexene-1-carboxylic acid (cis-63)[184] 
A 25 mL round bottom flask equipped with a reflux condenser was charged with cis-56 (2.94 g, 
19.4 mmol, 1.0 equiv.) and MeOH (10 mL) and the mixture was refluxed for 2 h. All volatiles were 
evaporated and the residue was dried under high vacuum. White solid (3.52 g, 19.1 mmol, 99%). 
1H-NMR (400 MHz, CDCl3) δH (ppm) = 10.22 (1 H, bs), 5.68 (2 H, s), 3.69 (3 H, s), 3.11 – 3.02 (2 H, m), 
2.64 – 2.50 (2 H, m), 2.42 – 2.31 (2 H, m); 13C-NMR (75 MHz, CDCl3) δC (ppm) = 179.88 (Cq), 173.81 (Cq), 
125.29 (+, CH), 125.16 (+, CH), 52.08 (+, CH3), 39.69 (+, CH), 39.54 (+, CH), 25.83 (-, CH2), 25.64 (-, CH2). 
 
 
Methyl cis-6-(((benzyloxy)carbonyl)amino)cyclohex-3-ene-1-carboxylate (cis-64)[174] 
A flame-dried two-necked Schlenk flask equipped with a reflux condenser, bubble counter and septum 
was charged with cis-63 (1.54 g, 8.35 mmol, 1.0 equiv.), NEt3 (1.2 mL, 8.7 mmol, 1.0 equiv.) and dry 
toluene (30 mL). DPPA (2.30 g, 8. 35 mmol, 1.0 equiv.) was added dropwise to the stirred mixture, 
followed by BnOH (1.8 mL, 17.3 mmol, 2.1 equiv.). The reaction was heated to 120 °C and stirred for 
5 h (gas evolution was observed). Subsequently, the mixture was allowed to cool to ambient 
temperature, transferred into a separating funnel and diluted with EtOAc (1x 30 mL). The organic phase 
was washed consecutively with 2 M HCl (1x 60 mL), sat. NaHCO3 (1x 60 mL) and sat. NaCl solutions (1x 
60 mL), then dried over MgSO4, filtered, all volatiles evaporated and the residue dried under high 
vacuum. The crude product was purified by flash column chromatography (DCM/MeOH 9:1). Yellowish 
oil (1.93 g, 6.67 mmol, 80%). 
Rf = 0.63 (DCM/MeOH 200:1); 1H-NMR (300 MHz, CDCl3) δH (ppm) = 7.40 – 7.28 (5 H, m), 5.72 – 5.55 
(2 H, m), 5.43 (1 H, d, J = 9.4 Hz), 5.08 (2 H, dd, J = 14.4, 12.3 Hz), 4.36 – 4.17 (1 H, m), 3.68 (3 H, s), 2.88 
– 2.74 (1 H, m), 2.61 – 2.12 (4 H, m); 13C-NMR (75 MHz, CDCl3) δC (ppm) = 173.89 (Cq), 155.91 (Cq), 
136.56 (Cq), 128.61 (+, CH), 128.23 (+, CH), 128.21 (+, CH), 125.05 (+, CH), 124.78 (+, CH), 66.78 (-, CH2), 
52.02 (+, CH3), 46.85 (+, CH), 42.10 (+, CH), 30.69 (-, CH2), 25.57 (-, CH2). 
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Methyl cis-2-aminocyclohexane-1-carboxylate (rac-65)[284] 
cis-46 (2.32 g, 8.02 mmol, 1.0 equiv.) was transferred into an autoclave vessel with MeOH (10 mL) and 
120 mg Pd/C (10 wt% Pd) added. The mixture was hydrogenated for 6 h with 30 bar H2. After the 
reaction was completed, the slurry was filtered* and the solvent removed carefully on a rotatory 
evaporator (the free amine tends to be volatile). The residue was diluted with H2O (40 mL) and 
transferred into a separating funnel, then acidified with 2 M HCl to approximately pH 3 and extracted 
with diethyl ether (2x). The aqueous phase was then basified with sat. Na2CO3 to pH 9 and extracted 
with DCM (5x), until TLC control showed no more remaining product. The combined organic phases 
were dried over Na2SO4, filtered and the solvent removed carefully on a rotatory evaporator. Yellowish 
liquid (973 mg, 6.19 mmol, 77%). 
Rf = 0.08 (DCM/MeOH 100:1); 1H-NMR (400 MHz, CDCl3) δH (ppm) =3.64 (3 H, s), 3.29 – 3.20 (1 H, m), 
2.51 (1 H, dt, J = 9.9, 3.8 Hz), 1.84 – 1.19 (10 H, m); 13C-NMR (101 MHz, CDCl3) δC (ppm) = 175.04(Cq), 
51.45 (+, CH3), 48.52 (+, CH), 47.29 (+, CH), 33.03 (-, CH2), 24.28 (-, CH2), 23.80 (-, CH2), 20.92 (-, CH2) 
 
3.2. Desymmetrization reactions 
 
 
(1S,6R)-6-(Methoxycarbonyl)cyclohex-3-ene-1-carboxylic acid ((-)-63) 
Pathway A - Kinetic resolution using (1R,2S)-(-)-ephedrine[191] 
In separate flasks, racemic cis-63 (22.63 g, 122.9 mmol, 1.0 equiv.) and (1R,2S)-(-)-ephedrine (20.30 g, 
122.9 mmol, 1.0 equiv.) were each dissolved in EtOH (60 mL) and heated to 70 °C. The hot ephedrine 
solution was then added to the cis-63 solution in one portion and the resulting yellow mixture was 
allowed to reach ambient temperature. After 2 h, a white solid had precipitated, was filtered off and 
washed with small amounts of hexanes.† The salt was recrystallized from EtOH three times, after which 
the enantiomeric excess was estimated to be >99%. The white solid (9.33 g) was dissolved in ice-cold 
                                                          
* Two paper filters were used to ensure that no palladium was washed into the filtrate. 
† Estimation of the enantiopurity was achieved using 1H-NMR, as the diastereomeric salts display slightly shifted 
resonances for the methyl ester groups (3.59 vs 3.61 ppm). 
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1 M H2SO4 (25 mL) and extracted with diethyl ether (6x 25 mL) The combined organic extracts were 
washed with 1 M H2SO4 (50 mL) and H2O (50 mL), dried over Na2SO4, filtered, the solvent evaporated 
off and the residue dried under high vacuum. Yellowish oil (4.78 g, .26.0 mmol, 42%). 
Analytical data is similar to cis-63. Enantiomeric excess was determined by derivatization according to 
GP-4 and subsequent chiral HPLC analysis, >99% ee.  
Pathway B - Desymmetrization using quinine[184–186] 
A flame-dried three-necked round bottom flask equipped with a septum and nitrogen inlet was 
charged with racemic cis-56 (1.52 g, 10.0 mmol, 1.0 equiv.) and quinine (3.57 g, 11.0, 1.1 equiv.) and 
evacuated for 3 h to remove remaining traces of humidity. The solids were suspended in dry toluene 
(100 mL) under a nitrogen atmosphere and the slurry was cooled down to -45 °C. Dry MeOH (1.3 mL, 
32.1 mmol, 3.2 equiv.) was added dropwise using a syringe and the mixture was stirred for 65 h at  
-45 °C. Subsequently, the now clear solution was allowed to warm up to ambient temperature and all 
volatiles were removed under reduced pressure. The residue was transferred into a separating funnel 
with small amounts of EtOAc and 2 M HCl. The organic phase was separated and the aqueous phase 
extracted with EtOAc. The combined organic extracts were dried over MgSO4, filtered, the solvent was 
distilled off and the product dried under high vacuum. Yellowish oil (1.66 g, 9.03 mmol, 90%). 
Analytical data is similar to cis-63. [α]D
22: -10.2 (c = 1.32, CHCl3). Enantiomeric excess was determined 
by derivatization according to GP-4 and subsequent chiral HPLC analysis, 93% ee. 
 
 
cis-Dimethyl cyclohex-4-ene-1,2-dicarboxylate (69)[285] 
In a 100 mL round bottom flask, racemic cis-63 (8.02 g, 43.5 mmol, 1.0 equiv.) was dissolved in MeOH 
(40 mL) and conc. H2SO4 (3 mL, 96 wt%) was added carefully while stirring. Subsequently, the mixture 
was refluxed for 5 d. After the reaction was complete, the solvent was distilled off, transferred into a 
separating funnel with H2O and extracted with MTBE (3x). The combined organic extracts were washed 
successively with H2O, sat. NaHCO3 solution and again H2O, then dried over Na2SO4, filtered and all 
volatiles removed by rotatory evaporation. The crude product was purified by distillation under 
reduced pressure (75 °C, 0.9 mbar). Colorless oil (6.55 g, 33.0 mmol, 76%).  
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Rf = 0.58 (hexanes/EtOAc 4:1); 1H-NMR (300 MHz, CDCl3) δH (ppm) = 5.66 (2 H, s), 3.68 (6 H, s),  
3.08 – 2.98 (2 H, m), 2.61 – 2.47 (4 H, m); 13C-NMR (75 MHz, CDCl3) δC (ppm) = 173.89 (Cq), 125.23  
(+, CH), 51.98 (+, CH3), 39.80 (+, CH), 25.83 (-, CH2). 
 
 
(1R,6S)-6-(Methoxycarbonyl)cyclohex-3-ene-1-carboxylic acid ((+)-63)[171] 
69 (4.00 g, 20.18 mmol, 1.0 equiv.) was suspended in 50 mM pH 8.0 phosphate buffer (100 mL) in a 
250 mL Erlenmeyer flask equipped with a pH meter. 2000 U PLE (111.1 mg, 18 U/mg, Aldrich) were 
added in one portion and the resulting yellowish slurry was stirred at 30 °C. The pH was monitored 
carefully, using 1 M NaOH to maintain a slightly basic pH (7.5 – 8.0). After 5 h and the total addition of 
20 mL 1 M NaOH (20 mmol, 1.0 equiv.), the reaction was aborted and filtered through a plug of Celite. 
The aqueous filtrate was extracted with diethyl ether (3x), then acidified to pH 2 using conc. HCl and 
extracted once more. The extraction process was hampered by excessive formation of foam and partial 
gelification/emulsification of the organic phase. The combined, gel-like organic extracts were pre-dried 
over Na2SO4 and then filtered off. As a consequence, the emulsion broke up, resulting in a distinct 
organic and aqueous phase. The organic phase was separated off, dried once more over Na2SO4, 
filtered, the solvent evaporated off and the product dried under high vacuum. Yellowish oil (3.21 g, 
17.5 mmol, 86%). 
Analytical data is similar to cis-63. Enantiomeric excess was determined by derivatization according to 
GP-4 and subsequent chiral HPLC analysis, 96% ee.  
 
General procedure for the derivatization of hemiesters for HPLC analysis (GP-4)[188] 
A 10 mL round bottom flask was charged with hemiester (+)-63 (50.0 mg, 271 µmol, 1.0 equiv.),  
4-Br-PhOH (47.0 mg, 271 µmol, 1.0 equiv.) and DCM (3 mL). The solution was cooled to 0 °C in an ice 
bath and DCC (56.0 mg, 271 µmol, 1.0 equiv.) and DMAP (8.3 mg, 68 µmol, 25 mol%) were added 
successively. The mixture was stirred for 25 h at ambient temperature, during which a white solid 
precipitated. The precipitate was removed by filtration and the solvent was removed with a rotatory 
evaporator. The crude product was purified by flash column chromatography (hexanes/EtOAc 9:1). 
White solid (69.4 mg, 205 µmol, 75%). 
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cis-1-(4-Bromophenyl) 2-methyl cyclohex-4-ene-1,2-dicarboxylate (108)[188] 
White solid. 
Rf = 0.30 (hexanes/EtOAc 9:1); 1H-NMR (300 MHz, CDCl3) δH (ppm) = 7.52 – 7.44 (2 H, m), 7.01 – 6.93 
(m, 2 H), 5.78 – 5.67 (2 H, s), 3.74 – 3.68 (3 H, s), 3.28 – 3.18 (2 H, m), 2.73 – 2.55 (2 H, m), 2.55 – 2.35 
(2 H, m); 13C-NMR (75 MHz, CDCl3) δC (ppm) = 173.60 (Cq), 171.82 (Cq), 149.92 (Cq), 132.62 (+, CH), 
132.52 (+, CH), 125.30 (+, CH), 124.99 (+, CH), 123.46 (+, CH), 118.95 (Cq), 52.15 (+, CH3), 40.01 (+, CH), 
26.00 (-, CH2), 25.52 (-, CH2); Chiral HPLC performed on Chiralcel Phenomenex Lux Cellulose-2  
(n-heptane/i-PrOH = 95:5, λ = 215 nm, 0.5 mL/min). tr = 15.2 min (1S,2R), tr = 18.2 min (1R,2S). 
 
3.3. Synthesis of peptides containing β-ACHC 
 
General procedure for the deprotection of methyl esters (GP-5)[176] 
A 25 mL round bottom flask was charged with a methyl ester (1.0 mmol, 1.0 equiv.), dissolved in THF 
(5 mL) and cooled to 0 °C in an ice bath. Meanwhile, a solution of LiOH (5.0 mmol, 5.0 equiv.) in H2O 
(5 mL) was prepared in a second flask, chilled to 0 °C as well and then added dropwise to the THF 
solution. After complete addition, the slightly turbid mixture was allowed to warm up to ambient 
temperature and stirred until TLC showed complete conversion. The reaction mixture was then 
transferred into a separating funnel with small amounts of H2O, acidified to pH 2 using 1 M HCl and 
then extracted with EtOAc (4x). The combined organic phases were dried over Na2SO4, filtered, all 
volatiles removed by rotatory evaporation and the product dried under high vacuum.  
 
General procedure for the consecutive Boc/Bn deprotection (GP-6) 
A 25 mL round bottom flask was charged with 68 (264 mg, 501 μmol, 1.0 equiv.) and EtOAc (5 mL, pre-
dried over K2CO3) and cooled to 0 °C. A 4.2 M solution of HCl in EtOAc (5.0 mL, 21 mmol, 42 equiv.) was 
added carefully and the mixture stirred for 3.5 h at 0°C, until complete conversion was detected by 
TLC. Subsequently, the solvent was removed directly under high vacuum, the residue diluted in H2O 
(15 mL) and transferred into a separating funnel. The aqueous phase was washed with diethyl ether 
(2x), then basified with sat. Na2CO3 to pH 9 and extracted with DCM (4x), until TLC control showed no 
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more remaining product in the extract. The combined organic phases were dried over Na2SO4, filtered 
and the solvent removed carefully on a rotatory evaporator. 
The white foam-like solid was transferred into a Schlenk flask filled with 50 mg Pd/C (10 wt% Pd) using 
MeOH (10 mL). The slurry was flushed with H2 and hydrogenated for 3 h until complete conversion 
was detected by TLC. The crude mixture was filtered through a plug of Celite and washed thoroughly 
with MeOH. The solvent was evaporated and the remaining product was dried under high vacuum. 
White solid (155 mg, 460 μmol, 92%). 
 
General procedure for the simultaneous Bn/Cbz deprotection (GP-7) 
50 mg Pd/C (10 wt% Pd) were filled into an autoclave vessel and suspended carefully with MeOH (1 
mL) under a nitrogen atmosphere. ent-72 (217 mg, 386 μmol, 1.0 equiv.) was transferred into the 
vessel with MeOH (5 mL) and the mixture was hydrogenated for 25 h with 40 bar H2 until complete 
conversion was observed with TLC. The crude mixture was filtered through a plug of Celite and washed 
thoroughly with MeOH. The solvent was evaporated off and the remaining product was dried under 
high vacuum. White solid (130 mg, 385 μmol, 100%). 
 
 
tert-Butyl (S)-2-(((1S,2R)-2-(methoxycarbonyl)cyclohexyl)carbamoyl)pyrrolidine-1-carboxylate  
(Boc-Pro-(-)--OMe, 66)[155,174] 
A flame-dried two-necked Schlenk flask equipped with a reflux condenser, bubble counter and septum 
was charged with (-)-63 (1.66 g, 9.03 mmol, 1.0 equiv.), NEt3 (1.3 mL, 9.4 mmol, 1.0 equiv.) and dry 
toluene (30 mL). DPPA (2.49 g, 9.03 mmol, 1.0 equiv.) was added dropwise to the stirred mixture, 
followed by BnOH (1.9 mL, 18.3 mmol, 2.0 equiv.). The reaction was heated to 120 °C and stirred for 
4 h (gas evolution was observed). Subsequently, the mixture was allowed to cool to ambient 
temperature, transferred into a separating funnel and diluted with EtOAc (1x 30 mL). The organic phase 
was washed consecutively with 2 M HCl (1x 60 mL), sat. NaHCO3 (1x 60 mL) and sat. NaCl solutions  
(1x 60 mL), then dried over MgSO4, filtered, all volatiles evaporated and the residue dried under high 
vacuum. 
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The yellow oil was transferred into an autoclave vessel with MeOH (10 mL) and 140 mg Pd/C  
(10 wt% Pd) added. The mixture was hydrogenated for 4 h with 30 bar H2. After the reaction was 
completed, the slurry was filtered* and the solvent removed carefully on a rotatory evaporator (the 
free amine tends to be volatile). The residue was diluted with H2O (20 mL) and transferred into a 
separating funnel, then acidified with 2 M HCl to approximately pH 3 and extracted with diethyl ether 
(2x). The aqueous phase was then basified with sat. Na2CO3 to pH 9 and extracted with DCM (15x), 
until TLC control showed no more remaining product. The combined organic phases were dried over 
Na2SO4, filtered and the solvent removed carefully on a rotatory evaporator.  
The yellowish liquid (1.29 g) was then diluted in dry DCM (5 mL) and cooled to 0 °C. Meanwhile, a 
cooled solution of N-Boc-L-Pro-OH (1.85 g, 8.60 mmol, 1.1 equiv., 58) in dry DCM (25 mL) was 
preactivated with EDC·HCl (1.65 g, 8.60 mol, 1.1 equiv.) for 60 min and then added dropwise to the 
crude amine. Subsequently, a cooled solution of triethylamine (1.4 mL, 10.2 mmol, 1.3 equiv.) in dry 
DCM (20 mL) was added as well. The reaction mixture was allowed to warm to ambient temperature 
and stirred for 20 h. The mixture was quenched with H2O (50 mL) and the solution acidified to pH 3 
with 1 M KHSO4. The solution was transferred into a separating funnel and the aqueous phase 
extracted with DCM (4x). The combined organic phases were washed successively with sat. NaHCO3 
(1x) and sat. NaCl solutions (1x), then dried over Na2SO4, filtered, all volatiles evaporated off and the 
residue dried under high vacuum. The crude product was purified by flash column chromatography 
(hexanes/ EtOAc 1:1). White solid (1.10 g, 3.09 mmol, 34% over 3 steps). 
Rf = 0.40 (hexanes/EtOAc 1:1); 1H-NMR (400 MHz, CD2Cl2, 300 K): δH (ppm) =7.36 (0.6 H, bs), 6.88  
(0.4 H, bs), 4.12 (2 H, bs), 3.65 (3 H, s), 3.50 – 3.25 (2 H, m), 2.71 (1 H, bs), 2.26 – 1.20 (21 H, m);  
13C-NMR (101 MHz, CD2Cl2, 233 K): δC (ppm) = 171.46 (Cq), 174.30 (Cq), 171.52 (Cq), 171.13 (Cq), 154.42 
(Cq), 79.98 (Cq), 79.77 (Cq), 61.16 (+, CH), 60.06 (+, CH), 52.04 (+, CH3), 51.92 (+, CH3), 47.20 (-, CH2), 
46.95 (-, CH2), 44.31 (+, CH), 31.30 (-, CH2), 29.45 (-, CH2), 28.08 (+, CH3), 27.96 (+, CH3), 24.66 (-, CH2), 
23.67 (-, CH2), 22.20 (-, CH2) (signal doubling due to rotamers); IR (neat): ?̅? = 3300, 2936, 2864, 1734, 
1689, 1654, 1540, 1389, 1363, 1310, 1245, 1159, 1118, 1036, 980, 924, 858, 771, 650, 590, 538;  
MS (+ESI, 120 V): m/z (%) = 255.2 (36) [(MH2-Boc)+], 355.2 (100) [(M+H)+], 377.2 (37) [(M+Na)+], 731.4 
(26) [(2M+Na)+]. HRMS (+ESI, 120 V): 355.2233 (C18H31N2O5 [(M+H)+]: calc. 355.2227). [α]D
22: -115.2  
(c = 1.01, CHCl3); Chiral HPLC performed on Chiralpak AS-H (n-heptane/i-PrOH = 90:10, λ = 215 nm, 
1.0 mL/min): tr(major) = 34.1 min; diastereomeric excess: >99%; m.p. 94 – 98 °C. 
 
                                                          
* Two paper filters were used to ensure that no palladium was washed into the filtrate. 
Experimental Part 
 
115 
 
 
tert-Butyl (S)-2-(((1S,2R)-2-((S)-2-((benzyloxy)carbonyl)pyrrolidine-1-carbonyl)cyclohexyl)-
carbamoyl)-pyrrolidine-1-carboxylate (Boc-Pro-(-)--Pro-OBn, 68)[155] 
The starting material 66 (640 mg, 1.81 mmol, 1.0 equiv.) was dissolved in THF (10 mL) and deprotected 
according to GP-5 using LiOH (216 mg, 9.03 mmol, 5.0 equiv.) in H2O (10 mL).  
The resulting white solid was dissolved in dry DCM (25 mL), charged with EDC·HCl (382 mg, 1.99 mmol, 
1.1 equiv.) and preactivated for 30 min at ambient temperature. To this mixture, H-L-Pro-OBn·HCl 
(525 mg, 2.17 mmol, 1.2 equiv., 67·HCl) and NEt3 (300 μL, 2.17 mmol, 1.2 equiv.) were added and the 
resulting slurry stirred for 24 h at ambient temperature. The mixture was quenched with H2O (20 mL) 
and the solution acidified to pH 2 with 1 M KHSO4. The crude mixture was transferred into a separating 
funnel and the organic phase washed successively with sat. NaHCO3 (1x) and sat. NaCl solutions (1x). 
The organic phase was dried over Na2SO4, filtered, all volatiles evaporated off and the residue dried 
under high vacuum. The crude product was purified using flash column chromatography (DCM/MeOH 
50:1). White solid (860 g, 1.63 mmol, 90% over 2 steps). 
Rf = 0.30 (DCM/MeOH 50:1); 1H-NMR (300 MHz, CDCl3): δH (ppm) =7.40 – 7.28 (5 H, m), 7.07 (0.6 H, bs) 
+ 6.61 (0.4 H, bs), 4.12 (2 H, bs), 5.25 – 5.01 (2 H, m), 4.55 – 4.48 (1 H, m), 4.30 – 4.02 (2 H, m),  
3.70 – 3.22 (4 H, m), 2.95 – 2.83 (1 H, m), 2.30 – 1.72 (11 H, m), 1.71 – 1.27 (14 H, m);  
13C-NMR (101 MHz, CD2Cl2): δC (ppm) = 172.83 (Cq), 172.02 (Cq), 155.75 (Cq), 154.72 (Cq), 136.62 (Cq), 
128.96 (+, CH), 128.61 (+, CH), 128.47 (+, CH), 80.19 (Cq), 80.04 (Cq), 66.97 (-, CH2), 61.45 (+, CH), 60.88 
(+, CH), 59.40 (-, CH2), 47.62 (-, CH2), 47.39 (-, CH2), 43.10 (+, CH), 31.87 (-, CH2), 31.77 (-, CH2), 29.62  
(-, CH2), 29.47 (-, CH2), 28.66 (+, CH3), 26.38 (-, CH2), 25.99 (-, CH2), 25.59 (-, CH2), 25.01 (-, CH2), 24.09 
(-, CH2), 23.79 (-, CH2), 23.15 (-, CH2), 22.82 (-, CH2) (signal doubling due to rotamers);  
IR (neat): ?̅? = 2932, 2873, 1742, 1692, 1638, 1509, 1430, 1389, 1246, 1161, 1121, 1090, 1031, 982, 921, 
737, 698; MS (+ESI, 120 V): m/z (%) = 428.3 (6) [(MH2-Boc)+], 528.3 (100) [(M+H)+], 550.3 (25), 
[(M+Na)+], 1077.6 (20) [(2M+Na)+]; HRMS (+ESI, 120 V): 528.3071 (C29H42N3O6 [(M+H)+]:  
calc. 528.3068); [α]D
22: -135.1 (c = 0.53, CHCl3); Chiral HPLC performed on Chiralcel Phenomenex Lux 
Cellulose-2 (n-heptane/i-PrOH = 70:30, λ = 215 nm, 0.5 mL/min): tr(major) = 13.0 min; diastereomeric 
excess: >99%; m.p. 51 – 74 °C. 
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((1R,2S)-2-((S)-Pyrrolidine-2-carboxamido)cyclohexane-1-carbonyl)-L-proline  
(H-Pro-(-)--Pro-OH, 52)[155] 
Synthesized from 68 (264 mg, 501 μmol, 1.0 equiv.) according to GP-6. White solid (155 mg, 460 μmol, 
92%). A crystal for X-ray analysis was obtained by recrystallization from MeOH. 
Rf = 0.03 (DCM/MeOH 4:1); 1H-NMR (400 MHz, CDCl3, 300 K): δH (ppm) =8.47 – 5.20 (1 H, bs), 7.87 (0.4 
H, d, J = 8.6 Hz) + 7.27 (0.6 H, bs), 4.43 – 3.85 (3 H, m), 3.70 – 3.39 (3 H, m), 3.34 – 3.11 (2 H, m), 2.88 
– 2.70 (1 H, m), 2.44 – 1.69 (10 H, m), 1.69 – 1.28 (6 H, m); 13C-NMR (101 MHz, CDCl3): δC (ppm) = 
178.43 (Cq), 176.31 (Cq), 173.18 (Cq), 172.38 (Cq), 170.67 (Cq), 169.04 (Cq), 62.26 (+, CH), 61.10 (+, CH), 
60.33 (+, CH), 59.51 (+, CH), 48.26 (+, CH), 47.68 (+, CH), 46.59 (-, CH2), 45.86 (-, CH2), 43.04 (+, CH), 
41.76 (+, CH), 31.94 (-, CH2), 31.15 (-, CH2), 29.60 (-, CH2), 29.51 (-, CH2), 29.33 (-, CH2), 28.79 (-, CH2), 
25.98 (-, CH2), 25.40 (-, CH2), 25.32 (-, CH2), 24.74 (-, CH2), 23.19 (-, CH2),.22.29 (-, CH2), 22.43 (-, CH2) 
(signal doubling due to rotamers); IR (neat): ?̅? = 3346, 2934, 2872, 1664, 1604, 1444, 1387, 1366, 1294, 
1253, 1195, 1130, 1093, 1042, 923, 856, 680; MS (+ESI, 120 V): m/z (%) = 338.2 (100) [(M+H)+], 
675.4 (1) [(2M+H)+]; HRMS (+ESI, 120 V): 338.2080 (C17H28N3O4 [(M+H)+]: calc. 338.2074); [α]D
22: -96.6 
(c = 0.97, CHCl3); m.p. 127 °C (decomposition). 
 
 
tert-Butyl (S)-2-(((1R,2S)-2-(methoxycarbonyl)cyclohexyl)carbamoyl)pyrrolidine-1-carboxylate  
(Boc-Pro-(+)--OMe, ent-66)[155,174] 
A flame-dried two-necked Schlenk flask equipped with a reflux condenser, bubble counter and septum 
was charged with (+)-63 (1.00 g, 5.43 mmol, 1.0 equiv.), dry NEt3 (0.78 mL, 5.6 mmol, 1.0 equiv.) and 
dry toluene (20 mL). DPPA (1.53 g, 5.57 mmol, 1.0 equiv.) was added dropwise to the stirred mixture, 
followed by BnOH (1.1 mL, 10.6 mmol, 2.0 equiv.). The reaction was heated to 120 °C and stirred for 
4 h (gas evolution was observed). Subsequently, the mixture was allowed to cool to ambient 
temperature, transferred into a separating funnel and diluted with EtOAc (10 mL). The organic phase 
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was washed consecutively with 2 M HCl (1x 30 mL), sat. NaHCO3 (1x 30 mL) and sat. NaCl solutions 
(1x 30 mL), then dried over Na2SO4, filtered, all volatiles removed and the residue dried under high 
vacuum. 
The yellow oil was transferred into an autoclave vessel with MeOH (10 mL) and 200 mg Pd/C (10 wt% 
Pd) added. The mixture was hydrogenated for 19 h at 45 bar H2. After the reaction was completed, the 
slurry was filtered and the solvent was removed carefully on a rotatory evaporator (the free amine 
tends to be volatile). The residue was diluted with H2O (10 mL) and transferred into a separating funnel, 
then acidified with 2 M HCl to approximately pH 3 and extracted with diethyl ether (2x). The aqueous 
phase was then basified with sat. Na2CO3 to pH 9 and extracted with DCM (12x), until TLC control 
showed no more remaining product in the extract. The combined organic phases were dried over 
Na2SO4, filtered and the solvent removed carefully on a rotatory evaporator. 
The yellowish liquid was then diluted with EtOAc (15 mL) and charged with pyridine (1.3 mL, 
16.3 mmol, 3.0 equiv.) and N-Boc-L-Pro-OH (1.23 g, 5.70 mmol, 1.1 equiv., 58). The slurry was cooled 
to -10 °C and T3P (50 wt% in EtOAc) (6.91 g, 10.91 mmol, 2.0 equiv.) added dropwise. The reaction 
mixture was allowed to warm up to ambient temperature and stirred for 20 h. The mixture was 
transferred into a separating funnel and diluted with H2O (25 mL). The organic phase was separated 
off, the aqueous phase extracted with EtOAc (3x) and the combined organic phases dried over Na2SO4. 
The drying agent was filtered off, all volatiles evaporated off and the residue dried under high vacuum. 
The crude product was purified by flash column chromatography (hexanes/ EtOAc 2:1 → 1:1). Colorless 
oil (1.23 g, 3.48 mmol, 64% over 3 steps). 
Rf = 0.35 (hexanes/EtOAc 1:1); 1H-NMR (400 MHz, CDCl3): δH (ppm) =7.22 (0.5 H, bs) + 6.79 (0.5 H, bs), 
4.21 – 3.90 (2 H, m), 3.49 (3 H, s), 3.41 – 3.04 (2 H, m), 2.55 (1 H, bs), 2.29 – 1.03 (21 H, m);  
13C-NMR (101 MHz, CDCl3): δC (ppm) = 174.54 (Cq), 173.78 (Cq), 171.52 (Cq), 171.02 (Cq), 155.30 (Cq), 
154.90 (Cq), 154.31 (Cq), 153.74 (Cq), 80.03 (Cq), 79.39 (Cq), 61.16 (+, CH), 60.00 (+, CH), 58.73 (+, CH), 
58.60 (+, CH), 51.34 (+, CH3), 47.14 (+, CH), 46.66 (-, CH2), 46.47 (-, CH2), 46.04 (-, CH2), 44.45 (+, CH), 
44.16 (+, CH), 30.94 (-, CH2), 30.67 (-, CH2), 29.32 (-, CH2), 28.12 (+, CH), 26.41 (-, CH2), 25.03 (-, CH2), 
24.07 (-, CH2), 23.36 (-, CH2), 22.95 (-, CH2), 22.23 (-, CH2) (signal doubling due to rotamers); IR (neat): 
?̅? = 3421, 3332, 2975, 2940, 2870, 1729, 1685, 1664, 1536, 1449, 1400, 1360, 1313, 1163, 1119, 1085, 
1039, 987, 918, 885, 846, 776, 753; MS (+ESI, 120 V): m/z (%) = 355.2 (100) [(M+H)+], 377.2 (20) 
[(M+Na)+], 731.4 (20) [(2M+Na)+]; HRMS (+ESI, 120 V): 355.2230 (C18H31N2O5 [(M+H)+]: calc. 355.2227); 
[α]D
22: -54.5 (c = 1.05, CHCl3); m.p. 42 – 55 °C; Chiral HPLC performed on Chiralpak AS-H  
(n-heptane/i-PrOH = 90:10, λ = 215 nm, 1.0 mL/min): tr(major) = 19.2 min; diastereomeric excess: 
>99%. 
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Benzyl (S)-2-(((1R,2S)-2-(methoxycarbonyl)cyclohexyl)carbamoyl)pyrrolidine-1-carboxylate  
(Cbz-Pro-(+)--OMe, ent-71)[174,195] 
A flame-dried two-necked Schlenk flask equipped with a reflux condenser, bubble counter and septum 
was charged with (+)-63 (1.00 g, 5.43 mmol, 1.0 equiv.), dry NEt3 (0.78 mL, 5.6 mmol, 1.0 equiv.) and 
dry toluene (20 mL). DPPA (1.53 g, 5.57 mmol, 1.0 equiv.) was added dropwise to the stirred mixture, 
followed by BnOH (1.1 mL, 10.6 mmol, 2.0 equiv.). The reaction was heated to 120 °C and stirred for 
4 h (gas evolution was observed). Subsequently, the mixture was allowed to cool to ambient 
temperature, transferred into a separating funnel and diluted with EtOAc (10 mL). The organic phase 
was washed consecutively with 2 M HCl (1x 30 mL), sat. NaHCO3 (1x 30 mL) and sat. NaCl solutions 
(1x 30 mL), then dried over Na2SO4, filtered, all volatiles removed and the residue dried under high 
vacuum. 
The yellow oil was transferred into an autoclave vessel with MeOH (10 mL) and 200 mg Pd/C (10 wt% 
Pd) added. The mixture was hydrogenated for 16 h at 45 bar H2. After the reaction was completed, the 
slurry was filtered and the solvent was removed carefully on a rotatory evaporator (the free amine 
tends to be volatile). The residue was diluted with H2O (10 mL) and transferred into a separating funnel, 
then acidified with 2 M HCl to approximately pH 3 and extracted with diethyl ether (2x). The aqueous 
phase was then basified with sat. Na2CO3 to pH 9 and extracted with DCM (10x), until TLC control 
showed no more remaining product. The combined organic phases were dried over Na2SO4, filtered 
and the solvent removed carefully on a rotatory evaporator.  
The yellowish liquid (653 mg) was then diluted with EtOAc (15 mL) and charged with pyridine (1.0 mL, 
12.5 mmol, 3.0 equiv.) and N-Cbz-L-Pro-OH (1.09 g, 4.36 mmol, 1.1 equiv., 70). The slurry was cooled 
to -10 °C and T3P (50 wt% in EtOAc) (5.29 g, 8.31 mmol, 2.0 equiv.) added dropwise. The reaction 
mixture was allowed to warm up to ambient temperature and stirred for 65 h. The mixture was 
transferred into a separating funnel and diluted with H2O (25 mL). The organic phase was separated 
off, the aqueous phase extracted with EtOAc (3x) and the combined organic phases dried over Na2SO4. 
The drying agent was filtered off, all volatiles evaporated and the residue dried under high vacuum. 
The crude product was purified using flash column chromatography (hexanes/ EtOAc 1:1). Colorless oil 
(929 mg, 2.39 mmol, 44% over 3 steps). 
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Rf = 0.23 (hexanes/EtOAc 1:1); 1H-NMR (300 MHz, CDCl3): δH (ppm) =7.57 – 6.43 (6 H, m), 5.30 – 4.77 
(2 H, m), 4.38 – 3.78 (2 H, m), 3.41 – 3.04 (5 H, m), 2.54 (1 H, bs), 2.34 – 0.80 (12 H, m);  
13C-NMR (75 MHz, CDCl3): δC (ppm) = 173.58 (Cq), 170.78 (Cq), 170.28 (Cq), 155.47 (Cq), 154.54 (Cq), 
136.21 (Cq), 128.02 (+, CH), 127.58 (+, CH), 127.43 (+, CH), 66.69 (-, CH2), 60.67 (+, CH), 60.30 (+, CH), 
51.08 (+, CH3), 46.98 (+, CH), 46.68 (+, CH), 46.37, 44.26 (+, CH), 43.78 (+, CH), 30.69 (-, CH2), 29.17  
(-, CH2), 28.78 (-, CH2), 28.05 (-, CH2), 26.03 (-, CH2), 25.11 (-, CH2), 23.94 (-, CH2), 23.01 (-, CH2), 22.65 
(-, CH2), 22.20 (-, CH2) (signal doubling due to rotamers); IR (neat): ?̅? = 3418, 3329, 2937, 2863, 1677, 
1513, 1450, 1409, 1357, 1238, 1170, 1115, 1088, 1036, 984, 917, 883, 749, 697; MS (+ESI, 120 V): 
m/z (%) = 389.2 (100) [(M+H)+], 411.2 (34) [(M+Na)+], 799.4 (1) [(2M+Na)+]; HRMS (+ESI, 120 V): 
389.2075 (C21H29N2O5 [(M+H)+]: calc. 389.2071); [α]D
22: -45.8 (c = 1.03, CHCl3); Chiral HPLC performed 
on Chiralcel Phenomenex Lux Cellulose-2 (n-heptane/i-PrOH = 90:10, λ = 215 nm, 1.0 mL/min): 
tr(major) = 36.2 min; diastereomeric excess: >99%. 
 
 
tert-Butyl (S)-2-(((1R,2S)-2-((S)-2-((benzyloxy)carbonyl)pyrrolidine-1-carbonyl)cyclohexyl)-
carbamoyl)-pyrrolidine-1-carboxylate (Boc-Pro-(+)--Pro-OBn, ent-68)[155] 
The starting material ent-66 (400 mg, 1.13 mmol, 1.0 equiv.) was dissolved in THF (10 mL) and 
deprotected according to GP-5 using LiOH (135 mg, 5.64 mmol, 5.0 equiv.) in H2O (10 mL).  
The resulting white solid was dissolved in EtOAc (10 mL) and charged with pyridine (0.37 mL, 
4.58 mmol, 4.1 equiv.), H-L-Pro-OBn·HCl (300 mg, 1.24 mmol, 1.1 equiv., 67·HCl) and NEt3 (175 μL, 
1.26 mmol, 1.1 equiv.). The slurry was cooled to -10 °C and T3P (50 wt% in EtOAc) (1.44 g, 2.26 mmol, 
2.0 equiv.) added dropwise. The reaction mixture was allowed to warm up to ambient temperature 
and stirred for 48 h. The mixture was transferred into a separating funnel and diluted with H2O (20 mL). 
The organic phase was separated off, the aqueous phase extracted with EtOAc (3x) and the combined 
organic phases washed with sat. NH4Cl, sat. NaHCO3 and sat. NaCl solutions. The organic phase was 
dried over Na2SO4, filtered, all volatiles evaporated off and the residue dried under high vacuum. The 
crude product was purified using flash column chromatography (hexanes/ EtOAc 1:2 → 1:4). White 
foam-like solid (489 mg, 926 μmol, 82% over 2 steps). 
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Rf = 0.25 (hexanes/EtOAc 1:4); 1H-NMR (400 MHz, CDCl3): δH (ppm) =7.58 – 6.51 (6 H, m), 5.19 – 4.93 
(2 H, m), 4.52 – 4.28 (1 H, m), 4.24 – 3.91 (2 H, m), 3.76 – 3.10 (4 H, m), 2.82 (1 H, bs), 2.44 – 1.07 
(25 H, m); 13C-NMR (101 MHz, CDCl3): δC (ppm) = 171.57 (Cq), 171.24 (Cq), 171.07 (Cq), 170.83 (Cq), 
153.55 (Cq), 134.66 (+, CH), 134.13 (+, CH), 127.59 (+, CH), 127.52 (+, CH), 127.42 (+, CH), 127.30  
(+, CH), 127.09 (+, CH), 126.91 (+, CH), 78.87 (Cq), 78.54 (Cq), 66.10 (-, CH2), 65.50 (-, CH2), 60.58 (+, CH), 
59.89 (+, CH), 58.00 (+, CH), 57.62 (+, CH), 46.30 (+, CH), 46.00 (-, CH2), 45.80 (-, CH2), 45.28 (-, CH2), 
44.69 (-, CH2), 42.30 (+, CH), 41.13 (+, CH), 30.20 (-, CH2), 28.90 (-, CH2), 28.46 (-, CH2), 27.82 (-, CH2), 
27.76 (-, CH2), 27.26 (+, CH3), 25.03 (-, CH2), 24.27 (-, CH2), 22.98 (-, CH2), 22.52 (-, CH2), 22.29 (-, CH2), 
21.49 (-, CH2), 21.24 (-, CH2), 20.82 (-, CH2) (signal doubling due to rotamers); IR (neat): ?̅? = 3392, 2978, 
2930, 2863, 1741, 1696, 1673, 1618, 1513, 1439, 1383, 1267, 1234, 1167, 1118, 857, 775, 731, 697; 
MS (+ESI, 120 V): m/z (%) = 528.3 (100) [(M+H)+], 550.3 (62) [(M+Na)+], 1077.6 (11) [(2M+Na)+];  
HRMS (+ESI, 120 V): 528.3079 (C29H42N3O6 [(M+H)+]: calc. 528.3068); [α]D
22: -83.1 (c = 1.00, CHCl3); 
Chiral HPLC performed on Chiralcel Phenomenex Lux Cellulose-2 (n-heptane/i-PrOH = 70:30, 
λ = 215 nm, 0.5 mL/min): tr(major) = 21.2 min; diastereomeric excess: >99%; m.p. 106 – 112 °C. 
 
 
Benzyl (S)-2-(((1R,2S)-2-((S)-2-((benzyloxy)carbonyl)pyrrolidine-1-carbonyl)cyclohexyl)carbamoyl)-
pyrrolidine-1-carboxylate (Cbz-Pro-(+)--Pro-OBn, ent-72)[195] 
The starting material ent-71 (401 mg, 1.03 mmol, 1.0 equiv.) was dissolved in THF (10 mL) and 
deprotected according to GP-5 using LiOH (124 mg, 5.16 mmol, 5.0 equiv.) in H2O (10 mL).  
The resulting white solid was dissolved in EtOAc (10 mL) and charged with pyridine (0.34 mL, 
4.21 mmol, 4.1 equiv.), H-L-Pro-OBn·HCl (275 mg, 1.14 mmol, 1.1 equiv., 67·HCl) and NEt3 (160 μL, 
1.15 mmol, 1.1 equiv.). The slurry was cooled to -10 °C and T3P (50 wt% in EtOAc) (1.31 g, 2.06 mmol, 
2.0 equiv.) added dropwise. The reaction mixture was allowed to warm up to ambient temperature 
and stirred for 48 h. The mixture was transferred into a separating funnel and diluted with H2O (20 mL). 
The organic phase was separated off, the aqueous phase extracted with EtOAc (3x) and the combined 
organic phases washed with sat. NH4Cl (1x), sat. NaHCO3 (1x) and sat. NaCl solutions (1x). The organic 
phase was dried over Na2SO4, filtered, all volatiles evaporated and the residue dried under high 
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vacuum. The crude product was purified by flash column chromatography (hexanes/ EtOAc 1:1 → 1:4). 
Colorless oil (430 mg, 765 μmol, 74% over 2 steps). 
Rf = 0.30 (hexanes/EtOAc 1:4); 1H-NMR (400 MHz, CDCl3): δH (ppm) =7.63 – 6.99 (10 H, m), 6.87 (0.5 H, 
d, J = 6.5 Hz) + 6.71 (0.5 H, d, J = 7.0 Hz), 5.31 – 4.85 (4 H, m), 4.57 – 4.36 (1 H, m), 4.32 – 3.89 (2 H, m), 
3.86 – 3.22 (4 H, m), 2.99 – 2.70 (1 H, m), 2.61 – 0.85 (16 H, m); 13C-NMR (101 MHz, CDCl3): δC (ppm) = 
172.81 (Cq), 172.65 (Cq), 172.22 (Cq), 172.10 (Cq), 171.76 (Cq), 171.42 (Cq), 155.08 (Cq), 136.79 (Cq), 
136.53 (Cq), 135.62 (Cq), 135.17 (Cq), 128.65 (+, CH), 128.58 (+, CH), 128.49 (+, CH), 128.37 (+, CH), 
127.90 (+, CH), 127.80 (+, CH), 67.16 (-, CH2), 66.99 (-, CH2), 66.87 (-, CH2), 66.59 (-, CH2), 61.20 (+, CH), 
59.10 (+, CH), 58.68 (+, CH), 47.43 (+, CH), 47.26 (-, CH2), 46.99 (-, CH2), 46.83 (-, CH2), 46.34 (-, CH2), 
43.19 (+, CH), 41.76 (+, CH), 31.23 (-, CH2), 30.05 (-, CH2), 29.34 (-, CH2), 28.79 (-, CH2), 25.91 (-, CH2), 
24.74 (-, CH2), 24.11 (-, CH2), 23.47 (-, CH2), 23.01 (-, CH2), 22.28 (-, CH2), 21.97 (-, CH2) (signal doubling 
due to rotamers); IR (neat): ?̅? = 3403, 3332, 2933, 2878, 1744, 1703, 1700, 1633, 1513, 1435, 1405, 
1267, 1238, 1167, 1115, 1030, 977, 917, 738, 697; MS (+ESI, 120 V): m/z (%) = 562.3 (100) [(M+H)+], 
584.3 (44) [(M+Na)+], 1145.6 (19) [(2M+Na)+]; HRMS (+ESI, 120 V): 562.2921 (C32H40N3O6 [(M+H)+]:  
calc. 562.2912); [α]D
22: -64.5 (c = 1.01, CHCl3); Chiral HPLC performed on Chiralcel Phenomenex Lux 
Cellulose-2 (n-heptane/i-PrOH = 50:50, λ = 215 nm, 0.5 mL/min): tr(major) = 29.2 min; diastereomeric 
excess: >99%. 
 
 
((1S,2R)-2-((S)-Pyrrolidine-2-carboxamido)cyclohexane-1-carbonyl)-L-proline  
(H-Pro-(+)--Pro-OH, ent-52)[155] 
Synthesized from ent-68 (202 mg, 383 μmol, 1.0 equiv.) according to GP-6. White solid (118 mg, 
349 μmol, 91%). 
Also synthesized from ent-72 (217 mg, 386 μmol, 1.0 equiv.) according to GP-7. White solid (130 mg, 
385 μmol, 100%).  
Rf = 0.07 (DCM/MeOH 10:1); 1H-NMR (300 MHz, CDCl3): δH (ppm) = 9.27 (1 H, d, J = 9.0 Hz), 9.06 (1 H, 
s), 8.76 (1 H, bs), 7.47 (1 H, bs), 5.42 – 4.79 (1 H, m), 4.78 – 4.43 (1 H, m), 4.42 – 3.84 (1 H, m), 3.83 – 0.96 
(20 H, m); 13C-NMR (75 MHz, CDCl3): δC (ppm) = 177.98 (Cq), 172.15 (Cq), 168.44 (Cq), 61.14 (+, CH), 
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59.01 (+, CH), 47.29 (-, CH2), 47.16 (-, CH2), 44.77 (+, CH), 44.07 (+, CH), 31.66 (-, CH2), 28.88 (-, CH2), 
28.56 (-, CH2), 25.74 (-, CH2), 24.80 (-, CH2), 24.65 (-, CH2), 22.96 (-, CH2), 20.06 (-, CH2) (signal doubling 
due to rotamers); IR (neat): ?̅? = 3216, 3049, 2930, 2858, 1667, 1611, 1577, 1441, 1378, 1357, 1287, 
1243, 1194, 1120, 1088, 1038, 975, 918, 846, 725; MS (+ESI, 120 V): m/z (%) = 338.2 (100) [(M+H)+], 
675.4 (1) [(2M+H)+]; HRMS (+ESI, 120 V): 338.2078 (C17H28N3O4 [(M+H)+]: calc. 338.2074); [α]D
22: -43.7 
(c = 1.01, CHCl3); m.p. 111 °C (decomposition). 
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3.4. Synthesis of peptides containing anthranilic acid 
 
 
Methyl 2-aminobenzoate (73)[198] 
Anthranilic acid (4.00 g, 29.2 mmol, 1.0 equiv., 54) was dissolved in MeOH (100 mL, 2.47 mol, 85 equiv.) 
and the dark yellow solution was cooled to 0°C. SOCl2 (8.50 mL, 13.9 g, 117.2 mmol, 4.0 equiv.) was 
added dropwise at 0°C with a syringe pump over 30 min under tarnishing of the solution. The solution 
was heated under reflux for 16 h. The solvent was then removed under reduced pressure yielding a 
light pink solid. The crude product was transferred into a separating funnel with sat. NaHCO3 solution. 
The aqueous phase was extracted with EtOAc (1x 60 mL), the organic layer washed with sat. NaHCO3 
(1x) and sat. NaCl solutions (1x), dried over Na2SO4, filtered and the solvent removed under reduced 
pressure. The resulting brown suspension was filtered and concentrated in vacuo. Brown liquid (3.02 g, 
20.0 mmol, 68%). 
1H-NMR (300 MHz, CDCl3): δH (ppm) = 7.86 (1 H, dd, J = 8.1 Hz, 1.4 Hz), 7.30 – 7.23 (1 H, m), 6.69 – 6.62 
(2 H, m), 3.87 (3 H, s); 13C-NMR (75 MHz, CDCl3) δC (ppm) = 168.68 (Cq), 150.39 (Cq), 134.20 (+, CH), 
131.32 (+, CH), 116.85 (+, CH), 116.47 (+, CH), 110.91 (Cq), 51.65 (+, CH3). 
 
 
tert-Butyl (S)-2-((2-(methoxycarbonyl)phenyl)carbamoyl)pyrrolidine-1-carboxylate 
(Boc-Pro-Ant-OMe, 74)[155,199]  
Methyl 2-aminobenzoate (759 mg, 5.02 mmol, 1.0 equiv., 73) was dissolved in EtOAc (10 mL) and 
charged with pyridine (1.2 mL, 15.1 mmol, 3.0 equiv.) and N-L-Boc-Pro-OH (1.13 g, 5.27 mmol, 
1.1 equiv., 58). The slurry was cooled to -10 °C and T3P (50 wt% in EtOAc) (6.39 g, 10.0 mmol, 
2.0 equiv.) added dropwise. The reaction mixture was allowed to warm up to ambient temperature 
and stirred for 30 h. The mixture was transferred into a separating funnel and diluted with H2O (25 mL). 
The organic phase was separated off and the aqueous phase extracted with EtOAc (3x). The combined 
organic phases were dried over Na2SO4, filtered, all volatiles evaporated and the residue dried under 
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high vacuum. The crude product was purified by flash column chromatography (hexanes/ EtOAc 4:1 
→ 3:1). Orange oil (1.70 g, 4.89 mmol, 97%). 
Rf = 0.18 (hexanes/EtOAc 6:1); 1H-NMR (400 MHz, CDCl3): δH (ppm) = 11.56 (0.4 H, bs) + 11.45 (0.6 H, 
bs) 8.80 – 8.71 (1 H, m), 8.07 – 7.95 (1 H, m), 7.59 – 7.47 (1 H, m), 7.14 – 7.01 (1 H, m), 4.50 – 4.22 (1 H, 
m), 3.90 (3 H, m), 3.76 – 3.40 ( 2 H, m), 2.38 – 2.05 (2 H, m), 2.04 – 1.80 (2 H, m), 1.57 – 1.26 (9 H, m); 
13C-NMR (101 MHz, CDCl3): δC (ppm) = 172.55 (Cq), 172.07 (Cq), 168.34 (Cq), 155.19 (Cq), 154.37 (Cq), 
141.28 (Cq), 141.06 (Cq), 134.69 (+, CH), 131.07 (+, CH), 130.82 (+, CH), 122.79 (+, CH), 120.41 (+, CH), 
120.20 (+, CH), 115.46 (Cq), 80.39 (Cq), 80.23 (Cq), 62.84 (+, CH), 62.25 (+, CH), 52.57 (+, CH), 52.25  
(+, CH), 47.26 (-, CH2), 46.93 (-, CH2), 31.67 (-, CH2), 30.64 (-, CH2), 28.56 (+, CH3), 28.34 (+, CH3), 24.46 
(-, CH2), 23.94 (-, CH2) (signal doubling due to rotamers); IR (neat): ?̅? = 3269, 2974, 2881, 1689, 1588, 
1513, 1450, 1368, 1297, 1260, 1159, 1088, 951, 921, 880, 753; MS (+ESI, 120 V): m/z (%) = 249.1  
[(MH2-Boc)+] (77), 293.1 [(MH-C4H8)+] (61), 349.2 (100) [(M+H)+], 371.2 (60) [(M+Na)+], 719.3 (52) 
[(2M+Na)+]; HRMS (+ESI, 120 V): 333.1769 (C21H23N2O5 [(M+H)+]: calc. 349.1758); [α]D
22: -121.4 
(c = 1.10, CHCl3). 
 
 
Benzyl (S)-2-((2-(methoxycarbonyl)phenyl)carbamoyl)pyrrolidine-1-carboxylate  
(Cbz-Pro-Ant-OMe, 75)[195,200] 
Methyl 2-aminobenzoate (1.08 g, 7.12 mmol, 1.0 equiv., 73) was dissolved in EtOAc (15 mL) and 
charged with pyridine (1.7 mL, 21.4 mmol, 3.0 equiv.) and N-L-Boc-Pro-OH (1.86 g, 7.47 mmol, 
1.1 equiv., 58). The slurry was cooled to -10 °C and T3P (50 wt% in EtOAc) (9.06 g, 14.2 mmol, 
2.0 equiv.) added dropwise. The reaction mixture was allowed to warm up to ambient temperature 
and stirred for 32 h. The mixture was transferred into a separating funnel and diluted with H2O (25 mL). 
The organic phase was separated off and the aqueous phase extracted with EtOAc (3x). The combined 
organic phases were dried over Na2SO4, filtered, all volatiles evaporated and the residue dried under 
high vacuum. The crude product was purified by flash column chromatography (hexanes/ EtOAc 4:1 
→ 1:1). Orange oil (2.55 g, 6.67 mmol, 94%). 
Rf = 0.30 (hexanes/EtOAc 1:2); 1H-NMR (400 MHz, CDCl3): δH (ppm) = 11.60 (0.5 H, bs) + 11.46 (0.5 H, 
bs), 8.74 (1 H, dd, J = 19.1, 8.4 Hz), 8.04 – 7.96 (1 H, m), 7.53 (1 H, pt, J = 7.8 Hz), 7.48 – 7.27 (2 H, m), 
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7.25 – 7.00 (4 H, m), 5.28 – 4.95 (2 H, m), 4.57 – 4.38 (1 H, m), 3.88 – 3.73 (4 H, m), 3.69 – 3.51  
(1 H, m), 2.38 – 2.14 (2 H, m), 2.06 – 1.88 (2 H, m); 13C-NMR (101 MHz, CDCl3): δC (ppm) = 171.88 (Cq), 
171.44 (Cq), 168.57 (Cq), 168.21 (Cq), 155.65 (Cq), 154.84 (Cq), 141.14 (Cq), 140.93 (Cq), 136.82 (Cq), 
136.45 (Cq), 134.61 (+, CH), 130.96 (+, CH), 130.88 (+, CH), 128.50 (+, CH), 128.23 (+, CH), 128.04  
(+, CH), 127.92 (+, CH), 127.81 (+, CH), 122.82 (+, CH), 120.39 (+, CH), 120.20 (+, CH), 115.49 (Cq), 67.36 
(-, CH2), 67.19 (-, CH2), 62.60 (+, CH), 62.48 (+, CH), 52.43 (+, CH3), 52.32 (+, CH3), 47.51 (-, CH2), 47.07 
(-, CH2), 31.63 (-, CH2), 30.53 (-, CH2), 24.43 (-, CH2), 23.79 (-, CH2) (signal doubling due to rotamers);  
IR (neat): ?̅? = 3265, 3064, 3034, 2952, 2881, 1685, 1588, 1517, 1450, 1402, 1353, 1260, 1163, 1115, 
1088, 984, 917, 753, 697; MS (+ESI, 120 V): m/z (%) = 383.2 (100) [(M+H)+], 405.1 (38) [(M+Na)+], 787.3 
(26) [(2M+Na)+]; HRMS (+ESI, 120 V): 333.1612 (C21H23N2O5 [(M+H)+]: calc. 383.1601); [α]D
22: -106.3  
(c = 1.11, CHCl3). 
 
 
tert-Butyl (S)-2-((2-((S)-2-((benzyloxy)carbonyl)pyrrolidine-1-carbonyl)phenyl)carbamoyl)-
pyrrolidine-1-carboxylate (Boc-Pro-Ant-Pro-OBn, 77)[155,197] 
The starting material 74 (1.17 g, 3.35 mmol, 1.0 equiv.) was dissolved in THF (7.5 mL) and deprotected 
according to GP-5 using LiOH (402 mg, 16.8 mmol, 5.0 equiv.) in H2O (7.5 mL).  
The now deprotected dipeptide 76 (334 mg, 1.00 mmol, 1.0 equiv.) was dissolved in dry DCM (25 mL) 
and EDC·HCl (230 mg, 1.20 mmol, 1.2 equiv.), HOBt·H2O (162 mg, 1.20 mmol, 1.2 equiv.), and 
H-Pro-OBn·HCl (290 mg, 1.20 mmol, 1.2 equiv., 67·HCl) were added at ambient temperature. 
Subsequently, NEt3 (1.0 mL, 7.5 mmol, 1.1 equiv.) was added and the reaction mixture stirred for 22 h. 
The pale yellow solution was transferred into a separating funnel and acidified with 1 M KHSO4 to pH 2. 
The organic layer was washed with sat. NaHCO3 (1x) and sat. NaCl solutions (1x), dried over Na2SO4, 
filtered and the solvent removed under reduced pressure, yielding an orange oil. The resulting crude 
product was purified by flash column chromatography (DCM/MeOH 50:1). White solid (191 mg, 
365 µmol, 36% over 2 steps). 
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Rf = 0.25 (DCM/MeOH 50:1); 1H-NMR (400 MHz, CDCl3): δH (ppm) = 9.84 – 9.54 (0.9 H, m) + 9.19 – 9.00 
(0.1 H, m), 8.55 – 8.28 (0.9 H, m) + 8.16 – 8.00 (0.1 H, m), 7.61 –  6.76 (8 H, m),5.31 – 4.82 (2 H, m), 
4.80 – 4.61 (1 H, m), 4.37 (0.5 H, bs) + 4.21 (0.5 H, bs), 3.83 – 3.27 (4 H, m), 2.43 – 1.70 (8 H, m), 1.43 
(4.5 H, s) + 1.33 (4.5 H, s); 13C-NMR (101 MHz, CDCl3): δC (ppm) = 171.93 (Cq), 171.57 (Cq), 168.40 (Cq), 
154.95 (Cq), 153.99 (Cq), 136.89 (Cq), 136.27 (Cq), 135.53 (Cq), 131.19 (+, CH), 130.80 (+, CH), 128.39  
(+, CH), 128.34 (+, CH), 128.25 (+, CH), 127.95 (+, CH), 127.34 (+, CH), 127.14 (+, CH), 126.44 (+, CH), 
124.67 (Cq), 123.57 (+, CH), 123.01 (+, CH), 122.72 (+, CH), 121.61 (+, CH), 120.92 (+, CH), 79.78 (Cq), 
66.85, 62.16 (+, CH), 61.59 (+, CH), 61.34 (+, CH), 58.96 (+, CH), 50.04 (-, CH2), 49.70 (-, CH2), 47.05  
(-, CH2), 46.64 (-, CH2), 31.31 (-, CH2), 30.16 (-, CH2), 29.12 (-, CH2), 28.38 (+, CH3), 28.21 (+, CH3), 25.12 
(-, CH2), 24.28 (-, CH2), 23.73 (-, CH2), 22.60 (-, CH2) (signal doubling due to rotamers); IR (neat):  
?̅? = 3310, 2974, 2881, 1744, 1689, 1625, 1588, 1517, 1454, 1383, 1297, 1249, 1159, 1118, 1088, 1040, 
984, 954, 861, 749; MS (+ESI, 120 V): m/z (%) = 422.2 (16) [(M-C4H8-CO2)+], 522.3 (100) [(M+H)+], 544.2 
(12) [(M+Na)+], 1065.5 (18) [(2M+Na)+]; HRMS (+ESI, 120 V): 522.2605 (C29H36N3O6 [(M+H)+]:  
calc. 522.2599); [α]D
22: - 109.6 (c = 0.75, CHCl3); m.p. 36 – 50 °C. 
 
 
Benzyl (S)-2-((2-((S)-2-((benzyloxy)carbonyl)pyrrolidine-1-carbonyl)phenyl)carbamoyl)pyrrolidine-1-
carboxylate (Cbz-Pro-Ant-Pro-OBn, 78)[195] 
The starting material 75 (1.20 g, 3.14 mmol, 1.0 equiv.) was dissolved in THF (7.5 mL) and deprotected 
according to GP-5 using LiOH (376 mg, 15.7 mmol, 5.0 equiv.) in H2O (7.5 mL).  
The resulting white solid (1.07 g) was dissolved in EtOAc (10 mL) and charged with pyridine (0.91 mL, 
8.8 mmol, 3.0 equiv.), H-L-Pro-OBn·HCl (712 mg, 2.94 mmol, 1.0 equiv., 67·HCl) and NEt3 (320 μL, 
2.95 mmol, 1.0 equiv.). The slurry was cooled to -20 °C and T3P (50 wt% in EtOAc) (3.71 g, 5.83 mmol, 
2.0 equiv.) added dropwise. The reaction mixture was allowed to warm up to ambient temperature 
and stirred for 48 h. The mixture was transferred into a separating funnel and diluted with H2O (20 mL). 
The organic phase was separated off, the aqueous phase extracted with EtOAc (3x) and the combined 
organic phases washed with sat. NH4Cl (1x), sat. NaHCO3 (1x) and sat. NaCl solutions (1x). The organic 
phase was dried over Na2SO4, filtered, all volatiles evaporated off and the residue dried under high 
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vacuum. The crude product was purified by flash column chromatography (hexanes/ EtOAc 1:1 → 1:4). 
Colorless oil (258 mg, 465 μmol, 15% over 2 steps). 
Rf  = 0.33 (hexanes/EtOAc 1:2); 1H-NMR (300 MHz, CDCl3): δH (ppm) = 9.84 – 9.56 (0.9 H, m) +  
9.25 – 9.10 (0.1 H, m), 8.54 – 8.32 (0.9 H, m) + 8.18 – 8.03 (0.1 H, m), 7.68 – 6.83 (13 H, m), 5.36 – 4.86 
(4 H, m), 4.85 – 4.57 (1 H. m), 4.56 – 4.30 (1 H, m), 3.92 – 3.12 (4 H, m), 2.51 – 1.53 (8 H, m); 13C-NMR 
(101 MHz, CDCl3): δC (ppm) = 172.00 (Cq), 171.20 (Cq), 170.84 (Cq), 168.23 (Cq), 168.09 (Cq), 155.21 (Cq), 
154.36 (Cq), 136.47 (Cq), 136.19 (Cq), 135.94 (Cq), 135.35 (Cq), 130.78 (+, CH), 130.67 (+, CH), 128.38  
(+, CH), 128.23 (+, CH), 128.10 (+, CH), 127.77 (+, CH), 127.71 (+, CH), 127.65 (+, CH), 127.42 (+, CH), 
127.18 (+, CH), 126.87 (+, CH), 124.66 (Cq), 124.06 (Cq), 123.03 (-, CH2), 122.89 (-, CH2), 121.40 (-, CH2), 
120.85 (-, CH2), 66.94 (-, CH2), 66.84 (-, CH2), 66.70 (-, CH2), 61.57 (+, CH), 61.42 (+, CH), 58.89 (+, CH), 
58.75 (+, CH), 49.59 (-, CH2), 49.37 (-, CH2), 47.21 (-, CH2), 46.75 (-, CH2), 31.17 (-, CH2), 30.01 (-, CH2), 
29.09 (-, CH2), 28.92 (-, CH2), 25.00 (-, CH2), 24.84 (-, CH2), 24.11 (-, CH2), 23.47 (-, CH2) (signal doubling 
due to rotamers); IR (neat): ?̅? = 3310, 3064, 3034, 2956, 2881, 1741, 1700, 1625, 1588, 1517, 1402, 
1349, 1297, 1163, 1115, 1088, 1029, 984, 913, 880, 738, 697; MS (+ESI, 120 V): m/z (%) = 556.2 (100) 
[(M+H)+], 578.2 (20) [(M+Na)+], 1133.5 (34) [(2M+Na)+]; HRMS (+ESI, 120 V): 556.2444 (C32H34N3O6 
[(M+H)+]: calc. 556.2442); [α]D
22: -109.3 (c = 0.99, CHCl3). 
 
 
(S)-1-(2-((S)-Pyrrolidine-2-carboxamido)benzoyl)pyrrolidine-2-carboxylic acid  
(H-Pro-Ant-Pro-OH, 53)[155] 
Synthesized from 77 (190 mg, 365 μmol, 1.0 equiv.) according to GP-6. White solid (112 mg, 338 μmol, 
92%).  
Rf = 0.03 (DCM/MeOH 15:1); 1H-NMR (300 MHz, CDCl3): δH (ppm) = 10.73 (1 H, s), 8.22 (1 H, d, 
J = 7.8 Hz), 8.12 – 6.10 (5 H, m + bs), 5.17 – 4.06 (2 H, m), 4.06 – 2.81 (4 H, m), 2.81 – 1.42 (8 H, m);  
13C-NMR (101 MHz, CDCl3): δC (ppm) = 178.01 (Cq), 169.37 (Cq), 167.48 (Cq), 134.38 (Cq), 130.07 (+, CH), 
128.46 (Cq), 126.25 (+, CH), 124.90 (+, CH), 121.48 (+, CH), 60.82 (+, CH), 58.95 (+, CH), 48.85 (-, CH2), 
46.55 (-, CH2), 31.83 (-, CH2), 30.24 (-, CH2), 25.00 (-, 2x CH2); IR (neat): ?̅? = 2971, 2878, 1696, 1618, 
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1588, 1551, 1454, 1420, 1379, 1290, 1252, 1204, 1088, 1040, 984, 951, 917, 872, 846, 749;  
MS (+ESI, 120 V): m/z (%) = 332.2 (100) [(M+H)+]; HRMS (+ESI, 120 V): 332.1612 (C17H22N3O4 [(M+H)+]: 
calc. 332.1605); [α]D
30: -150.8 (c = 1.01, CHCl3); m.p. 154 °C (decomposition). 
 
 
Benzyl (S)-2-(4-oxo-4H-benzo[d][1,3]oxazin-2-yl)pyrrolidine-1-carboxylate (83)[227] 
Obtained as a side product in the synthesis of 78. Colorless oil (700 mg, 2.00 mmol, 64% over 2 steps). 
Rf  = 0.75 (hexanes/EtOAc 1:2); 1H-NMR (400 MHz, CDCl3): δH (ppm) =8.14 – 8.04 (1 H, m), 7.76 – 7.68 
(1 H, m), 7.56 – 7.39 (2 H, m), 7.37 – 7.22 (2 H, m), 7.08 – 6.92 (3 H, m), 5.22 – 5.14 (0.5 H, m) + 
4.89 – 4.82 (0.5 H, m), 5.11 (1 H, s), 4.78 – 4.64 (1 H, m), 3.78 – 3.67 (1 H, m), 3.65 – 3.51 (1 H, m), 2.41 
– 2.24 (1 H, m), 2.20 – 2.00 (2 H, m), 2.00 – 184 (1 H, m); 13C-NMR (101 MHz, CDCl3): δC (ppm) = 162.08 
(Cq), 161.78 (Cq), 159.22 (Cq), 158.89 (Cq), 146.09 (Cq), 145.89 (Cq), 136.57 (Cq), 136.34 (+, CH), 136.30 
(+, CH), 136.09 (Cq), 128.33 (+, CH), 128.28 (+, CH), 128.20 (+, CH), 128.03 (+, CH), 127.83 (+, CH), 127.64 
(+, CH), 127.59 (+, CH), 127.47 (+, CH), 126.87 (+, CH), 126.72 (+, CH), 116.94 (Cq), 116.72 (Cq), 66.85  
(-, CH2), 66.77 (-, CH2), 59.72 (+, CH), 59.19 (+, CH), 47.05 (-, CH2), 46.62 (-, CH2), 31.63 (-, CH2), 30.73  
(-, CH2), 24.05 (-, CH2), 23.27 (-, CH2) (signal doubling due to rotamers); IR (neat): ?̅? = 3064, 3034, 2956, 
2881, 1756, 1700, 1644, 1607, 1469, 1409, 1353, 1260, 1215, 1163, 1111, 1036, 1006, 772, 738, 693; 
MS (+ESI, 120 V): m/z (%) = 351.1 (100) [(M+H)+] 373.1 (26) [(M+Na)+], 723.2 (13) [(2M+Na)+];  
HRMS (+ESI, 120 V): 353.1341 (C20H19N2O4 [(M+H)+]: calc. 353.1339); [α]D
22: -127.1 (c = 1.19, CHCl3). 
 
 
Benzyl (S)-2-((2-(pyrrolidine-1-carbonyl)phenyl)carbamoyl)pyrrolidine-1-carboxylate (90) 
83 (100 mg, 286 µmol, 1.0 equiv.) was filled into a snap cap vial and dissolved in 1 mL of deactivated 
CHCl3 (previously filtered through basic Al2O3). Pyrrolidine (30 µL, 337 µmol, 1.2 equiv.) was added and 
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the solution stirred for 45 min. The crude mixture was filtered through a short silica plug (CHCl3/MeOH 
50:1), all volatiles were evaporated and the product dried under high vacuum. Colorless oil (120 mg, 
285 µmol, 100%). 
Rf  = 0.23 (hexanes/EtOAc 1:2); 1H-NMR (400 MHz, CDCl3): δH (ppm) =10.12 – 9.96 (1 H, m), 8.36- 8.22 
(1 H, m), 7.46 – 7.02 (8 H, m), 5.27 – 5.04 (2 H, m), 4.50 – 4.31 (1 H, m), 3.80 – 3.16 (6 H, m), 2.33 – 1.53 
(8 H, m); 13C-NMR (101 MHz, CDCl3): δC (ppm) = 171.11 (Cq), 170.59 (Cq), 168.41 (Cq), 168.31 (Cq), 155.57 
(Cq), 154.56 (Cq), 136.54 (Cq), 136.47 (Cq), 130.84 (+, CH), 130.68 (+, CH), 128.43 (+, CH), 128.33 (+, CH), 
127.97 (+, CH), 127.88 (+, CH), 127.70 (+, CH), 127.46 (+, CH), 127.34 (+, CH), 127.25 (+, CH), 125.31 
(Cq), 124.79 (Cq), 122.98 (+, CH), 121.91 (+, CH), 121.67 (+, CH), 67.22 (-, CH2), 66.84 (-, CH2), 61.95  
(+, CH), 49.90 (-, CH2), 47.36 (-, CH2), 46.97 (-, CH2), 46.26 (-, CH2), 31.31 (-, CH2), 30.01 (-, CH2), 26,35  
(-, CH2), 24.32 (-, CH2), 23.63 (-, CH2) (signal doubling due to rotamers); IR (neat): ?̅? = 3276, 2956, 2878, 
1692, 1621, 1588, 1513, 1454, 1405, 1342, 1297, 1252, 1174, 1115, 1085, 1029, 984, 917, 876, 746, 
697; MS (+ESI, 120 V): m/z (%) = 422.2 (100) [(M+H)+], 865.4 (19) [(2M+Na)+]; HRMS (+ESI, 120 V): 
422.2081 (C24H28N3O4 [(M+H)+]: calc. 422.2074); [α]D
22: -91.8 (c = 0.97, CHCl3). 
 
 
2-Acetamidobenzoic acid (88)[230,231]  
A 25 mL round bottom flask was charged with anthranilic acid (5.00 g, 36.5 mmol, 1.0 equiv., 54), AcOH 
(7.5 mL, 0.13 mol, 3.6 equiv.) and Ac2O (7.5 mL, 79 mmol, 2.2 equiv.). The mixture was refluxed at 
120 °C, whereby the initially formed slurry turned into a yellow solution. After 3 h, the still hot reaction 
mixture was poured onto 20 g of ice in a 100 mL beaker and cooled in an ice bath. After 15 min, a 
yellowish solid started to crash out of the solution. The precipitate was filtered off and washed with 
ice-cold H2O (10 mL). The crude product was purified by recrystallization from EtOH/H2O (1:1). Slightly 
yellow solid (5.53 g, 30.9 mmol, 85%). 
H-NMR (300 MHz, CD3OD): δH (ppm) =8.53 (1 H, d, J = 8.4 Hz), 8.06 (1 H, d, J = 8.0 Hz), 7.53 (1 H, t, 
J = 7.9 Hz), 7.12 (1 H, t, J = 7.6 Hz), 2.20 (3 H, s); 13C-NMR (75 MHz, CD3OD): δC (ppm) = 171.39 (Cq), 
171.24 (Cq), 142.32 (Cq), 135.13 (+, CH), 132.45 (+, CH), 123.90 (+, CH), 121.28 (+, CH), 117.30 (Cq), 25.05 
(+, CH3). 
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2-Methyl-4H-benzo[d][1,3]oxazin-4-one (89)[231,286] 
88 (2.00 g, 11.2 mmol, 1.0 equiv.) and pyridine (2.7 mL, 34 mmol, 3.0 equiv.) were suspended in EtOAc 
(10 mL) and chilled to -20 °C. NEt3 (1.6 mL, 12 mmol, 1.0 equiv.) was added, followed by the dropwise 
addition of T3P (50 wt% in EtOAc) (14.2 g, 22.3 mmol, 2.0 equiv.). The mixture was allowed to reach 
ambient temperature and stirred for 4 d. Na2SO4 (5 g) was added and the mixture stirred for a further 
3 d. The yellowish solution was transferred into a separating funnel and diluted with H2O (25 mL). The 
organic phase was separated, the aqueous phase extracted with EtOAc (3x). The combined organic 
phases were washed with sat. NH4Cl (1x), sat. NaHCO3 (1x), and sat. NaCl solutions (1x), dried over 
Na2SO4, filtered and all volatiles evaporated off. The crude product was purified by flash column 
chromatography (hexanes/EtOAc 1:2). Slightly yellow solid (147 mg, 911 µmol, 8%). A crystal for X-ray 
analysis was obtained by recrystallization from hexanes/EtOAc. 
Rf  = 0.73 (hexanes/EtOAc 1:2); 1H-NMR (300 MHz, CDCl3): δH (ppm) =8.16 – 8.10 (1 H, m), 7.80 – 7.71 
(1 H, m), 7.53 – 7.42 (2 H, m), 2.44 – 2.43 (3 H, m); 13C-NMR (75 MHz, CDCl3): δC (ppm) = 160.27 (Cq), 
159.71 (Cq), 146.44 (Cq), 136.61 (+, CH), 128.47 (+, CH), 128.25 (+, CH), 126.42 (+, CH), 116.66 (Cq), 21.43 
(+, CH3); m.p. 74 – 77 °C. 
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4. Catalysis with tripeptides containing unnatural β-amino acids 
 
General procedure for aldol reactions under ambient conditions (GP-8) 
A snap cap vial was charged with 4-nitrobenzaldehyde (151 mg, 1.00 mmol, 1.0 equiv., 92) and the 
catalyst 52 (3.3 mg, 10 μmol, 1 mol%). The reaction was started via the addition of an acetone/H2O 
mixture (2 mL, 10:1, v/v) and stirred for 24 h at ambient temperature (22 °C). At the end of the reaction, 
the mixture was spiked with the internal standard diphenoxymethane (180 μL, 200 mg, 1.00 mmol, 
1.0 equiv., 46), the volatiles evaporated, the residue dissolved in CDCl3 and a 1H-NMR spectrum 
measured immediately. For HPLC analysis, the crude mixture was purified via flash column 
chromatography, using hexanes/EtOAc as eluent (hexanes/ EtOAc 3:1 → EtOAc). 
 
General procedure for high-pressure aldol reactions (GP-9) 
A PTFE tube (ø = 0.5 cm, ↕ = 10 cm) was sealed off on one side using heated crucible tongs and charged 
with 4-nitrobenzaldehyde (151 mg, 1.00 mmol, 1.0 equiv.). The reaction was started by the addition of 
a freshly mixed solution of the catalyst 52 (3.3 mg, 10 μmol, 1 mol%) in an acetone/H2O mixture (2 mL, 
10:1, v/v). The PTFE tube was then completely sealed, all reactants mixed thoroughly through shaking 
and the tube inserted into the pressure vessel. The vessel was filled with the pressurizing medium, 
inserted into the high-pressure apparatus and pressurized for 7 h. After depressurization, the mixture 
was filled into a round bottom flask and spiked with the internal standard diphenoxymethane (180 μL, 
200 mg, 1.00 mmol, 1.0 equiv., 46). All volatiles were evaporated off, the residue was dissolved in CDCl3 
and a 1H-NMR spectrum measured immediately. For HPLC analysis, the crude mixture was purified via 
flash column chromatography, using hexanes/EtOAc as eluent (hexanes/ EtOAc 3:1 → EtOAc). 
 
 
(R)-4-Hydroxy-4-(4-nitrophenyl)butan-2-one (93)[153,155] 
Slightly yellow solid (136 mg, 650 μmol, 65%). 
Rf = 0.19 (hexanes/EtOAc 2:1); 1H-NMR (300 MHz, CDCl3): δH (ppm) =8.20 (2 H, d, J = 8.7 Hz), 7.53 (2 H, 
d, J = 8.7 Hz), 5.26 (1 H, dd, J = 7.4, 4.9 Hz), 3.63 (1 H, bs), 2.86 (1 H, s), 2.84 (1 H, d, J = 3.2 Hz), 2.22 
(3 H, s); 13C-NMR (75 MHz, CDCl3): δC (ppm) = 208.69, 150.07, 147.42, 126.54, 123.90, 69.02, 51.62, 
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30.85; Chiral HPLC performed on Chiralcel AS-H (n-heptane/i-PrOH = 70:30, λ = 254 nm, 0.5 mL/min): 
tr = 23.5 min (R), t = 28.7 min (S). 
 
General procedure for Michael reactions under ambient conditions (GP-10) 
A snap cap vial was charged with trans-β-nitrostyrene (74.6 mg, 500 μmol, 1.0 equiv., 40) and the 
catalyst 52 (16.9 mg, 50.0 μmol, 10 mol%). The reaction was started via the addition of an acetone/H2O 
mixture (2 mL, 10:1, v/v) and stirred for 48 h at ambient temperature (22 °C). At the end of the reaction, 
the mixture was spiked with the internal standard diphenoxymethane (90 μL, 0.10 g, 0.50 mmol, 
1.0 equiv., 46), the volatiles evaporated, the residue dissolved in CDCl3 and a 1H-NMR measured 
immediately. For HPLC analysis, the crude mixture was transferred into a separating funnel and washed 
with H2O (1x 2 mL, 1x 1 mL). The organic phase was dried over Na2SO4, filtered, all volatiles evaporated 
off and the residue purified by flash column chromatography, using hexanes/EtOAc as eluent 
(hexanes/ EtOAc 4:1).  
 
General procedure for high-pressure Michael reactions (GP-11) 
A PTFE tube (ø = 0.5 cm, ↕ = 10 cm) was sealed off on one side using heated crucible tongs and charged 
with trans-β-nitrostyrene (74.6 mg, 500 μmol, 1.0 equiv., 40). The reaction was started via the addition 
of a freshly mixed solution of the catalyst 52 (16.9 mg, 50.0 μmol, 10 mol%) in an acetone/H2O mixture 
(2 mL, 10:1, v/v). The PTFE tube was then completely sealed, all reactants mixed thoroughly through 
shaking and the tube inserted into the pressure vessel. The vessel was filled with the pressurizing 
medium, inserted into the high-pressure apparatus and pressurized for 7 h. After depressurization, the 
mixture was filled into a round bottom flask and spiked with the internal standard diphenoxymethane 
(90 μL, 0.10 g, 0.50 mmol, 1.0 equiv., 46). All volatiles were evaporated off, the residue was dissolved 
in CDCl3 and a 1H-NMR measured immediately. For HPLC analysis, the crude mixture was transferred 
into a separating funnel and washed with H2O (1x 2 mL, 1x 1mL). The organic phase was dried over 
Na2SO4, filtered, all volatiles evaporated off and the residue purified via flash column chromatography, 
using hexanes/EtOAc as eluent (hexanes/ EtOAc 4:1). The catalyst could be recovered by evaporation 
of the aqueous phase. 
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(R)-5-Nitro-4-phenylpentan-2-one (94)[124,287] 
White solid (85.5 mg, 413 μmol, 83%). 
Rf = 0.20 (hexanes/EtOAc 4:1); 1H-NMR (400 MHz, CDCl3): δH (ppm) =7.38 – 7.18 (5 H, m), 4.69 (1 H, dd, 
J = 12.3, 6.8 Hz), 4.59 (1 H, dd, J = 12.4, 7.7 Hz), 4.00 (1 H, quint, J = 7.0 Hz), 2.91 (2 H, d, J = 7.0 Hz), 
2.11 (3 H, s); 13C-NMR (101 MHz, CDCl3): δC (ppm) = 205.48 (Cq), 138.95 (Cq), 129.08 (+, CH), 127.91 
(+, CH), 127.44 (+, CH), 79.51 (-, CH2), 46.16 (-, CH2), 39.09 (+, CH), 30.38 (+, CH3); Chiral HPLC performed 
on Chiralcel AS-H (n-heptane/i-PrOH = 65:35, λ = 215 nm, 0.5 mL/min): tr = 19.7 min (S), t = 25.5 min 
(R). 
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5. Synthesis of β-ACHC model compounds 
 
Preparation of a solution of dimethylamine in dry THF 
A 100 mL flame-dried Schlenk tube, the receiving flask, was filled with dry THF (50 mL), and a Pasteur 
pipette was inserted through a bored rubber stopper into the solution. A second Schlenk flask, the 
producing flask, containing pre-dried dimethylamine hydrochloride (9.79 g, 120 mmol, 1.0 equiv.), was 
sealed with a rubber septum. The producing flasks Schlenk valve and the Pasteur pipette were 
connected using rubber tubing, with a drying tube filled with KOH set in between (to dry the HNMe2). 
The receiving flask was cooled to 0 °C and the Schlenk valve was connected to two wash bottles, the 
first one empty, the second one filled with 1 M HCl. Using a syringe pump, an 18 M NaOH solution 
(7.50 mL, 5.40 g, 135 mmol, 1.1 equiv.) was slowly added to the dimethylamine hydrochloride over 
1 h, using a gentle stream of nitrogen to bubble the developing HNMe2 into the THF. After complete 
addition, another 2.5 mL of the 18 M NaOH solution (1.80 g, 45.0 mmol, 0.4 equiv.) was added and the 
producing flask was heated in a water bath to 60 °C for 1 h to ensure complete conversion. 
In order to determine the concentration, 0.5 mL of the prepared solution were transferred into a 10 
mL pear flask and diluted with 1 mL H2O. One drop of a bromothymol blue solution (17.7 mg in 18 mL 
EtOH/H2O (1:1)) was added as pH indicator and the blue solution titrated against 1 M HCl until it turned 
yellow. The concentration was determined to be 1.64 M.  
 
General procedure for the acetylation with thionyl chloride (GP-12) 
 
A 25 mL round bottom flask was charged with cis-101 (166.6 mg, 899.5 μmol, 1.0 equiv.), dry DCM 
(10 mL) and DMF (5 μL), then sealed with a rubber septum. The slurry was cooled to 0 °C and thionyl 
chloride (0.33 mL, 4.6 mmol, 5.1 equiv.) was added dropwise. Thereby, the reaction became 
homogeneous. The septum was exchanged for a bubble counter and the mixture was stirred for 9.5 h 
at ambient temperature. Afterwards, all volatiles from the now pink solution were removed by directly 
applying high vacuum for 30 min. The brownish foam-like solid was then redissolved in dry THF (5 mL) 
and cooled to 0 °C. A 1.64 M solution of diethylamine in THF (2.2 mL, 3.6 mmol, 4.0 equiv.) was then 
added dropwise and the resulting brownish solution was stirred for 2 h at ambient temperature. The 
solvent was distilled off and the residue was transferred in a separating funnel with H2O (20 mL). The 
aqueous phase was extracted with DCM (4x), the combined organic extracts dried over Na2SO4, 
filtered, the solvent evaporated and the crude product dried under high vacuum. Purification was 
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accomplished by recrystallization from DCM/diethyl ether, followed by flash column chromatography 
(DCM/MeOH 50:1). Slight yellow solid (93.8 mg, 442 μmol, 49% over 2 steps). 
 
General procedure for acetylation with T3P (GP-13)[195] 
In a 25 mL round bottom flask, cis-101 (305.0 mg, 1.65 mmol, 1.0 equiv.) was suspended in EtOAc 
(10 mL, pre-dried over K2CO3) and dry DMF (1.5 mL) and cooled to -15 °C. To the chilled slurry, pyridine 
(0.40 mL, 5.0 mmol, 3.0 equiv.), a 1.26 M solution of dimethylamine in THF (3.9 mL, 4.9 mmol, 
3.0 equiv.) and T3P (50 wt% in EtOAc) (2.10 g, 3.29 mmol, 2.0 equiv.) were added in succession and 
the resulting mixture was stirred at ambient temperature for 21 h. The reaction was then transferred 
into a separating funnel and quenched with H2O (30 mL). The organic phase was separated off and the 
aqueous phase was extracted with DCM (5x). The combined organic extracts were dried over Na2SO4, 
filtered and all volatiles evaporated. The residue was redissolved in toluene and evaporated twice to 
remove residual DMF and then dried under high vacuum. The crude product was purified by flash 
column chromatography (DCM/MeOH 15:1). White solid (318 mg, 1.50 mmol, 91%). 
 
 
trans-Cyclohex-4-ene-1,2-dicarboxylic acid (99)[248] 
A flame-dried 250 mL two-necked Schlenk flask was equipped with fumaric acid (6.30 g, 54.3 mmol, 
1.0 equiv., 98), 3-sulfolene (10.0 g, 84.6 mmol, 1.6 equiv., 62) and 65 mL glacial acetic acid, stirred for 
15 min and then heated to 110 °C. After 48 h, an additional batch of 3-sulfolene (2.00 g, 16.9 mmol, 
0.3 equiv., 62) was added and stirred until TLC showed complete conversion. The still warm mixture 
was charged with 1 g fine powdered activated charcoal and then allowed to cool to ambient 
temperature while stirring. The yellowish solution was filtered off, the charcoal washed with small 
amounts of acetic acid and the solvent evaporated off on a rotatory evaporator. The resulting white 
solid was transferred into a 50 mL flask, treated with EtOAc (10 mL) and stirred for 1 h at 50 °C. After 
this washing step, the solid was filtered off, washed with small amounts of ice-cold EtOAc and dried 
under high vacuum. Off-white solid (7.82 g, 46.0 mmol, 85%). 
1H-NMR (300 MHz, (CD3)2SO) δH (ppm) = 12.26 (2 H, s), 5.70 – 5.64 (2 H, m), 2.61 – 2. 53 (2 H, m), 
2.39 – 2.26 (2 H, m), 2.11 – 1.97 (2 H, m); 13C-NMR (75 MHz, (CD3)2SO) δC (ppm) = 175.98 (Cq), 125.20 
(+, CH), 40.84 (+, CH), 27.52 (-, CH2). 
Experimental Part 
 
136 
 
 
 
trans-4-Cyclohexene-1,2-dicarboxylic acid anhydride (trans-56)[249] 
A 50 mL round bottom flask was charged with 99 (2.00 g, 11.8 mmol, 1.0 equiv.) and acetic anhydride 
(20.0 mL, 212 mmol, 18 equiv.) and the mixture was refluxed for 45 min. The reaction was allowed to 
cool to ambient temperature, upon which a solid crystallized from the solution. The precipitate was 
filtered off, washed with ice-cold n-pentane and dried under high vacuum. White solid (566 mg, 
3.72 mmol, 32%). A second batch of product was isolated through complete evaporation of the mother 
liquor. Off-white solid (1.15 g, 7.56 mmol, 64%). 
1H-NMR (300 MHz, CDCl3) δH (ppm) = 5.83 – 5.77 (2 H, m), 2.94 – 2. 85 (2 H, m), 2.65 – 2.52 (2 H, m), 
2.49 – 2.35 (2 H, m); 13C-NMR (75 MHz, CDCl3) δC (ppm) = 170.47 (Cq), 126.13 (+, CH), 42.99 (+, CH), 
25.36 (-, CH2). 
 
 
trans-2-Methoxycarbonyl-4-cyclohexene-1-carboxylic acid (trans-63)[288] 
A 50 mL round bottom flask equipped with a reflux condenser was charged with trans-56 (2.78 g, 
18.3 mmol, 1.0 equiv.) and MeOH (20 mL) and the mixture was refluxed for 30 min. All volatiles were 
evaporated and the residue was dried under high vacuum. Yellowish solid (3.19 g, 17.3 mmol, 95%). 
1H NMR (300 MHz, CDCl3) δH (ppm) = 10.18 (1 H, bs), 5.70 (2 H, d, J = 2.7 Hz), 3.71 (3 H, s), 2.97 – 2.77 
(2 H, m), 2.54 – 2.37 (2 H, m), 2.30 – 2.11 (2 H, m); 13C NMR (75 MHz, CDCl3) δC (ppm) = 181.05 (Cq), 
175.38 (Cq), 125.06 (+, CH), 124.89 (+, CH), 52.18 (+, CH3), 41.11 (+, CH), 40.94 (+, CH), 27.85 (-, CH2). 
  
Experimental Part 
 
137 
 
 
cis-6-(Dimethylcarbamoyl)cyclohex-3-ene-1-carboxylic acid (cis-96) 
A flame-dried 50 mL Schlenk flask was charged with cis-56 (2.00 g, 13.1 mmol, 1.0 equiv.) and the solid 
dissolved in dry THF (25 mL). A Pasteur pipette was inserted through a bored rubber stopper into the 
solution. The Schlenk valve was connected to two wash bottles, the first one empty, the second one 
filled with 1 M HCl. A second Schlenk flask, the HNMe2-producing flask, was filled with dimethylamine 
hydrochloride (3.22 g, 39.4 mmol, 3.0 equiv.) and sealed with a rubber septum. The producing flasks 
Schlenk valve and the Pasteur pipette were connected with a rubber tube. The whole system was 
flushed with nitrogen and the THF solution was cooled to 0 °C with an ice bath. Using a syringe pump, 
a 10 M NaOH solution (6.6 mL, 2.6 g, 66 mmol, 5.0 equiv.) was slowly added to the dimethylamine 
hydrochloride over 30 min. The generated gaseous HNMe2 was bubbled into the THF solution with the 
aid of a gentle stream of nitrogen. After complete addition, the mixture was stirred for 2 h at 0°C, 
during which a white solid started to precipitate from the solution. The producing flask was then 
exchanged for a new one, containing another 3.22 g of dimethylamine hydrochloride (39.4 mmol, 
3.0 equiv.). Again, a 10 M NaOH solution (6.6 mL, 2.63 g, 65.7 mmol, 5.0 equiv.) was added to the fresh 
dimethylamine hydrochloride over 30 min. After stirring for further 30 min, the THF was removed using 
a rotatory evaporator. The white residue was dissolved in sat. NaHCO3 solution and transferred into a 
separating funnel (pH 8). The aqueous phase was washed with diethyl ether (2x), then acidified to pH 
2 by the use of 1 M HCl. The now acidic aqueous phase was extracted with DCM (4x). The combined 
organic phases were dried over Na2SO4, filtered and the solvent evaporated. The crude product was 
then purified by column chromatography (DCM/MeOH 50:1). White solid (1.72 g, 13.2 mmol, 66%). 
Rf = 0.25 (DCM/MeOH 25:1); 1H-NMR (300 MHz, CDCl3): δH (ppm) = 14.18 (1 H, bs), 5.83 – 5.59 (2 H, m), 
3.26 – 3.17 (1 H, m), 3.14 (3 H, s), 3.09 – 2.93 (4 H, m), 2.88 – 2.76 (m, 1 H), 2.41 – 2.10 (m, 3 H);  
13C-NMR (75 MHz CDCl3): δC (ppm) = 176.89 (Cq), 173.29 (Cq), 127.29 (+, CH), 124.51 (+, CH), 40.59  
(+, CH), 39.33 (+, CH), 38.24 (+, CH3), 36.66 (+, CH3), 29.20 (-, CH2), 26.28 (-, CH2); IR (neat): ?̅? = 3027, 
2971, 2941, 2907, 2840, 2639, 1692, 1633, 1502, 1402, 1342, 1305, 1256, 1144, 1059, 947, 917, 801, 
760; MS (+ESI, 120 V): m/z (%) = 180.1 (24) [(M+H)+-H2O], 198.1 (100) [(M+H)+], 417.2 (2) [(2M+Na)+]; 
HRMS (+ESI, 120 V): 198.1128 (C10H16NO3 [(M+H)+]: calc. 198.1125); m.p. 110 – 118 °C. 
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trans-6-(Dimethylcarbamoyl)cyclohex-3-ene-1-carboxylic acid (trans-96) 
A flame-dried 50 mL Schlenk flask was charged with trans-56 (1.34 g, 8.81 mmol, 1.0 equiv.) and the 
solid dissolved in dry THF (25 mL). A Pasteur pipette was inserted through a bored rubber stopper into 
the solution. The Schlenk valve was connected to two wash bottles, the first one empty, the second 
one filled with 1 M HCl. A second Schlenk flask, the HNMe2-producing flask, was filled with 
dimethylamine hydrochloride (2.16 g, 26.5 mmol, 3.0 equiv.) and sealed with a rubber septum. The 
producing flasks Schlenk valve and the Pasteur pipette were connected using a rubber tube. The whole 
system was flushed with nitrogen and the THF solution was cooled to 0 °C with an ice bath. Using a 
syringe pump, a 10 M NaOH solution (4.4 mL, 1.8 g, 44 mmol, 5.0 equiv.) was slowly added to the 
dimethylamine hydrochloride over 30 min. The generated gaseous HNMe2 was bubbled into the THF 
solution with the aid of a gentle stream of nitrogen. After complete addition, the mixture was stirred 
for a further 2 h at 0°C, the solution remained clear. The producing flask was then exchanged for a new 
one, containing another 2.16 g of dimethylamine hydrochloride (26.5 mmol, 3.0 equiv.). Again, a 10 M 
NaOH solution (4.4 mL, 1.77 g, 44.2 mmol, 5.0 equiv.) was added to the fresh dimethylamine 
hydrochloride over 30 min. After further stirring for 15 h at ambient temperature, the THF was distilled 
off using a rotatory evaporator. The white residue was taken up in sat. NaHCO3 solution and 
transferred into a separating funnel (pH 8). The aqueous phase was washed with diethyl ether (2x), 
then acidified to pH 2 by the use of 1 M HCl. The now acidic aqueous phase was extracted with DCM 
(4x), the combined organic phases dried over Na2SO4, filtered and the solvent evaporated. The product 
was dried under high vacuum. White solid (1.63 g, 8.28 mmol, 94%). 
1H NMR (300 MHz, CDCl3): δH (ppm) = 10.86 (1 H, bs), 5.69 (2 H, bs), 3.10 (3 H, s), 3.06 – 2.97 (2 H, m), 
2.95 (3 H, s), 2.58 – 2.41 (1 H, m), 2.29 – 2.03 (3 H, m); 13C-NMR (75 MHz, CDCl3): δC (ppm) = 179.72 
(Cq), 175.57 (Cq), 125.26 (+, CH), 41.91 (+, CH), 38.46 (+, CH), 37.60 (+, CH3), 36.02 (+, CH3), 28.53  
(-, CH2), 27.93 (-, CH2); IR (neat): ?̅? = 3030, 2974, 2915, 2844, 2646, 1741, 1595, 1510, 1435, 1364, 1252, 
1190, 1159, 1070, 973, 869, 760; MS (+ESI, 120 V): m/z (%) = 180.1 (36) [(MH-H2O)+], 198.1 (100) 
[(M+H)+], 395.2 (10) [(2M+H)+]; HRMS (+ESI, 120 V): 198.1129 (C10H16NO3 [(M+H)+]: calc. 198.1125); 
m.p. 136 – 139 °C. 
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cis-2-(Acetylamino)cyclohexanecarboxylic acid methyl ester (cis-100)[289] 
A 100 mL flame-dried two-necked Schlenk flask equipped with a reflux condenser with bubble counter 
was charged with cis-63 (2.00 g, 10.9 mmol, 1.0 equiv.) and dry toluene (40 mL). Dry triethylamine 
(1.55 mL, 11.2 mmol, 1.0 equiv.) was added to the solution and the flask sealed with a rubber septum. 
DPPA (3.02 g, 11.0 mmol, 1.0 equiv.) and benzyl alcohol (2.3 mL, 22 mmol, 2.0 equiv.) were added 
dropwise in succession using a syringe and the mixture was refluxed for 18.5 h. The reaction was then 
allowed to cool to ambient temperature, transferred into a separating funnel and diluted with EtOAc 
(30 mL). The aqueous phase was discarded and the organic phase washed with 2 M HCl (1x), sat. 
NaHCO3 (1x) and sat. NaCl solutions (1x). The organic phase was dried over MgSO4, filtered, the solvent 
evaporated and the residue dried under high vacuum. The remaining oil was transferred with MeOH 
(10 mL) into an autoclave vessel filled with 200 mg Pd/C (10 wt% Pd). The mixture was hydrogenated 
for 17 h at 40 bar H2. After the reaction was completed, the slurry was filtered and the solvent removed 
carefully on a rotatory evaporator (the free amine tends to be volatile). The residue was transferred 
into a separating funnel using H2O (10 mL), acidified with 2 M HCl to approximately pH 3 and extracted 
with diethyl ether (2x). The aqueous phase was then basified with sat. Na2CO3 (pH 9) and extracted 
with DCM (10x), until TLC control showed no more remaining product in the extract. The combined 
organic phases were dried over MgSO4, filtered and the solvent removed carefully on a rotatory 
evaporator. The yellowish liquid (1.07 g, 6.80 mmol, 1.0 equiv.) was then diluted in DCM (10 mL), 
charged with triethylamine (0.95 mL, 6.9 mmol, 1.0 equiv.) and cooled to 0 °C. Subsequently, acetyl 
chloride (0.49 mL, 6.9 mmol, 1.0 equiv.) was added dropwise and the reaction was stirred for 18 h at 
ambient temperature. Upon completion, the mixture was transferred into a separating funnel and 
washed successively with 1 M HCl (1x), sat. NaHCO3 (1x) and sat. NaCl (1x) solutions. The organic phase 
was dried over Na2SO4, filtered, all volatiles evaporated off and the residue dried under high vacuum. 
The crude yellow oil was purified by column chromatography (hexanes/ EtOAc 9:1 → EtOAc). White 
solid (999 mg, 5.01 mmol, 46% over 3 steps). 
Rf = 0.20 (hexanes/ EtOAc 1:1); 1H NMR (400 MHz, CDCl3): δH (ppm) = 6.39 (1 H, bs), 4.12 (1 H, tt, J = 9.7, 
4.1 Hz), 3.69 (3 H, s), 2.80 (q, J = 4.6 Hz, 1 H), 2.18 – 2.00 (1 H, m), 1.95 (3 H, s), 1.80 – 1.55 (4 H, m), 
1.54 – 1.32 (2 H, m), 1.29 – 1.15 (1 H, m); 13C-NMR (75 MHz, CDCl3): δC (ppm) = 174.85 (Cq), 169.33 (Cq), 
51.78 (+, CH3), 47.87 (+, CH), 44.37 (+, CH), 29.32 (-, CH2), 27.46 (-, CH2), 24.29 (-, CH2), 23.72 (+, CH3), 
22.46 (-, CH2); IR (neat): ?̅? = 3332, 2933, 2851, 1733, 1648, 1539, 1468, 1435, 1372, 1338, 1297, 1223, 
1189, 1133, 1036, 977, 943, 895, 682; MS (+APCI, 120 V): m/z (%) = 168.1 (22) [(MH-MeOH)+], 200.1 
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(100) [(M+H)+], 399.2 (2) [(2M+H)+]; HRMS (+APCI, 120 V): 200.1285 (C10H18NO3 [(M+H)+]:  
calc. 200.1281); m.p. 73 – 76 °C. 
 
 
trans-2-(Acetylamino)cyclohexanecarboxylic acid methyl ester (trans-100)[289] 
A 100 mL flame-dried two-necked Schlenk flask equipped with a reflux condenser with bubble counter 
was charged with trans-63 (2.00 g, 10.9 mmol, 1.0 equiv.) and dry toluene (40 mL). Dry triethylamine 
(1.55 mL, 11.2 mmol, 1.0 equiv.) was added to the solution under stirring and the flask sealed with a 
rubber septum. DPPA (3.02 g, 11.0 mmol, 1.0 equiv.) and benzyl alcohol (2.3 mL, 22 mmol, 2.0 equiv.) 
were added dropwise in succession using a syringe and the mixture was refluxed for 16 h. The reaction 
was then allowed to cool to ambient temperature, transferred into a separating funnel and diluted 
with EtOAc (30 mL). The aqueous phase was discarded and the organic phase washed with 2 M HCl 
(1x), sat. NaHCO3 (1x) and sat. NaCl solutions (1x). The organic phase was dried over MgSO4, filtered, 
the solvent distilled off using a rotatory evaporator and dried under high vacuum. The oily residue was 
transferred into an autoclave vessel with MeOH (10 mL) and 200 mg Pd/C (10 wt% Pd) added. The 
mixture was hydrogenated for 16 h at 40 bar H2. After the reaction was completed, the slurry was 
filtered and the solvent was removed carefully on a rotatory evaporator (the free amine tends to be 
volatile). The residue was transferred into a separating funnel using 10 mL H2O, acidified with 2 M HCl 
to approximately pH 3 and extracted with diethyl ether (2x). The aqueous phase was then basified with 
sat. Na2CO3 (pH 9) and extracted with DCM (10x), until TLC control showed no more remaining product 
in the extract. The combined organic phases were dried over MgSO4, filtered and the solvent removed 
carefully on a rotatory evaporator. The yellowish liquid (1.49 g, 9.47 mmol, 1.0 equiv.) was diluted in 
DCM (10 mL), charged with triethylamine (1.35 mL, 9.74 mmol, 1.0 equiv.) and cooled to 0 °C. 
Subsequently, acetyl chloride (0.68 mL, 9.5 mmol, 1.0 equiv.) was added dropwise and the reaction 
was stirred for 30 min at 0 °C. Upon completion, the mixture was transferred into a separating funnel 
and washed successively with 1 M HCl (1x), sat. NaHCO3 (1x) and sat. NaCl (1x) solutions. The organic 
phase was dried over Na2SO4, filtered, all volatiles evaporated off and the residue dried under high 
vacuum. The crude yellow oil was purified using column chromatography (hexanes/ EtOAc 1:2 → 
EtOAc). White solid (1.07 g, 5.38 mmol, 50% over 3 steps). 
Rf = 0.22 (hexanes/ EtOAc 1:2); 1H NMR (300 MHz, CDCl3): δH (ppm) = 5.58 (1 H, bs), 4.05 – 3.84 (1 H, m), 
3.65 (3 H, s ), 2.31 – 2.17 (1 H, m), 2.10 – 1.98 (1 H, m), 1.97 – 1.84 (4 H, m), 1.80 - 1.05 (6 H, m). 
13C-NMR (75 MHz, CDCl3): δC (ppm) = 174.40 (Cq), 169.43 (Cq), 52.01 (+, CH3), 50.17 (+, CH), 50.04  
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(+, CH), 32.88 (-, CH2), 28.56 (-, CH2), 24.71 (-, CH2), 24.54 (-, CH2), 23.53 (+, CH3). IR (neat): ?̅? = 3267, 
3079, 2937, 2855, 1737, 1640, 1554, 1429, 1372, 1316, 1249, 1167, 1126, 1029, 969, 902, 846, 723; 
MS (+APCI, 120 V): m/z (%) = 168.1 (23) [(MH-MeOH)+], 200.1 (100) [(M+H)+], 399.2 (1) [(2M+H)+]; 
HRMS (+APCI, 120 V): 200.1283 (C10H18NO3 [(M+H)+]: calc. 200.1281); m.p. 104 – 107 °C. 
 
 
cis-2-Acetamidocyclohexane-1-carboxylic acid (cis-101)[290,291] 
Synthesized according to general procedure GP-5 using cis-100 (204 mg, 1.02 mmol, 1.0 equiv.) in THF 
(5 mL) and LiOH (123 mg, 5.12 mmol, 5.0 equiv.) in H2O (5 mL). White solid (181 mg, 976 μmol, 95%). 
1H NMR (300 MHz, CD3OD): δH (ppm) = 4.30 – 4.12 (1 H, m), 2.81 – 2.65 (1 H, m), 2.12 – 1.33 (11 H, m); 
13C-NMR (75 MHz, CD3OD): δC (ppm) = 176.98 (Cq), 172.58 (Cq), 48.89(+, CH), 45.37 (+, CH), 30.46  
(-, CH2), 26.47 (-, CH2), 24.15 (-, CH2), 23.70 (-, CH2), 22.61 (+, CH3); IR (neat): ?̅? = 3321, 2922, 2859, 
2803, 2583, 2486, 1685, 1610, 1547, 1439, 1383, 1275, 1129, 1044, 984, 962, 895, 753, 701;  
MS (+ESI, 120 V): m/z (%) = 168.1 (32) [(M+H)+-MeOH], 186.1 (100) [(M+H)+], 371.2 (19) [(2M+H)+]; 
HRMS (+ESI, 120 V): 186.1125 (C9H16NO3 [(M+H)+]: calc. 186.1125); m.p. 151 – 153 °C. 
 
 
trans-2-Acetamidocyclohexane-1-carboxylic acid (trans-101)[290,291] 
Synthesized according to general procedure GP-5 using trans-100 (277 mg, 1.39 mmol, 1.0 equiv.) in 
THF (8 mL) and LiOH (166.2 mg, 6.938 mmol, 5.0 equiv.) in H2O (8 mL). White solid (208 mg, 1.13 mmol, 
81%). 
1H NMR (300 MHz, CD3OD): δH (ppm) = 3.92 (1 H, td, J = 11.1, 4.1 Hz), 2.36 – 2.24 (1 H, m), 2.05 – 1.83 
(5 H, m), 1.82 – 1.64 (2 H, m), 1.62 – 1.12 (4 H, m); 13C-NMR (75 MHz, CD3OD): δC (ppm) = 177.81 (Cq), 
172.32 (Cq), 50.91 (+, CH), 50.17 (+, CH), 33.33 (-, CH2), 30.35 (-, CH2), 25.83 (-, CH2), 25.74 (-, CH2) 22.65 
(+, CH3); IR (neat): ?̅? = 3295, 3101, 2937, 2855, 2710, 2661, 2587, 2546, 2490, 1722, 1692, 1607, 1566, 
1439, 1379, 1323, 1256, 1208, 1126, 1040, 992, 954, 854, 794, 693; MS (+ESI, 120 V): m/z (%) = 168.1 
(37) [(M+H)+-MeOH], 186.1 (100) [(M+H)+], 371.2 (13) [(2M+H)+]; HRMS (+ESI, 120 V): 186.1128 
(C9H16NO3 [(M+H)+]: calc. 186.1125); m.p. 208 – 211 °C. 
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cis-2-Acetamido-N,N-dimethylcyclohexane-1-carboxamide (cis-95) 
Synthesized via GP-12 using cis-101 (166.6 mg, 899.5 μmol, 1.0 equiv.), thionyl chloride (0.33 mL, 
4.6 mmol, 5.1 equiv.) and a 1.64 M solution of diethylamine in THF (2.2 mL, 3.6 mmol, 4.0 equiv.). The 
crude product was purified by recrystallization from DCM/diethyl ether, followed by flash column 
chromatography (DCM/MeOH 50:1). Slight yellow solid (93.8 mg, 442 μmol, 49% over 2 steps). 
Synthesized via GP-13 using cis-101 (305 mg, 1.65 mmol, 1.0 equiv.), pyridine (0.40 mL, 5.0 mmol, 
3.0 equiv.), a 1.26 M solution of dimethylamine in THF (3.9 mL, 4.9 mmol, 3.0 equiv.) and T3P (50 wt% 
in EtOAc) (2.10 g, 3.29 mmol, 2.0 equiv.). The crude product was purified by flash column 
chromatography (DCM/MeOH 15:1). White solid (318 mg, 1.50 mmol, 91%).  
A crystal for X-ray analysis was obtained by recrystallization from acetone/hexanes. 
Rf = 0.22 (DCM/MeOH 50:1); 1H NMR (600 MHz, CDCl3): δH (ppm) = 6.25 (1 H, d, J = 4.5 Hz), 4.10 – 4.02 
(1 H, m), 3.01 (3 H, s), 2.99 – 2.95 (1 H, m), 2.89 (3 H, s), 2.26 – 2.18 (1 H, m), 1.92 (3 H, s), 1.86 – 1.78 
(1 H, m), 1.64 – 1.54 (2 H, m), 1.53 – 1.43 (2 H, m), 1.42 – 1.33 (m, 2 H); 13C-NMR (151 MHz, CDCl3):  
δC (ppm) = 173.79 (Cq), 169.80 (Cq), 47.37 (+, CH), 40.90 (+, CH), 37.51 (+, CH3), 35.59 (+, CH3), 29.29  
(-, CH2), 26.19 (-, CH2), 23.72 (+, CH3), 23.00 (-, CH2), 22.71 (-, CH2); IR (neat): ?̅? = 3340, 3068, 2926, 
2855, 1670, 1621, 1543, 1506, 1446, 1420, 1362, 1256, 1133, 1059, 947, 913, 779, 723, 682;  
MS (+APCI, 120 V): m/z (%) = 168.1 (26) [(MH-HNMe2)+], 213.2 (100) [(M+H)+]; HRMS (+APCI, 120 V): 
213.1601 (C11H21N2O2 [(M+H)+]: calc. 213.1598); m.p. 134 – 138 °C. 
 
 
trans-2-Acetamido-N,N-dimethylcyclohexane-1-carboxamide (trans-95) 
Synthesized via GP-12 using trans-101 (199 mg, 1.08 mmol, 1.0 equiv.), thionyl chloride (0.39 mL, 
5.4 mmol, 5.0 equiv.) and a 1.64 M solution of diethylamine in THF (2.6 mL, 4.3 mmol, 4.0 equiv.). The 
crude product was purified by flash column chromatography (DCM/MeOH 20:1). Slight yellow solid 
(69.9 mg, 329 μmol, 31% over 2 steps). 
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Synthesized via GP-13 using trans-101 (100 mg, 540 μmol, 1.0 equiv.), pyridine (130 μL, 1.62 mmol, 
3.0 equiv.), a 1.26 M solution of dimethylamine in THF (0.86 mL, 1.1 mmol, 2.0 equiv.), T3P (50 wt% in 
EtOAc) (687 mg, 1.08 mmol, 2 equiv.) and 1 mL dry DMF. The crude product was purified by 
recrystallization from hexanes/EtOAc. White solid (59.8 mg, 282 μmol, 52%).  
A crystal for X-ray analysis was obtained by recrystallization from acetone/hexanes. 
Rf = 0.23 (DCM/MeOH 20:1); Major conformer: 1H NMR (400 MHz, CDCl3): δH (ppm) = 6.15 (1 H, d, 
J = 6.2 Hz), 3.61 – 3.49 (1 H, m), 3.30 – 2.18 (1 H, td, J = 11.3, 3.5 Hz), 3.04 (3 H, s), 2.91 (3 H, s),  
1.97 – 1.64 (5 H, m), 1.84 (3 H, s), 1.44 – 1.09 (3 H,m); 13C-NMR (101 MHz, CDCl3): δc (ppm) = 174.45 
(Cq), 170.07 (Cq), 52.66 (+, CH), 43.97 (+, CH), 37.38 (+, CH3), 35.74 (-, CH3), 30.73 (-, CH2), 29.33 (-, CH2), 
25.26 (-, CH2), 24.93 (-, CH2), 23.90 (+, CH3): Minor conformer: 1H NMR (400 MHz, CDCl3):  
δH (ppm) = 6.06 (1 H, d, J = 10.4 Hz), 3.71 – 3.61 (1 H, m), 3.02 (3 H, s), 2.89 (3 H, s), 2.57 – 2.50  
(1 H, td, J = 10.3, 3.3 Hz), 2.04 (3 H, s), 1.97 – 1.64 (5 H, m), 1.55 – 1.09 (3 H, m); 13C-NMR (101 MHz, 
CDCl3): δC (ppm) = 173.65 (Cq), 173.05 (Cq), 54.03 (+, CH), 46.74 (+, CH), 37.34 (+, CH3), 35.86 (-, CH3), 
33.98 (-, CH2), 29.09 (-, CH2), 25.03 (-, CH2), 24.74 (-, CH2), 20.26 (+, CH3); IR (neat): ?̅? = 3291, 3071, 
2933, 2855, 16670, 1618, 1547, 1502, 1428, 1275, 1211, 1163, 1062, 954, 902, 813, 716; MS (+APCI, 
120 V): m/z (%) = 168.1 (20) [(M+H)+-HNMe2], 213.2 (100) [(M+H)+], 425.3 (1) [(2M+H)+]; HRMS (+APCI, 
120 V): 213.1597 (C11H21N2O2 [(M+H)+]: calc. 213.1598); m.p. 153 – 155 °C. 
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6. Synthesis of 15N-labeled compounds 
 
 
Trimethylamine 15N-oxide dihydrate (15N-102·2H2O)[266,292] 
In a 25 mL Schlenk flask equipped with magnetic stirring bar and reflux condenser with bubble counter, 
15NH4Cl (2.00 g, 36.7 mmol, 1.0 equiv., 15N-104) and paraformaldehyde (5.05 g, 168 mmol, 4.6 equiv.) 
were added. The mixture was carefully heated to 115 °C under gentle stirring. At that point, the mixture 
liquefied and gas evolution observed. Heating of the resulting yellow solution was continued at 115 °C 
in such a manner that gas evolution did not become too violent. After 1.5 h, gas evolution ceased 
almost completely and the mixture was heated at 160 °C for another 1.5 h. The mixture was allowed 
to cool to ambient temperature and a white solid started crystallizing, being 15N-trimethylamine 
hydrochloride (15N-105). The reflux condenser was removed, and the Schlenk flask was sealed with a 
rubber septum. 
A 10 mL Schlenk tube with magnetic stirring bar and bubble counter was filled with 30 wt% H2O2 
(4.20 mL, 41.1 mmol, 1.1 equiv.) and diluted with H2O (7 mL). A Pasteur pipette was inserted through 
a bored rubber stopper into the solution, and the tube was cooled to 0 °C with an ice bath. The Schlenk 
flask containing the crude trimethylamine hydrochloride was connected to the Schlenk tube containing 
the H2O2 solution with a rubber tube. A nitrogen inlet was attached to the Schlenk flask and the system 
was flushed with nitrogen. Subsequently, 10 M NaOH (4.20 mL, 42.0 mmol, 1.1 equiv.) was added 
constantly to the crude trimethylamine hydrochloride over 30 min using a syringe pump, causing the 
evolution of gaseous trimethylamine. After complete addition, the Schlenk flask was heated to 60 °C 
for 30 min to ensure the complete transfer of trimethylamine to the H2O2 solution. After gas evolution 
had ceased completely, the Pasteur pipette was removed, the Schlenk tube was sealed, and the 
mixture was stirred at ambient temperature for 47 h. The crude solution was transferred into a 50 mL 
round bottom flask and excess H2O was distilled off under reduced pressure (90 °C, 200 mbar). The 
product was further dried under high vacuum, giving yield to the crude product as a white solid 
(3.36 g). Recrystallization from MeCN afforded the pure compound. White solid (2.74 g, 24.5 mmol, 
67%). 
1H NMR (400 MHz, D2O) δH (ppm) = 3.25 (9 H, s); 13C NMR (101 MHz, D2O) δC (ppm) = 59.49 (+, CH3, d, 
J = 7.2 Hz); IR (neat): ?̅? = 3332, 2952, 2289, 1685, 1469, 1398, 1230, 1126, 939, 857, 757 cm-1;  
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MS (+EI, 70 eV): 76.1 (100) [(M)+·], 61.1 (29) [(M-CH3)+·], 60.2 (52) [(M-O)+·], 59.1 (67) [(M-OH)+·];  
HMRS (+ESI, 120 V): 77.0730 (C3H1015NO [(M+H)+]: calc. 77.0727); m.p. 92 °C. 
 
 
2,2,2-Trifluoroethyl acetate (107)[274] 
A flame-dried 50 mL Schlenk flask was filled with 2,2,2-trifluoroethanol (25.0 mL, 33.1 g, 331 mmol, 
1.0 equiv.), sealed with a rubber septum and cooled down to 0 °C with an ice bath. The flask was 
connected to two wash bottles, the first one empty, the second one filled with a diluted sodium 
hydroxide solution. To the cooled solution, acetyl chloride (25.0 mL, 27.5 g, 350 mmol, 1.1 equiv.) was 
added dropwise with a syringe at 0 °C. After complete addition, the mixture was allowed to reach 
ambient temperature and then stirred for 20 h. The solution was then transferred into a separating 
funnel and washed with H2O (2x 50 mL), the organic phase dried over Na2SO4 and filtered off. Colorless 
liquid (37.8 g, 266 mmol, 80%). 
1H NMR (300 MHz, CDCl3) δH (ppm) = 4.41 (2 H, d, J = 8.5 Hz), 2.10 (3 H, s); 19F NMR (283 MHz, CDCl3) 
δF (ppm) = -74.7 (3 F, s); 13C NMR (75 MHz, CDCl3) δC (ppm) = 169.40 (Cq), 123.11 (CF3, q, J = 277 Hz), 
60.36 (- , CH2, q, J = 36.6 Hz), 20.19 (+, CH3). 
 
 
15N-Acetamide (15N-106)[267,293] 
A 10 mL Schlenk tube with magnetic stirring bar and bubble counter was filled with H2O (2 mL), a 
Pasteur pipette was inserted through a bored rubber stopper into the solution, and the tube was 
cooled down to 0 °C with an ice bath. To this setup, a 25 mL Schlenk flask with magnetic stirring bar 
and nitrogen inlet, containing a well-dispersed mixture of 15NH4Cl (2.02 g, 37.1 mmol, 1.0 equiv.,  
15N-104) and Ca(OH)2 (3.30 g, 44.5 mmol, 1.2 equiv.) was connected using a rubber tube. The mixture 
was then heated gradually up to 550 °C with a heat gun, leading to the evolution of 15NH3 which was 
then trapped in the cooled H2O. To ensure complete conversion of 15NH4Cl (15N-104), a small amount 
of H2O (0.5 mL) was added to the solid mixture after the gas evolution had ceased, and the mixture 
was heated to 550 °C again. This procedure was repeated two more times. After gas evolution had 
ceased completely, the Pasteur pipette was removed from the aqueous 15NH3 solution, and  
2,2,2-Trifluoroethyl acetate (4.60 mL, 40.8 mmol, 1.1 equiv., 107) was added. The biphasic mixture was 
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stirred vigorously at ambient temperature for 116 h. The volatiles were distilled of at reduced pressure 
(75 °C, 100 mbar). The residue was redissolved in MeOH and distilled off again (50 °C, 100 mbar), 
leaving a colorless solution which solidified after several hours at high vacuum. The compound was 
further dried in a desiccator over silica gel. White solid (1.82 g, 30.2 mmol, 82%). 
Rf = 0.13 (DCM/MeOH 20:1); 1H NMR (300 MHz, CDCl3) δH (ppm) = 5.48 (2 H, d, J = 88.4 Hz), 2.02  
(3 H, d, J = 1.1 Hz); 13C NMR (75 MHz, CDCl3) δC (ppm) = 173.49 (Cq), 22.67 (+, CH3, d, J = 8.7 Hz);  
IR (neat): ?̅? = 3336, 3150, 2806, 1737, 1644, 1461, 1387, 1148, 1047, 1006, 872, 828 cm-1;  
MS (+EI, 70 eV): 60.0 (100) [(M)+·], 45.0 (95) [(M-CH3)+·]; HMRS (+EI, 70 eV): 60.0333 (C2H515NO [(M)+·]: 
calc. 60.0336); m.p. 70 – 72 °C. 
 
 
15N-Methylacetamide (15N-103)[267,277] 
In a flame-dried 50 mL two-necked Schlenk flask equipped with magnetic stirring bar and reflux 
condenser with bubble counter, 15N-Acetamide (1.00 g, 16.7 mmol, 1.0 equiv., 15N-106), dicumyl 
peroxide (9.00 g, 33.3 mmol, 2.0 equiv.), and CuCl (165 mg, 1.67 mmol, 10 mol%) were added under 
nitrogen and the apparatus was flushed with nitrogen for several minutes. Chlorobenzene (15 mL) was 
added and the mixture was refluxed for 15 h. During this time, the initially green mixture turned into 
a deep brown solution. The solution was allowed to cool to ambient temperature, filtered and the 
volatiles removed in vacuo. Initial purification was performed by flash chromatography on silica gel 
(DCM/MeOH 20:1), giving rise to a brown liquid. The compound was then further purified by micro-
distillation under reduced pressure (45 °C, 0.3 mbar), using a liquid nitrogen bath to cool the receiving 
Schlenk flask. Colorless liquid (553 mg, 7.47 mmol, 45%) which solidified slowly upon standing in the 
refrigerator. 
Rf = 0.19 (DCM/MeOH 20:1); 1H NMR (400 MHz, CDCl3) δH (ppm) = 6.28 (1 H, dq, J = 91.6, 4.8 Hz), 2.73 
(3 H, d, J = 4.5 Hz), 1.93 (3 H, d, J = 1.1 Hz); 13C NMR (101 MHz, CDCl3) δC (ppm) = 171.12 (d, J = 14.7 Hz), 
26.35 (d, J = 11.2 Hz), 23.00 (d, J = 8.6 Hz); IR (neat): ?̅? = 3276, 3086, 2948, 1629, 1543, 1439, 1413, 
1372, 1297, 1156, 1085, 1044, 992 cm-1; MS (+EI, 70 eV): 74.0 (100) [M+·], 59.0 (45) [(M-CH3)+·], 43.0 
(81) [(CH3CO)+·], 31.0 (54) [(M-CH3CO)+·]; HMRS (+EI, 70 eV): 74.0491 (C3H715NO [(M)+·]: calc. 74.0439). 
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G. Appendix 
1. Tables 
Table 7: Results of the Michael reactions using pyrrolidine (42) as catalyst. 
 
Entry Substrate Product 
Catalyst 
loading 
[mol%] 
Time [h] Conditions 
Conversion 
[%] 
Yield 
[%] 
dr 
(syn/anti) 
1 39a 41a - 45 
AP/AT 
HT 
HP 
7 
11 
6 
0 
0 
0 
n/a 
2 39a 41a 1 1 
AP/AT 
HT 
HP 
59 
100 
100 
52 
95 
95 
2.8:1 
1.4:1 
8.1:1 
3 39b 41b 1 1 
AP/AT 
HT 
HP 
56 
63 
89 
49 
57 
80 
2.6:1 
1.3:1 
4.3:1 
4 39c 41c 1 1 
AP/AT 
HT 
HP 
41 
100 
100 
37 
95 
99 
4.9:1 
1.8:1 
11.5:1 
5 39d 41d 1 1 
AP/AT 
HT 
HP 
61 
44 
42 
60 
42 
93 
4.0:1 
1.9:1 
5.7:1 
6 39e 41e 2.5 1 
AP/AT 
HT 
HP 
44 
69 
100 
35 
65 
95 
11.5:1 
4.3:1 
24.0:1 
7 39f 41f 10 4 
AP/AT 
HT 
HP 
26 
47 
85 
12 
30 
67 
n/a 
8 39g 41g 10 4 
AP/AT 
HT 
HP 
18 
44 
46 
0 
26 
31 
n/a 
Conditions: 1.00 mmol trans-β-nitrostyrene (40), 4 equiv. aldehyde (39a-g), 4-NO2-PhOH equimolar to catalyst, 2 mL solvent. 
Conversion, yield and dr determined by NMR using 1.00 mmol diphenoxymethane (46) as internal standard. 
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Table 8: Results of the Michael reactions using the Jørgensen-Hayashi catalyst (28). 
 
Entry Substrate Product 
Catalyst 
loading 
[mol%] 
Time 
[h] 
Conditions 
Conversion 
[%] 
Yield 
[%] 
dr 
(syn/anti) 
ee 
[%] 
1 39a 41a 1 1 
AP/AT 
HT 
HP 
40 
21 
43 
35 
14 
38 
13.3:1 
4.6:1 
15.7:1 
99 
97 
98 
2 39b 41b 1 1 
AP/AT 
HT 
HP 
18 
12 
28 
12 
9 
23 
11.5:1 
5.7:1 
15.7:1 
99 
95 
99 
3 39c 41c 1 1 
AP/AT 
HT 
HP 
44 
50 
58 
44 
45 
55 
24.0:1 
7.3:1 
24.0:1 
99 
98 
99 
4 39d 41d 2.5 1 
AP/AT 
HT 
HP 
19 
16 
59 
18 
14 
54 
9.0:1 
3.0:1 
24.0:1 
93 
93 
95 
5 39e 41e 2.5 1 
AP/AT 
HT 
HP 
15 
18 
71 
10 
11 
65 
11.5:1 
4.3:1 
32.3:1 
99 
99 
99 
6 39f 41f 10 4 
AP/AT 
HT 
HP 
30 
84 
100 
24 
74 
78 
n/a 
39 
12 
78 
7 39g 41g 10 4 
AP/AT 
HT 
HP 
8 
9 
30 
2 
2 
18 
n/a 
n.d. 
n.d. 
64 
Conditions: 1.00 mmol trans-β-nitrostyrene (40), 4 equiv. aldehyde (39a-g), 4-NO2-PhOH equimolar to catalyst, 2 mL solvent. 
Conversion, yield and dr determined by NMR using 1.00 mmol diphenoxymethane (46) as internal standard, ee determined 
by chiral HPLC. 
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Table 9: Examination of the hydrolytic stability of the 4H-3,1-benzoxazin-4-one 83. 
 
Entry Solvent Additive (Nu) Result Time 
1 CHCl3 - partial hydrolysis > 24 h 
2 CHCl3 solvent filtered over basic Al2O3 no change > 24 h 
3 CHCl3 EtOH (dry) no change 30 min 
4 CHCl3 EtOH (dry) + AcOH partial hydrolysis > 24 h 
5a) CHCl3 pyrrolidine (42) 90 (100%) 45 min 
6b) CHCl3 JH catalyst (28) no change > 72 h 
7 acetone 6 M HCl(aq) complete hydrolysis 5 min 
8 acetone 1 M NaOH(aq) complete hydrolysis 15 min 
9 MeOH 6 M HCl(aq) complete hydrolysis 5 min 
10 MeOH NaOH(s) complete hydrolysis 45 min 
11c) MeOH Pd/C, H2 (50 bar) complex mixture 20 h 
Reaction conditions: 10 mg of 83, 0.5 mL solvent. One drop of additive (30 - 60 μL) for liquids, 30 mg for solids. All reactions 
carried out at room temperature. a) 83 (100 mg, 286 μmol), 42 (30 μL, 337 μmol, 1.2 equiv.), 1 mL CHCl3; b) 83 (11 mg, 
32 μmol), 2.5 mL 12.5 μM 28 in CHCl3 (1.0 equiv.); c) 83 (114 mg, 325 μmol), 50 mg Pd/C, 1 mL MeOH. Hydrolysis leads to 
formation of 79. 
 
Table 10: Solvent Screening of the tripeptide-catalyzed aldol reaction. 
 
Entrya) solvent (v/v) 
24 h 48 h 
Conversion [%] Yield [%] Conversion [%] Yield [%] 
1 Acetone/H2O (3:1) 44 36 68 52 
2 Acetone/H2O (5:1) 69 58 91 80 
3 Acetone/H2O (10:1) 74 62 95 84 
4 Acetone/H2O (100:1) 73 66 94 78 
5 Acetone/H2O (1000:1) 41 25 46 30 
6 Acetone 27 12 30 19 
7 CHCl3 28 14 38 23 
8 CHCl3/i-PrOH (9:1) 14 4 18 7 
9 CHCl3/i-PrOH (1:1) 13 2 14 3 
10 CHCl3/i-PrOH (1:9) 11 1 11 1 
11 i-PrOH 11 1 11 1 
Reaction conditions: 1.00 mmol 4-Nitrobenzaldehyde (92), 10 equiv. acetone (34) (if not present as solvent), 2 mL solvent. a) 
Conversion and yield determined by NMR using diphenoxymethane (46) as internal standard. 
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2. NMR spectra 
 
1H NMR spectra          upper image 
 
13 C NMR spectra          lower image 
 
Frequency, solvent and temperature (if not ambient) are noted at the top of the spectra. 
  
Appendix 
 
161 
 
(2S)-2-[Diphenyl[(trimethylsilyl)oxy]methyl]pyrrolidine (28) 
1H NMR (300 MHz, CDCl3) 
 
13C NMR (75 MHz, CDCl3) 
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trans-β-Nitrostyrene (40) 
1H NMR (300 MHz, CDCl3) 
 
13C NMR (75 MHz, CDCl3) 
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 (2R,3S)-2-Ethyl-4-nitro-3-phenylbutanal (41a) 
1H NMR (400 MHz, CDCl3) (syn/anti = 1.7:1.0) 
 
13C NMR (101 MHz, CDCl3) 
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(R)-2-((S)-2-Nitro-1-phenylethyl)pentanal (41b) 
1H NMR (400 MHz, CDCl3) (syn/anti = 1.5:1.0) 
 
13C NMR (101 MHz, CDCl3) 
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(R)-2-((S)-2-Nitro-1-phenylethyl)octanal (41c) 
1H NMR (400 MHz, CDCl3) (syn/anti = 51.3:1.0) 
 
13C NMR (101 MHz, CDCl3) 
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(2R,3S)-2-Isopropyl-4-nitro-3-phenylbutanal (41e) 
1H NMR (400 MHz, CDCl3) (syn/anti = 2.5:1.0) 
 
13C NMR (101 MHz, CDCl3) 
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(R)-2,2-Dimethyl-4-nitro-3-phenylbutanal (41f) 
1H NMR (400 MHz, CDCl3)  
 
13C NMR (101 MHz, CDCl3) 
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(R)-1-(2-Nitro-1-phenylethyl)cyclohexane-1-carbaldehyde (41g) 
1H NMR (400 MHz, CDCl3)  
 
13C NMR (101 MHz, CDCl3) 
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N-Ethoxycarbonyl-L-proline methyl ester (43)  
1H NMR (300 MHz, CDCl3) 
 
13C NMR (75 MHz, CDCl3) 
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(2R)-α,α-Diphenyl-2-pyrrolidinemethanol (44) 
1H NMR (300 MHz, CDCl3) 
 
13C NMR (75 MHz, CDCl3) 
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Diphenoxymethane (46) 
1H NMR (300 MHz, CDCl3) 
 
13C NMR (75 MHz, CDCl3) 
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H-Pro-(-)--Pro-OH (52) 
1H NMR (400 MHz, CDCl3, 300 K)  
 
13C NMR (101 MHz, CDCl3) 
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H-Pro-(+)--Pro-OH (ent-52) 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3) 
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H-Pro-Ant-Pro-OH (53) 
1H NMR (300 MHz, CDCl3) 
 
13C NMR (75 MHz, CDCl3) 
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cis-4-Cyclohexene-1,2-dicarboxylic acid anhydride (cis-56) 
1H NMR (300 MHz, CDCl3)  
 
13C NMR (75 MHz, CDCl3) 
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trans-4-Cyclohexene-1,2-dicarboxylic acid anhydride (trans-56) 
1H NMR (300 MHz, CDCl3) 
 
13C NMR (75 MHz, CDCl3) 
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cis-2-Methoxycarbonyl-4-cyclohexene-1-carboxylic acid (cis-63) 
1H NMR (300 MHz, CDCl3) 
 
13C NMR (75 MHz, CDCl3) 
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trans-2-Methoxycarbonyl-4-cyclohexene-1-carboxylic acid (trans-63) 
1H NMR (300 MHz, CDCl3) 
 
13C NMR (75 MHz, CDCl3) 
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Methyl cis-6-(((benzyloxy)carbonyl)amino)cyclohex-3-ene-1-carboxylate (cis-64) 
1H NMR (300 MHz, CDCl3) 
 
13C NMR (75 MHz, CDCl3)
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Methyl cis-2-aminocyclohexane-1-carboxylate (rac-65) 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3)
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Boc-Pro-(-)--OMe (66)  
1H NMR (400 MHz, CDCl3, 300 K) 
 
13C NMR (101 MHz, CDCl3, 233 K)
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Boc-Pro-(+)--OMe (ent-66) 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3) 
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Boc-Pro-(-)--Pro-OBn (68) 
1H NMR (300 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3) 
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Boc-Pro-(+)--Pro-OBn (ent-68) 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3) 
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cis-Dimethyl cyclohex-4-ene-1,2-dicarboxylate (69) 
1H NMR (300 MHz, CDCl3) 
 
13C NMR (75 MHz, CDCl3) 
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Cbz-Pro-(+)--OMe (ent-71) 
1H NMR (300 MHz, CDCl3) 
 
13C NMR (75 MHz, CDCl3) 
 
Appendix 
 
187 
 
Cbz-Pro-(+)--Pro-OBn (ent-72) 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3) 
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Methyl 2-aminobenzoate (73) 
1H NMR (300 MHz, CDCl3) 
 
13C NMR (75 MHz, CDCl3) 
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Boc-Pro-Ant-OMe (74) 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3) 
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Cbz-Pro-Ant-OMe (75) 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3) 
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Boc-Pro-Ant-Pro-OBn (77) 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3) 
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Cbz-Pro-Ant-Pro-OBn (78) 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3) 
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Benzyl (S)-2-(4-oxo-4H-benzo[d][1,3]oxazin-2-yl)pyrrolidine-1-carboxylate (83) 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3) 
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2-Acetamidobenzoic acid (88) 
1H NMR (300 MHz, CD3OD) 
 
13C NMR (75 MHz, CD3OD) 
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2-Methyl-4H-benzo[d][1,3]oxazin-4-one (89) 
1H NMR (300 MHz, CDCl3) 
 
13C NMR (75 MHz, CDCl3) 
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Benzyl (S)-2-((2-(pyrrolidine-1-carbonyl)phenyl)carbamoyl)pyrrolidine-1-carboxylate (90) 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3)
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 (R)-4-Hydroxy-4-(4-nitrophenyl)butan-2-one (93) 
1H NMR (300 MHz, CDCl3) 
 
13C NMR (75 MHz, CDCl3) 
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(R)-5-Nitro-4-phenylpentan-2-one (94) 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3) 
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cis-2-Acetamido-N,N-dimethylcyclohexane-1-carboxamide (cis-95) 
1H NMR (600 MHz, CDCl3) 
 
13C NMR (151 MHz, CDCl3) 
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COSY (600 MHz, CDCl3) 
 
1H,13C-HSQC (600 MHz, CDCl3) 
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1H,13C-HMBC (600 MHz, CDCl3) 
 
2D-NOESY (600 MHz, CDCl3) 
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trans-2-Acetamido-N,N-dimethylcyclohexane-1-carboxamide (trans-95) 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3) 
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COSY (400 MHz, CDCl3) 
 
1H,13C-HSQC (400 MHz, CDCl3) 
 
  
Appendix 
 
204 
 
1H,13C-HMBC (600 MHz, CDCl3) 
 
2D-NOESY (400 MHz, CDCl3) 
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cis-6-(Dimethylcarbamoyl)cyclohex-3-ene-1-carboxylic acid (cis-96) 
1H NMR (300 MHz, CDCl3) 
 
13C NMR (75 MHz, CDCl3)
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trans-6-(Dimethylcarbamoyl)cyclohex-3-ene-1-carboxylic acid (trans-96) 
1H NMR (300 MHz, CDCl3) 
 
13C NMR (75 MHz, CDCl3)
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trans-Cyclohex-4-ene-1,2-dicarboxylic acid (trans-99) 
1H NMR (300 MHz, (CD3)2SO) 
 
13C NMR (75 MHz, (CD3)2SO) 
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cis-2-(Acetylamino)cyclohexanecarboxylic acid methyl ester (cis-100) 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (75 MHz, CDCl3) 
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trans-2-(Acetylamino)cyclohexanecarboxylic acid methyl ester (trans-100) 
1H NMR (300 MHz, CDCl3) 
 
13C NMR (75 MHz, CDCl3) 
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cis-2-Acetamidocyclohexane-1-carboxylic acid (cis-101) 
1H NMR (300 MHz, CD3OD) 
 
13C NMR (75 MHz, CD3OD) 
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trans-2-Acetamidocyclohexane-1-carboxylic acid (trans-101) 
1H NMR (300 MHz, CD3OD) 
 
13C NMR (75 MHz, CD3OD) 
 
Appendix 
 
212 
 
Trimethylamine 15N-oxide dihydrate (15N-102·2H2O) 
1H NMR (400 MHz, D2O) 
 
13C NMR (101 MHz, D2O) 
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15N-Methylacetamide (15N-103) 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3) 
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15N-Acetamide (15N-106) 
1H NMR (300 MHz, CDCl3) 
 
13C NMR (75 MHz, CDCl3) 
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2,2,2-Trifluoroethyl acetate (107) 
1H NMR (300 MHz, CDCl3) 
 
13C NMR (75 MHz, CDCl3) 
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cis-1-(4-Bromophenyl) 2-methyl cyclohex-4-ene-1,2-dicarboxylate (108) 
1H NMR (300 MHz, CDCl3) 
 
13C NMR (75 MHz, CDCl3) 
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3. HPLC chromatograms 
2-Ethyl-4-nitro-3-phenylbutanal (41a)
 
(2R,3S)-2-Ethyl-4-nitro-3-phenylbutanal ((2R,3S)-41a) 
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2-(2-Nitro-1-phenylethyl)pentanal (41b) 
 
(R)-2-((S)-2-Nitro-1-phenylethyl)pentanal ((R,2S)-41b) 
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2-(2-Nitro-1-phenylethyl)octanal (41c) 
 
(R)-2-((S)-2-Nitro-1-phenylethyl)octanal ((R,2S)-41c) 
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2-Benzyl-4-nitro-3-phenylbutanal (41d) 
 
(2R,3S)-2-Benzyl-4-nitro-3-phenylbutanal ((2R,3S)-41d) 
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2-Isopropyl-4-nitro-3-phenylbutanal (41e) 
 
(2R,3S)-2-Isopropyl-4-nitro-3-phenylbutanal ((2R,3S)-41e) 
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2,2-Dimethyl-4-nitro-3-phenylbutanal (41f) 
 
(R)-2,2-Dimethyl-4-nitro-3-phenylbutanal ((R)-41f) 
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1-(2-Nitro-1-phenylethyl)cyclohexane-1-carbaldehyde (41g) 
 
(R)-1-(2-Nitro-1-phenylethyl)cyclohexane-1-carbaldehyde ((R)-41g) 
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Boc-Pro-(±)--OMe (rac-66) 
 
Boc-Pro-(-)--OMe (66)  
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Boc-Pro-(+)--OMe (ent-66)  
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Boc-Pro-(±)--Pro-OBn (rac-68) 
 
Boc-Pro-(-)--Pro-OBn (68) 
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Boc-Pro-(+)--Pro-OBn (ent-68) 
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Cbz-Pro-(±)--OMe (rac-71) 
 
Cbz-Pro-(+)--OMe (ent-71)  
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Cbz-Pro-(±)--Pro-OBn (rac-72) 
 
Cbz-Pro-(+)--Pro-OBn (ent-72) 
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4-Hydroxy-4-(4-nitrophenyl)butan-2-one (93) 
 
(R)-4-Hydroxy-4-(4-nitrophenyl)butan-2-one ((R)-93)  
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5-Nitro-4-phenylpentan-2-one (94) 
 
(R)-5-Nitro-4-phenylpentan-2-one ((R)-94) 
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cis-1-(4-bromophenyl) 2-methyl cyclohex-4-ene-1,2-dicarboxylate (108)  
 
1-(4-bromophenyl) 2-methyl (1S,2R)-cyclohex-4-ene-1,2-dicarboxylate (108) 
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1-(4-bromophenyl) 2-methyl (1R,2S)-cyclohex-4-ene-1,2-dicarboxylate (108) 
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4. X-ray crystallography data 
((1R,2S)-2-((S)-Pyrrolidine-2-carboxamido)cyclohexane-1-carbonyl)-L-proline (52) 
 
Table 1. Crystal data and structure refinement for 52.  
Empirical formula  C20.83H40.94N3O8.08  
Formula weight  462.71  
Temperature/K  122.98(10)  
Crystal system  tetragonal  
Space group  I41  
a/Å  21.04247(13)  
b/Å  21.04247(13)  
c/Å  11.87171(15)  
α/°  90  
β/°  90  
γ/°  90  
Volume/Å3  5256.62(9)  
Z  8  
ρcalcg/cm3  1.169  
μ/mm-1  0.742  
F(000)  2012.0  
Crystal size/mm3  0.248 × 0.2025 × 0.1215  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection/°  5.94 to 147.862  
Index ranges  -24 ≤ h ≤ 26, -24 ≤ k ≤ 26, -14 ≤ l ≤ 14  
Reflections collected  26960  
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Independent reflections  5251 [Rint = 0.0470, Rsigma = 0.0253]  
Data/restraints/parameters  5251/8/338  
Goodness-of-fit on F2  1.058  
Final R indexes [I>=2σ (I)]  R1 = 0.0530, wR2 = 0.1503  
Final R indexes [all data]  R1 = 0.0541, wR2 = 0.1524  
Largest diff. peak/hole / e Å-3  0.73/-0.23  
Flack parameter -0.10(6) 
  
Table 2. Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement Parameters 
(Å2×103) for 52. Ueq is defined as 1/3 of of the trace of the orthogonalised UIJ tensor. 
Atom x y z U(eq) 
O5AA 7216(1) 3429.8(10) 269(2) 36.4(5) 
O3AA 6829.5(10) 5708(1) 511(3) 47.1(6) 
N1AA 8620.7(10) 4149.1(10) -2397(3) 28.5(5) 
N2AA 10089.7(10) 4016(1) -803(2) 27.0(5) 
O4AA 9247.0(9) 4909.1(9) -1602(2) 34.5(5) 
N7 7783.4(11) 5532.6(11) -1058(3) 34.0(5) 
C8 9085.7(12) 4345.6(12) -1728(3) 28.0(5) 
C9 10185.5(18) 3994(2) 446(3) 46.8(8) 
C10 8214.2(13) 4591.4(13) -3022(3) 31.4(6) 
C11 9414.7(12) 3826.5(12) -1056(3) 31.4(6) 
C12 7163.7(13) 4080.4(15) -2464(3) 35.6(6) 
C13 7384.2(16) 5652.3(15) 898(3) 42.0(7) 
C14 7568.5(13) 4685.5(13) -2423(3) 32.2(6) 
C15 7679.7(12) 4909.6(13) -1224(3) 30.9(5) 
C16 7937.6(13) 5748.6(14) 81(3) 36.8(6) 
C17 7751.2(19) 6054.9(15) -1872(4) 48.8(8) 
C18 7042.6(16) 3896.4(18) -3682(4) 45.5(8) 
C19 8072.0(15) 6460.5(15) -99(4) 48.5(9) 
O20 7512.1(16) 5553.4(18) 1900(3) 66.0(8) 
C21 7673.6(18) 6633.4(15) -1111(4) 50.8(9) 
C22 7541.8(17) 3252.8(19) 1261(4) 48.4(8) 
C23 8103.5(15) 4366.6(16) -4225(3) 40.2(7) 
C24 7669.3(17) 3784.0(17) -4302(3) 45.0(7) 
C27 9110.7(17) 3740(2) 111(4) 53.1(9) 
C32 9533(4) 4110(4) 901(6) 55(2) 
C33 9625(4) 3561(5) 858(7) 52(3) 
O1AA 7699.1(10) 4536.8(9) -417(2) 36.2(5) 
O6AA 8766(3) 5413(4) 2403(4) 104(2) 
O3 7364(4) 5749(4) -5755(6) 67(3) 
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C5 7733(4) 6289(4) -5452(7) 73(3) 
C6 8835(6) 4879(6) 3078(9) 126(4) 
O2AA 9421(3) 6400(3) 3274(5) 100(3) 
C1 9671(3) 5806(3) -4088(5) 73.7(13) 
O2 9367(5) 6284(4) -4246(8) 96(3) 
C5A 7566(14) 6039(12) -4734(11) 130(13) 
O0AA 10023(4) 5712(4) -5012(6) 71(2) 
  
Table 3. Anisotropic Displacement Parameters (Å2×103) for 52. The Anisotropic displacement factor 
exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…]. 
Atom U11 U22 U33 U23 U13 U12 
O5AA 25.7(9) 30.9(10) 52.6(12) 2.8(9) 3.9(9) 0.9(7) 
O3AA 26.2(10) 30.3(10) 84.8(18) 0.0(11) 19.7(11) -1.7(8) 
N1AA 23(1) 20.9(10) 41.5(11) 0.5(9) -2.7(9) -0.9(8) 
N2AA 21.9(10) 20.3(9) 38.7(12) -0.8(8) -2.2(8) -2.6(8) 
O4AA 26.7(9) 19.8(9) 56.9(12) -0.5(8) -4.5(8) -3.0(7) 
N7 28.6(11) 22.5(11) 50.8(14) -1.6(10) 8.2(10) 0.4(8) 
C8 20.9(11) 22.7(12) 40.4(13) -1.4(10) 2.7(10) -2.0(9) 
C9 45.7(18) 57(2) 37.6(16) -1.5(14) -5.9(13) -10.3(15) 
C10 26.0(12) 26.6(12) 41.7(14) 2.8(11) -2.5(11) 1.6(10) 
C11 21.4(12) 24.1(12) 48.6(15) 2.3(11) -1.5(11) -5.4(9) 
C12 23.3(12) 34.0(14) 49.7(16) -2.6(12) -2.4(11) -1.7(10) 
C13 35.5(16) 28.8(13) 62(2) -8.1(13) 15.7(14) -4.5(11) 
C14 23.4(12) 27.2(12) 46.1(15) 1.9(11) -1.8(11) 3.6(9) 
C15 22.4(11) 22.3(12) 47.8(14) -1.6(11) 1.5(11) 0.8(9) 
C16 23.3(12) 31.2(14) 55.8(17) -10.6(13) 6.3(12) -4.2(10) 
C17 54.5(19) 25.3(14) 66(2) 5.3(14) 12.2(17) -0.7(13) 
C18 33.6(15) 48.2(18) 54.7(19) -5.9(15) -12.5(14) -1.3(13) 
C19 31.0(14) 31.1(14) 83(3) -15.3(16) 22.8(16) -9.9(11) 
O20 60.4(17) 78(2) 59.6(18) -9.3(15) 18.8(14) -5.9(15) 
C21 45.5(18) 22.6(13) 84(3) 0.7(15) 20.8(18) -3.5(12) 
C22 38.3(16) 54(2) 52.5(17) 13.6(16) 4.1(14) -2.6(14) 
C23 36.2(15) 43.2(16) 41.1(15) 3.5(12) -2.5(12) 3.5(12) 
C24 42.2(17) 46.2(18) 46.4(17) -7.8(14) -11.2(14) 1.7(14) 
C27 34.5(16) 68(2) 57(2) 27.1(18) 9.0(15) -4.7(15) 
C32 60(4) 58(5) 46(3) 9(3) 16(3) 8(3) 
C33 49(5) 61(6) 47(4) 21(4) 2(3) -5(4) 
O1AA 35.7(10) 26.2(9) 46.5(11) -0.2(8) 0.5(9) 0.6(7) 
O6AA 89(4) 160(6) 62(3) 30(3) -6(2) -26(4) 
O3 59(5) 91(6) 49(4) -2(3) 2(3) -1(4) 
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C5 68(5) 90(6) 61(4) -6(4) -13(3) -2(4) 
C6 135(9) 158(10) 86(5) 56(6) 15(5) -6(7) 
O2AA 107(4) 122(5) 70(3) 33(3) -27(3) -55(4) 
C1 94(4) 64(3) 63(3) 0(2) 13(3) -12(3) 
O2 128(8) 67(5) 94(6) -7(4) -46(5) 25(4) 
C5A 180(30) 87(15) 130(20) -36(14) 76(19) -56(16) 
O0AA 70(5) 79(5) 64(4) -2(3) -2(3) 12(3) 
  
Table 4. Bond Lengths for 52. 
Atom Atom Length/Å  Atom Atom Length/Å 
O5AA C22 1.412(4)  C12 C18 1.518(5) 
O3AA C13 1.260(5)  C13 C16 1.529(4) 
N1AA C8 1.326(4)  C13 O20 1.238(5) 
N1AA C10 1.466(3)  C14 C15 1.517(4) 
N2AA C9 1.497(4)  C15 O1AA 1.239(4) 
N2AA C11 1.505(3)  C16 C19 1.540(4) 
O4AA C8 1.243(3)  C17 C21 1.525(5) 
N7 C15 1.344(4)  C18 C24 1.529(5) 
N7 C16 1.463(4)  C19 C21 1.509(7) 
N7 C17 1.465(4)  C23 C24 1.532(5) 
C8 C11 1.520(4)  C27 C32 1.508(10) 
C9 C32 1.496(8)  C27 C33 1.448(9) 
C9 C33 1.569(9)  O6AA C6 1.387(11) 
C10 C14 1.546(4)  O3 C5 1.423(12) 
C10 C23 1.522(4)  O3 C5A 1.423(12) 
C11 C27 1.537(5)  C1 O2 1.207(10) 
C12 C14 1.533(4)  C1 O0AA 1.339(9) 
  
Table 5. Bond Angles for 52. 
Atom Atom Atom Angle/˚  Atom Atom Atom Angle/˚ 
C8 N1AA C10 122.4(2)  C12 C14 C10 111.5(2) 
C9 N2AA C11 108.4(2)  C15 C14 C10 109.6(2) 
C15 N7 C16 118.4(3)  C15 C14 C12 112.0(2) 
C15 N7 C17 128.8(3)  N7 C15 C14 117.8(3) 
C16 N7 C17 112.8(3)  O1AA C15 N7 119.9(3) 
N1AA C8 C11 115.2(2)  O1AA C15 C14 122.3(2) 
O4AA C8 N1AA 124.8(3)  N7 C16 C13 112.1(2) 
O4AA C8 C11 119.9(2)  N7 C16 C19 102.4(3) 
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N2AA C9 C33 103.0(4)  C13 C16 C19 110.9(2) 
C32 C9 N2AA 103.3(4)  N7 C17 C21 102.3(3) 
N1AA C10 C14 111.2(2)  C12 C18 C24 110.7(3) 
N1AA C10 C23 111.5(2)  C21 C19 C16 104.1(3) 
C23 C10 C14 109.7(2)  C19 C21 C17 102.7(3) 
N2AA C11 C8 110.1(2)  C10 C23 C24 113.4(3) 
N2AA C11 C27 104.1(2)  C18 C24 C23 111.2(3) 
C8 C11 C27 111.6(3)  C32 C27 C11 104.8(3) 
C18 C12 C14 109.6(3)  C33 C27 C11 105.7(4) 
O3AA C13 C16 117.5(3)  C9 C32 C27 103.4(5) 
O20 C13 O3AA 124.6(3)  C27 C33 C9 102.7(5) 
O20 C13 C16 117.8(3)      
  
Table 6. Torsion Angles for 52. 
A B C D Angle/˚  A B C D Angle/˚ 
O3AA C13 C16 N7 -33.2(4)  C11 N2AA C9 C33 19.2(5) 
O3AA C13 C16 C19 80.5(4)  C11 C27 C32 C9 -37.3(5) 
N1AA C8 C11 N2AA 152.2(2)  C11 C27 C33 C9 39.7(7) 
N1AA C8 C11 C27 -92.6(3)  C12 C14 C15 N7 -153.0(2) 
N1AA C10 C14 C12 -68.4(3)  C12 C14 C15 O1AA 29.5(4) 
N1AA C10 C14 C15 56.2(3)  C12 C18 C24 C23 -55.8(4) 
N1AA C10 C23 C24 71.2(3)  C13 C16 C19 C21 -91.7(3) 
N2AA C9 C32 C27 39.3(5)  C14 C10 C23 C24 -52.4(3) 
N2AA C9 C33 C27 -36.5(7)  C14 C12 C18 C24 59.0(4) 
N2AA C11 C27 C32 20.4(4)  C15 N7 C16 C13 -65.5(3) 
N2AA C11 C27 C33 -28.0(5)  C15 N7 C16 C19 175.6(2) 
O4AA C8 C11 N2AA -29.8(4)  C15 N7 C17 C21 160.0(3) 
O4AA C8 C11 C27 85.3(3)  C16 N7 C15 C14 -175.6(2) 
N7 C16 C19 C21 28.1(3)  C16 N7 C15 O1AA 1.9(4) 
N7 C17 C21 C19 35.3(3)  C16 N7 C17 C21 -18.5(4) 
C8 N1AA C10 C14 -100.2(3)  C16 C19 C21 C17 -39.7(3) 
C8 N1AA C10 C23 137.0(3)  C17 N7 C15 C14 6.0(4) 
C8 C11 C27 C32 -98.4(4)  C17 N7 C15 O1AA -176.5(3) 
C8 C11 C27 C33 -146.8(5)  C17 N7 C16 C13 113.2(3) 
C9 N2AA C11 C8 123.8(3)  C17 N7 C16 C19 -5.7(3) 
C9 N2AA C11 C27 4.0(3)  C18 C12 C14 C10 -59.4(3) 
C10 N1AA C8 O4AA -3.8(4)  C18 C12 C14 C15 177.4(2) 
C10 N1AA C8 C11 174.1(2)  O20 C13 C16 N7 149.9(3) 
C10 C14 C15 N7 82.6(3)  O20 C13 C16 C19 -96.3(4) 
C10 C14 C15 O1AA -94.8(3)  C23 C10 C14 C12 55.4(3) 
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C10 C23 C24 C18 53.3(4)  C23 C10 C14 C15 180.0(2) 
C11 N2AA C9 C32 -26.9(4)       
  
Table 7. Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement Parameters (Å2×103) for 
52. 
Atom x y z U(eq) 
H5AD 7377 3753 8 55 
H1AA 8555 3748 -2466 34 
H2AA 10358 3751 -1142 32 
H2AB 10164 4407 -1058 32 
H9AA 10345 3582 681 56 
H9AB 10479 4321 691 56 
H9BC 10158 4415 774 56 
H9BD 10594 3808 635 56 
H10 8430 5004 -3053 38 
H11 9406 3425 -1473 38 
H12A 7383 3738 -2080 43 
H12B 6762 4153 -2084 43 
H14 7337 5021 -2822 39 
H16 8319 5532 359 44 
H17A 7391 6007 -2374 59 
H17B 8138 6082 -2315 59 
H18A 6807 4232 -4054 55 
H18B 6788 3513 -3706 55 
H19A 7946 6706 555 58 
H19B 8519 6533 -247 58 
H21A 7831 7015 -1473 61 
H21B 7232 6696 -903 61 
H22A 7939 3058 1065 73 
H22B 7288 2956 1680 73 
H22C 7620 3623 1712 73 
H23A 8510 4264 -4564 48 
H23B 7916 4711 -4655 48 
H24A 7583 3691 -5088 54 
H24B 7884 3419 -3978 54 
H27A 8681 3908 121 64 
H27B 9098 3295 320 64 
H27C 8915 4133 361 64 
H27D 8788 3411 90 64 
H32A 9429 4559 888 66 
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H32B 9495 3954 1667 66 
H33A 9729 3114 778 63 
H33B 9518 3648 1638 63 
H6AA 8630 5708 2782 156 
H3A 7398 5683 -6433 100 
H3B 7608 5847 -6264 100 
H5A 7918 6471 -6117 110 
H5B 8065 6162 -4944 110 
H5C 7466 6598 -5092 110 
H6A 8580 4540 2783 189 
H6B 8700 4977 3831 189 
H6C 9273 4752 3087 189 
H2AC 9490 6721 2871 149 
H2AD 9160 6152 2945 149 
H2 9581 6538 -4609 144 
H5AA 8017 5984 -4648 194 
H5AB 7350 5846 -4110 194 
H5AC 7469 6485 -4755 194 
H0AA 9869 5909 -5542 106 
  
Table 8. Atomic Occupancy for 52. 
Atom Occupancy  Atom Occupancy  Atom Occupancy 
H9AA 0.550(14)  H9AB 0.550(14)  H9BC 0.450(14) 
H9BD 0.450(14)  H27A 0.550(14)  H27B 0.550(14) 
H27C 0.450(14)  H27D 0.450(14)  C32 0.550(14) 
H32A 0.550(14)  H32B 0.550(14)  C33 0.450(14) 
H33A 0.450(14)  H33B 0.450(14)  O6AA 0.827(12) 
H6AA 0.827(12)  O3 0.439(15)  H3A 0.68(2) 
H3B 0.32(2)  C5 0.68(2)  H5A 0.68(2) 
H5B 0.68(2)  H5C 0.68(2)  C6 0.827(12) 
H6A 0.827(12)  H6B 0.827(12)  H6C 0.827(12) 
O2AA 0.814(15)  H2AC 0.814(15)  H2AD 0.814(15) 
O2 0.519(12)  H2 0.519(12)  C5A 0.32(2) 
H5AA 0.32(2)  H5AB 0.32(2)  H5AC 0.32(2) 
O0AA 0.481(12)  H0AA 0.481(12)    
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2-Methyl-4H-benzo[d][1,3]oxazin-4-one (89) 
 
Table 1. Crystal data and structure refinement for 89.  
Empirical formula  C9H7NO2  
Formula weight  161.16  
Temperature/K  123.00(10)  
Crystal system  monoclinic  
Space group  P21/c  
a/Å  7.2435(3)  
b/Å  10.3965(5)  
c/Å  10.1746(6)  
α/°  90  
β/°  102.676(5)  
γ/°  90  
Volume/Å3  747.54(7)  
Z  4  
ρcalcg/cm3  1.432  
μ/mm-1  0.853  
F(000)  336.0  
Crystal size/mm3  0.141 × 0.074 × 0.056  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection/°  12.328 to 147.078  
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Index ranges  -7 ≤ h ≤ 8, -12 ≤ k ≤ 12, -9 ≤ l ≤ 12  
Reflections collected  3569  
Independent reflections  1453 [Rint = 0.0224, Rsigma = 0.0282]  
Data/restraints/parameters  1453/0/110  
Goodness-of-fit on F2  1.082  
Final R indexes [I>=2σ (I)]  R1 = 0.0373, wR2 = 0.0911  
Final R indexes [all data]  R1 = 0.0518, wR2 = 0.0991  
Largest diff. peak/hole / e Å-3  0.18/-0.19  
  
Table 2. Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement Parameters 
(Å2×103) for 89. Ueq is defined as 1/3 of of the trace of the orthogonalised UIJ tensor. 
Atom x y z U(eq) 
O1 6721.3(13) 3327.3(10) 3513.5(10) 27.9(3) 
O2 5465.5(15) 4872.0(11) 2106.4(11) 37.4(3) 
N1 8377.7(15) 3681.1(12) 5745.6(12) 27.5(3) 
C1 7977.2(17) 4993.9(14) 5568.6(14) 25.0(3) 
C2 6903.9(17) 5489.4(14) 4356.9(14) 23.9(3) 
C3 6280.9(17) 4610.6(14) 3234.4(14) 26.0(3) 
C8 7736.6(18) 2938.7(15) 4755.1(15) 27.4(3) 
C7 8660.5(19) 5841.6(16) 6627.6(15) 31.4(4) 
C4 6474.0(19) 6799.4(15) 4224.2(16) 29.5(3) 
C5 7150(2) 7621.5(15) 5287.5(17) 34.2(4) 
C6 8262(2) 7136.7(16) 6483.9(17) 35.2(4) 
C9 7985(2) 1519.6(15) 4801.4(18) 37.6(4) 
  
Table 3. Anisotropic Displacement Parameters (Å2×103) for 89. The Anisotropic displacement factor 
exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…]. 
Atom U11 U22 U33 U23 U13 U12 
O1 27.7(5) 27.9(5) 25.0(6) 0.3(4) -0.8(4) -2.2(4) 
O2 41.7(6) 41.4(7) 24.1(6) 3.9(5) -3.5(4) 0.9(5) 
N1 24.2(5) 31.4(7) 24.8(7) 4.2(5) 0.7(5) -3.2(5) 
C1 20.8(6) 30.9(8) 23.5(7) 2.8(6) 5.4(5) -2.7(5) 
C2 20.0(6) 30.4(8) 21.8(7) 1.5(6) 5.5(5) -2.0(5) 
C3 22.0(6) 29.9(7) 25.5(8) 2.9(6) 3.7(5) -1.5(5) 
C8 21.1(6) 31.9(8) 27.1(8) 5.9(6) 1.0(5) -2.5(5) 
C7 30.6(7) 41.0(9) 22.6(8) -1.6(6) 5.5(6) -5.9(6) 
C4 23.8(6) 33.7(8) 31.9(8) 3.6(6) 8.2(6) 0.8(5) 
C5 31.8(7) 29.7(8) 44.7(10) -3.0(7) 16.3(7) -0.6(6) 
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C6 34.7(7) 40.4(9) 33.5(9) -11.7(7) 14.1(6) -7.7(7) 
C9 33.8(7) 29.1(8) 44.8(10) 3.4(7) -2.4(7) -2.9(6) 
  
Table 4. Bond Lengths for 89. 
Atom Atom Length/Å  Atom Atom Length/Å 
O1 C3 1.3866(17)  C2 C3 1.455(2) 
O1 C8 1.3755(17)  C2 C4 1.397(2) 
O2 C3 1.2010(17)  C8 C9 1.486(2) 
N1 C1 1.3988(19)  C7 C6 1.378(2) 
N1 C8 1.2734(19)  C4 C5 1.381(2) 
C1 C2 1.4032(19)  C5 C6 1.398(2) 
C1 C7 1.396(2)     
  
Table 5. Bond Angles for 89. 
Atom Atom Atom Angle/˚  Atom Atom Atom Angle/˚ 
C8 O1 C3 121.55(11)  O2 C3 O1 117.14(13) 
C8 N1 C1 117.40(12)  O2 C3 C2 127.66(14) 
N1 C1 C2 122.05(13)  O1 C8 C9 110.94(13) 
C7 C1 N1 119.23(13)  N1 C8 O1 125.27(14) 
C7 C1 C2 118.73(14)  N1 C8 C9 123.79(13) 
C1 C2 C3 118.41(13)  C6 C7 C1 120.29(14) 
C4 C2 C1 120.77(13)  C5 C4 C2 119.63(14) 
C4 C2 C3 120.81(13)  C4 C5 C6 119.76(15) 
O1 C3 C2 115.19(12)  C7 C6 C5 120.80(15) 
  
Table 6. Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement Parameters (Å2×103) for 
89. 
Atom x y z U(eq) 
H7 9388.19 5531.01 7433.65 38 
H4 5736.71 7116.17 3424.62 35 
H5 6867 8494.42 5207.61 41 
H6 8737.42 7694.8 7191.48 42 
H9A 6891.42 1123.37 5017.86 56 
H9B 9087.91 1301.3 5476.94 56 
H9C 8134.4 1217.16 3939.47 56 
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cis-2-Acetamido-N,N-dimethylcyclohexane-1-carboxamide (cis-95) 
 
Table 1. Crystal data and structure refinement for cis-95.  
Empirical formula  C11H20N2O2  
Formula weight  212.29  
Temperature/K  294.15(10)  
Crystal system  triclinic  
Space group  P-1  
a/Å  8.0260(4)  
b/Å  8.4029(4)  
c/Å  9.4537(3)  
α/°  108.763(4)  
β/°  95.599(4)  
γ/°  102.128(4)  
Volume/Å3  580.75(5)  
Z  2  
ρcalcg/cm3  1.214  
μ/mm-1  0.674  
F(000)  232.0  
Crystal size/mm3  0.59 × 0.223 × 0.107  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection/°  10.042 to 147.492  
Index ranges  -9 ≤ h ≤ 9, -10 ≤ k ≤ 10, -11 ≤ l ≤ 11  
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Reflections collected  12685  
Independent reflections  2302 [Rint = 0.0431, Rsigma = 0.0234]  
Data/restraints/parameters  2302/0/216  
Goodness-of-fit on F2  1.047  
Final R indexes [I>=2σ (I)]  R1 = 0.0364, wR2 = 0.0966  
Final R indexes [all data]  R1 = 0.0404, wR2 = 0.1026  
Largest diff. peak/hole / e Å-3  0.26/-0.22  
  
Table 2. Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement Parameters 
(Å2×103) for cis-95. Ueq is defined as 1/3 of of the trace of the orthogonalised UIJ tensor. 
Atom x y z U(eq) 
O2 5383.1(11) 4151.0(11) 6436.6(11) 32.8(2) 
O1 -32.0(12) 880.5(12) 3164.0(11) 37.2(2) 
N2 5254.2(13) 1628.1(13) 6820.6(12) 28.9(2) 
N1 2146.5(13) 3305.8(14) 4303.6(11) 26.9(2) 
C9 4514.6(14) 2866.3(14) 6629.9(12) 22.9(2) 
C2 1224.2(15) 1953.3(15) 3090.7(13) 26.0(3) 
C4 2588.8(14) 2632.1(14) 6669.2(12) 22.0(2) 
C5 2286.1(16) 3175.9(16) 8324.4(13) 27.7(3) 
C3 1756.7(15) 3653.2(15) 5830.0(13) 24.7(3) 
C8 2209.5(18) 5614.4(16) 6678.7(15) 32.0(3) 
C1 1842.2(18) 1827.6(19) 1609.1(15) 33.4(3) 
C6 2849.5(19) 5136.0(18) 9139.9(15) 35.9(3) 
C10 4416.4(19) 127.8(17) 7179.7(18) 36.0(3) 
C11 7106.7(17) 1856(2) 6839.9(18) 37.7(3) 
C7 1878(2) 6042.5(19) 8305.2(16) 39.6(3) 
  
Table 3. Anisotropic Displacement Parameters (Å2×103) for cis-95. The Anisotropic displacement 
factor exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…]. 
Atom U11 U22 U33 U23 U13 U12 
O2 23.1(4) 30.9(5) 47.7(5) 21.6(4) 8.8(4) 0.1(3) 
O1 31.0(5) 30.7(5) 43.6(5) 13.3(4) 7.1(4) -5.8(4) 
N2 21.5(5) 26.7(5) 40.6(6) 13.8(4) 8.1(4) 6.3(4) 
N1 22.1(5) 30.1(5) 27.4(5) 14.9(4) 3.6(4) -3.0(4) 
C9 21.2(5) 23.0(5) 23.1(5) 8.3(4) 4.7(4) 2.3(4) 
C2 22.9(5) 25.5(6) 31.8(6) 14.4(5) 3.4(4) 4.8(4) 
C4 19.2(5) 21.8(6) 25.5(5) 10.5(4) 5.8(4) 1.9(4) 
C5 25.7(6) 34.3(7) 26.8(6) 14.3(5) 8.7(5) 8.1(5) 
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C3 20.3(5) 28.6(6) 27.4(6) 13.8(5) 5.1(4) 4.1(4) 
C8 32.7(7) 28.5(6) 38.2(7) 15.0(5) 4.4(5) 10.9(5) 
C1 33.2(7) 36.2(7) 29.6(6) 12.5(5) 5.7(5) 5.0(6) 
C6 40.9(8) 36.7(7) 27.7(6) 6.7(5) 6.3(5) 12.4(6) 
C10 33.6(7) 29.4(7) 51.0(8) 21.4(6) 8.2(6) 8.6(6) 
C11 22.8(6) 40.1(8) 49.9(8) 12.5(6) 9.2(6) 11.6(6) 
C7 45.7(8) 33.3(7) 40.4(7) 8.2(6) 9.4(6) 18.4(6) 
  
Table 4. Bond Lengths for cis-95. 
Atom Atom Length/Å  Atom Atom Length/Å 
O2 C9 1.2329(14)  C2 C1 1.5105(17) 
O1 C2 1.2271(15)  C4 C5 1.5418(15) 
N2 C9 1.3515(15)  C4 C3 1.5450(15) 
N2 C10 1.4562(16)  C5 C6 1.5211(19) 
N2 C11 1.4562(16)  C3 C8 1.5272(17) 
N1 C2 1.3405(16)  C8 C7 1.5261(19) 
N1 C3 1.4563(15)  C6 C7 1.5256(19) 
C9 C4 1.5222(15)     
  
Table 5. Bond Angles for cis-95. 
Atom Atom Atom Angle/˚  Atom Atom Atom Angle/˚ 
C9 N2 C10 126.22(10)  C9 C4 C5 110.25(9) 
C9 N2 C11 119.05(11)  C9 C4 C3 112.69(9) 
C10 N2 C11 114.39(11)  C5 C4 C3 109.91(9) 
C2 N1 C3 123.58(10)  C6 C5 C4 112.48(10) 
O2 C9 N2 120.67(10)  N1 C3 C4 111.98(9) 
O2 C9 C4 121.18(10)  N1 C3 C8 109.55(10) 
N2 C9 C4 118.15(10)  C8 C3 C4 114.54(10) 
O1 C2 N1 122.99(11)  C7 C8 C3 111.47(11) 
O1 C2 C1 121.75(11)  C5 C6 C7 110.53(11) 
N1 C2 C1 115.27(11)  C6 C7 C8 110.59(11) 
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Table 6. Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement Parameters (Å2×103) for 
cis-95. 
Atom x y z U(eq) 
H3 491(19) 3160(17) 5698(15) 26(3) 
H5A 2870(20) 2568(19) 8878(17) 34(4) 
H5B 1030(20) 2740(19) 8292(16) 32(4) 
H10A 4720(20) -900(20) 6538(18) 42(4) 
H10B 3200(20) -100(20) 7000(18) 39(4) 
H1 2950(20) 4010(20) 4172(19) 42(4) 
H8A 1560(20) 6150(20) 6154(19) 46(4) 
H4 1990(17) 1392(18) 6153(15) 21(3) 
H6A 4120(20) 5590(20) 9213(18) 41(4) 
H10C 4840(20) 310(20) 8260(20) 46(4) 
H8B 3420(20) 6124(19) 6682(17) 33(4) 
H6B 2630(20) 5430(20) 10180(20) 52(5) 
H7A 610(20) 5630(20) 8270(20) 49(5) 
H7B 2260(20) 7330(20) 8830(20) 49(5) 
H11A 7730(30) 2070(20) 7880(20) 61(5) 
H11B 7330(20) 800(30) 6170(20) 62(5) 
H1A 900(30) 1720(30) 840(20) 65(6) 
H1B 2170(30) 770(30) 1190(20) 74(6) 
H1C 2760(30) 2770(30) 1680(20) 70(6) 
H11C 7570(30) 2840(30) 6580(20) 71(6) 
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trans-2-Acetamido-N,N-dimethylcyclohexane-1-carboxamide (trans-95) 
 
Table 1. Crystal data and structure refinement for trans-95.  
Empirical formula  C11H20N2O2  
Formula weight  212.29  
Temperature/K  122.98(11)  
Crystal system  monoclinic  
Space group  Cc  
a/Å  17.0252(4)  
b/Å  8.82890(10)  
c/Å  18.1222(4)  
α/°  90  
β/°  118.029(3)  
γ/°  90  
Volume/Å3  2404.52(10)  
Z  8  
ρcalcg/cm3  1.173  
μ/mm-1  0.651  
F(000)  928.0  
Crystal size/mm3  0.311 × 0.207 × 0.189  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection/°  11.062 to 148.604  
Index ranges  -20 ≤ h ≤ 20, -10 ≤ k ≤ 10, -22 ≤ l ≤ 22  
Reflections collected  28229  
Independent reflections  4725 [Rint = 0.0244, Rsigma = 0.0126]  
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Data/restraints/parameters  4725/2/277  
Goodness-of-fit on F2  1.075  
Final R indexes [I>=2σ (I)]  R1 = 0.0262, wR2 = 0.0717  
Final R indexes [all data]  R1 = 0.0265, wR2 = 0.0720  
Largest diff. peak/hole / e Å-3  0.14/-0.13  
Flack parameter 0.02(4) 
  
Table 2. Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement Parameters 
(Å2×103) for trans-95. Ueq is defined as 1/3 of of the trace of the orthogonalised UIJ tensor. 
Atom x y z U(eq) 
O3 4624.0(9) 5095.1(14) 5655.0(9) 41.5(3) 
O2 1468.5(8) 2595.9(14) 4344.0(9) 41.5(3) 
O1 2833.7(9) 714.6(18) 6621.0(8) 44.5(3) 
O4 3711.7(9) 3215.8(18) 3377.9(8) 44.5(3) 
N2 -16.2(10) 2662.7(15) 3778.4(9) 32.0(3) 
N4 3704.8(10) 5163.0(15) 6219.6(9) 31.9(3) 
N3 3123.7(9) 2789.2(17) 4247.8(8) 32.7(3) 
N1 1375.3(9) 290.3(17) 5750.9(8) 32.7(3) 
C9 761.5(11) 1923.9(18) 4140.5(10) 28.9(3) 
C20 4119.9(10) 4424.1(18) 5858.5(10) 28.8(3) 
C2 2054.1(12) 722(2) 6478.8(11) 36.3(4) 
C3 1505.1(10) -322.2(19) 5068.7(9) 29.2(3) 
C14 3934.8(10) 2178.2(19) 4929.8(9) 29.2(3) 
C13 3074.4(12) 3222(2) 3520(1) 36.3(4) 
C15 4022.5(10) 2706.2(18) 5768.4(9) 28.0(3) 
C16 4852.9(12) 2011.2(19) 6494.9(10) 34.9(4) 
C4 753.7(10) 206.6(18) 4230.1(9) 28.0(3) 
C21 3896.3(12) 6772(2) 6403.3(12) 39.8(4) 
C17 4849.5(13) 284(2) 6437.7(11) 37.1(4) 
C10 -7.4(14) 4271(2) 3595.2(12) 39.8(4) 
C5 857.0(12) -487(2) 3502.9(10) 34.8(4) 
C8 1550.7(11) -2048(2) 5111.0(11) 35.3(4) 
C6 910.4(13) -2215(2) 3560.7(11) 37.2(4) 
C7 1672.0(12) -2720(2) 4396.7(12) 38.8(4) 
C19 3939.3(12) 452(2) 4887.8(11) 35.3(4) 
C18 4774.4(13) -218(2) 5601.5(12) 38.9(4) 
C11 -869.8(13) 2012(2) 3618.9(16) 51.3(5) 
C22 3011.9(17) 4512(2) 6380.9(16) 51.1(5) 
C12 2170.5(14) 3764(3) 2875.4(14) 61.2(7) 
C1 1794.4(16) 1265(3) 7123.1(14) 61.2(7) 
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Table 3. Anisotropic Displacement Parameters (Å2×103) for trans-95. The Anisotropic displacement 
factor exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…]. 
Atom U11 U22 U33 U23 U13 U12 
O3 36.5(7) 37.1(6) 60.3(8) -0.8(6) 30.6(6) -9.1(5) 
O2 32.6(7) 37.6(7) 60.0(8) 0.7(6) 26.4(6) -8.3(5) 
O1 29.2(6) 63.9(9) 38.5(6) -3.1(6) 14.3(5) -11.2(6) 
O4 37.2(7) 63.6(9) 38.7(6) 2.9(6) 22.9(6) -8.8(6) 
N2 30.7(7) 29.1(7) 35.8(7) -1.7(5) 15.3(6) -2.8(5) 
N4 33.7(7) 28.8(7) 36.4(7) 1.7(5) 19.2(6) -1.1(6) 
N3 21.3(6) 47.1(8) 30.6(7) 1.3(6) 13.0(5) -3.7(6) 
N1 24.8(6) 46.9(8) 30.6(7) -1.4(6) 16.5(5) -4.7(6) 
C9 30.5(8) 32.6(8) 29.1(7) -1.7(6) 18.3(6) -4.7(6) 
C20 22.7(7) 32.3(8) 29.0(7) 1.2(6) 10.2(6) -3.2(6) 
C2 34.6(9) 44.3(9) 31.8(8) -1.2(7) 17.2(7) -10.2(7) 
C3 22.4(7) 39.0(9) 28.4(7) 0.0(6) 13.8(6) -2.8(6) 
C14 22.5(7) 39.0(9) 28.3(7) -0.3(6) 13.8(6) -3.3(6) 
C13 31.1(8) 44.5(9) 31.7(8) 1.2(7) 13.4(7) -9.0(7) 
C15 26.0(8) 31.5(8) 29.4(7) -1.4(6) 15.5(6) -4.6(6) 
C16 37.7(9) 31.8(8) 30.5(8) 1.1(6) 12.1(7) -3.2(7) 
C4 24.1(7) 31.6(8) 29.2(7) 1.4(6) 13.3(6) -3.5(6) 
C21 37.3(9) 30.7(8) 44.2(9) -1.4(7) 13.2(7) 1.1(7) 
C17 41.8(10) 32.1(8) 36.3(9) 3.6(7) 17.4(7) 0.0(7) 
C10 51.9(11) 30.8(8) 44.1(9) 1.2(7) 28.8(8) 2.4(7) 
C5 42.2(9) 32.0(8) 30.2(8) -1.6(6) 17.2(7) -4.2(7) 
C8 27.7(8) 41.3(9) 35.6(8) 7.3(7) 13.6(6) 3.3(7) 
C6 42.2(10) 32.2(8) 36.1(9) -3.5(7) 17.4(8) -3.0(7) 
C7 33.0(9) 36.3(9) 46.3(10) -0.4(7) 17.9(8) 2.1(7) 
C19 34.6(9) 40.8(9) 35.8(8) -7.4(7) 20.8(7) -4.1(7) 
C18 41.4(10) 35.9(9) 46.5(10) 0.3(7) 26.5(8) 2.7(7) 
C11 26.5(9) 37.4(10) 78.5(15) -5.0(9) 15.0(9) -1.6(7) 
C22 67.5(14) 37.6(10) 78.1(14) 5.0(9) 59.1(12) 2.7(9) 
C12 34.5(10) 98.5(19) 42.9(10) 24.4(11) 11.9(8) -2.9(11) 
C1 51.1(12) 98.2(19) 43.1(11) -24.5(11) 29.4(10) -26.8(12) 
 
Table 4. Bond Lengths for trans-95. 
Atom Atom Length/Å  Atom Atom Length/Å 
O3 C20 1.233(2)  C20 C15 1.526(2) 
O2 C9 1.233(2)  C2 C1 1.508(3) 
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O1 C2 1.227(2)  C3 C4 1.529(2) 
O4 C13 1.227(2)  C3 C8 1.526(2) 
N2 C9 1.339(2)  C14 C15 1.528(2) 
N2 C10 1.460(2)  C14 C19 1.526(2) 
N2 C11 1.460(2)  C13 C12 1.507(3) 
N4 C20 1.337(2)  C15 C16 1.536(2) 
N4 C21 1.460(2)  C16 C17 1.528(2) 
N4 C22 1.460(2)  C4 C5 1.536(2) 
N3 C14 1.457(2)  C17 C18 1.526(3) 
N3 C13 1.337(2)  C5 C6 1.529(2) 
N1 C2 1.337(2)  C8 C7 1.524(3) 
N1 C3 1.458(2)  C6 C7 1.526(3) 
C9 C4 1.526(2)  C19 C18 1.522(3) 
 
Table 5. Bond Angles for trans-95. 
Atom Atom Atom Angle/˚  Atom Atom Atom Angle/˚ 
C9 N2 C10 118.15(14)  N3 C14 C15 109.97(13) 
C9 N2 C11 124.64(14)  N3 C14 C19 110.64(13) 
C11 N2 C10 116.97(15)  C19 C14 C15 110.72(13) 
C20 N4 C21 118.25(14)  O4 C13 N3 123.62(16) 
C20 N4 C22 124.65(14)  O4 C13 C12 121.34(16) 
C22 N4 C21 116.88(15)  N3 C13 C12 115.03(16) 
C13 N3 C14 122.54(14)  C20 C15 C14 111.37(13) 
C2 N1 C3 122.47(14)  C20 C15 C16 107.18(13) 
O2 C9 N2 120.92(15)  C14 C15 C16 110.55(13) 
O2 C9 C4 120.17(15)  C17 C16 C15 111.58(14) 
N2 C9 C4 118.71(14)  C9 C4 C3 111.36(13) 
O3 C20 N4 120.93(15)  C9 C4 C5 107.14(13) 
O3 C20 C15 120.09(15)  C3 C4 C5 110.58(13) 
N4 C20 C15 118.77(14)  C18 C17 C16 110.71(14) 
O1 C2 N1 123.62(16)  C6 C5 C4 111.47(14) 
O1 C2 C1 121.38(16)  C7 C8 C3 111.74(14) 
N1 C2 C1 114.98(16)  C7 C6 C5 110.80(14) 
N1 C3 C4 109.90(13)  C8 C7 C6 109.77(14) 
N1 C3 C8 110.62(13)  C18 C19 C14 111.75(14) 
C8 C3 C4 110.73(13)  C19 C18 C17 109.86(14) 
 
Appendix 
 
252 
 
Table 6. Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement Parameters (Å2×103) for 
trans-95. 
Atom x y z U(eq) 
H3 2658.63 2875.04 4315.81 39 
H1 842.08 376.99 5682.62 39 
H3A 2069.8 63.47 5123.61 35 
H14 4444.69 2564.42 4875.22 35 
H15 3493.3 2393.26 5811.49 34 
H16A 5380.96 2404.93 6487.41 42 
H16B 4875.51 2304.97 7020.32 42 
H4 181.31 -106.13 4186.86 34 
H21A 4512.15 6959.91 6568.43 60 
H21B 3771.46 7057.74 6848.69 60 
H21C 3531.1 7355.78 5913.42 60 
H17A 5393.87 -115.12 6889.69 45 
H17B 4352.2 -118.38 6497.31 45 
H10A 124.24 4854.12 4086.93 60 
H10B -579.69 4560.4 3154.01 60 
H10C 438.92 4456.28 3424.19 60 
H5A 353.99 -193.01 2977.56 42 
H5B 1392.69 -93.78 3510.42 42 
H8A 2043.66 -2356.38 5639.73 42 
H8B 1007.21 -2440.95 5087.11 42 
H6A 353.33 -2616.23 3501.44 45 
H6B 1001.79 -2614.93 3108.4 45 
H7A 1681.41 -3816.72 4432.07 47 
H7B 2234.86 -2387.05 4439.48 47 
H19A 3419.74 57.92 4911.38 42 
H19B 3903.79 143.88 4359.19 42 
H18A 5294.32 115.67 5558.89 47 
H18B 4748.94 -1315.12 5565.85 47 
H11A -936.92 1032.2 3366.18 77 
H11B -1343.17 2662.68 3248.77 77 
H11C -890.73 1912.28 4136.91 77 
H22A 2470.1 4423.99 5864.4 77 
H22B 2915.05 5156.81 6757.05 77 
H22C 3195 3527.31 6627.28 77 
H12A 2186.68 4840.22 2807.42 92 
H12B 1737.88 3526.3 3056.54 92 
H12C 2011.26 3271.55 2351.69 92 
H1A 2159.47 773.37 7647.11 92 
H1B 1180.79 1025.31 6941.98 92 
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H1C 1877.65 2340.99 7190.39 92 
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